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1. ABSTRACT 
Prominin-1 is a lipid raft–associated, cholesterol-binding membrane glycoprotein 
selectively associated with plasma membrane protrusions and extracellular vesicles 
derived therefrom. Despite its worldwide use for stem cell isolation and its clinical 
importance in cancer-initiating cells and photoreceptor morphogenesis the function of 
prominin-1 remains elusive. This prompted me to investigate its role in the architecture 
and dynamics of microvilli and primary cilia at the apical plasma membrane of Madin-
Darby canine kidney (MDCK) cells. Therefore, stably transfected cell lines were 
established expressing human prominin-1 splice variant 1 or 2.  
Upon the overexpression of prominin-1 the number of individual microvilli and 
clusters of them increased significantly. I also noticed alterations in their architecture, 
i.e. branching microvilli. Fascinatingly, two point mutations (Pro37→Ala and Tyr41→Ser) 
in the ganglioside GM1-binding motif of prominin-1 increased the number of branched 
microvilli and generated irregular ones with knob-like structures at their tip. 
Additionally, the release of prominin-1+ vesicles was impaired. Interestingly, both 
phenotypes were suppressed by the inhibition of the phosphoinositide 3-kinase (PI3K) 
or the Arp2/3 complex. Impaired interaction of prominin-1 with the PI3K through the 
introduction of an additional mutation (Tyr828→Phe) in its PI3K-binding site also reduced 
the amount of structurally altered microvilli. Thus, the interaction of prominin-1 with 
the PI3K may drive the conversion of the docking phospholipid 
phosphatidylinositol(4,5)-bisphosphate into phosphatidylinositol(3,4,5)-trisphosphate 
resulting in the uncoupling of the microvillar membrane from the underlying actin 
filaments thereby creating irregular/knob-like microvilli. Simultaneously, the phospholipid 
conversion might modulate the activity of regulators and/or activators of the Arp2/3 
complex leading to the branching of microvilli.  
The overexpression of human prominin-1 also increased the length of primary cilia. 
Remarkably, a mutation in the histone deacetylase 6-binding site that mimics acetylation 
produces shorter cilia in cells expressing human prominin-1.s2. Additionally, it stimulates 
membrane vesicle release and dome formation. Above these striking observations, I 
observed branching cilia and cilia with a pearling shape. 
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Collectively, the data suggest that a complex interplay of prominin-1 with its lipid 
and protein interaction partners regulates the architecture and dynamics of cellular 
protrusions. 
Finally, a growing number of studies use canine prominin-1 as an antigenic marker 
despite the absence of specific antibodies. Studies investigating its expression in dog 
tissues or cells derived therefrom rely on antibodies directed against its human and 
murine orthologs. To determine its cross-species immunoreactivity I cloned canine 
prominin-1 and overexpressed it as a green fluorescent protein fusion protein in MDCK 
cells. Here, I show that the genomic structure of the canine prom1 gene is similar to that 
of human and mouse. Canine prominin-1 shows the common characteristics of the 
prominin-1 family but the primary structure is poorly conserved. Like human and mouse 
protein, it is targeted to the apical membrane of MDCK cells and specifically enriched in 
microvilli and primary cilia. Immunocytochemistry, flow cytometry and immunoblotting 
techniques revealed that none of the applied antibodies against human or mouse 
prominin-1 recognizes the canine protein. 
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2. ZUSAMMENFASSUNG 
 
Prominin-1 ist ein cholesterinbindendes Membranglykoprotein, welches sich bevorzugt 
in Lipid Rafts von Plasmamembranausstülpungen und davon abstammenden Vesikeln 
anreichert. Trotz der weltweiten Verwendung von Prominin-1 bei der 
Stammzellisolierung und seiner klinischen Relevanz für krebsauslösende Zellen sowie für 
die Photorezeptormorphogenese ist seine Funktion bisher nicht genau bekannt. 
Aufgrund dessen beschloss ich die Rolle von Prominin-1 in der Architektur und 
Dynamik der Mikrovilli und primären Zilien auf der apikalen Plasmamembran von 
MDCK-Zellen zu untersuchen. Dafür wurden stabil transfizierte Zelllinien etabliert, 
welche die Splicevarianten 1 oder 2 des humanen Prominin-1 exprimieren. 
Die Überexpression von Prominin-1 verursachte einen signifikanten Anstieg der 
Anzahl einzelner Mikorovilli und Mikrovillicluster. Ich stellte ebenfalls Veränderung in 
ihrer Architektur fest, d.h. einige Mikrovilli wiesen Verzweigungen auf. Die Erzeugung 
zweier Punktmutationen (Pro37→Ala und Tyr41→Ser) in der Gangliosid GM1-bindenden 
Region von Prominin-1 bewirkte einen Anstieg der Anzahl verzweigter Mikrovilli und 
generierte Mikrovilli mit unregelmäßiger Form und erweiterter Spitze. Die Abgabe von 
Prominin-1+ Vesikeln von diesen Mikrovilli war beeinträchtigt. Durch die Hemmung der 
Phosphoinositid-3-kinase (PI3K) oder des Arp2/3-Komplexes konnte die Ausbildung 
beider Phänotypen unterdrückt werden. Die Einführung einer weiteren Mutation 
(Tyr828→Phe) in der PI3K-bindenden Region zur Störung der Interaktion von Prominin-1 
mit der Kinase reduzierte ebenfalls die Anzahl strukturell veränderter Mikrovilli. 
Demzufolge scheint die Interaktion von Prominin-1 mit der PI3K die Umwandlung des 
Phospholipids Phosphatidylinositol-4,5-bisphosphat in Phosphatidylinositol-3,4,5-
trisphosphat zu stimulieren. Dies führt vermutlich zum Abkoppeln der 
Mikrovillimembran von den darunterliegenden Aktinfilamenten und somit zur 
Ausbildung unregelmäßiger Mikrovilli mit erweiterter Spitze. Gleichzeitig scheint die 
Phospholipidumwandlung dazu zu führen, dass Regulatoren und/oder Aktivatoren des 
Arp2/3-Komplexes angesteuert werden und so die Verzweigung von Mikrovilli 
hervorrufen. 
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Weiterhin führte die Überexpression von Prominin-1 zum Anstieg der Länge der 
primären Zilien. Interessanterweise resultierte das Einbringen einer Mutation in die 
Histon-Deacetylase 6-bindende Region von Prominin-1.s2 in sehr viel kürzeren Zilien. 
Diese Mutation ahmt die Acetylierung von Prominin-1 nach und stimulierte die Abgabe 
von Prominin-1+ Vesikeln sowie die Ausbildung von ‘Domes’. Außerdem traten 
verzweigte Zilien sowie solche mit perlschnurartiger Form auf.  
Zusammenfassend zeigen diese Daten, dass ein komplexes Zusammenspiel von 
Prominin-1 mit seinen Interaktionspartnern (Lipide und Proteine) die Architektur und 
Dynamik von zellulären Ausstülpungen reguliert. 
Abschließend habe ich die artübergreifende Immunoreaktivität des Prominin-1 aus 
dem Hund untersucht. Eine wachsende Anzahl an Studien benutzt dieses Protein als 
Marker obwohl keine spezifischen Antikörper dagegen erhältlich sind. Alle Studien, die 
die Expression von Prominin-1 in Geweben oder Zellen aus dem Hund untersuchten, 
verwendeten Antikörper, welche gegen das humane oder murine Ortholog gerichtet 
sind. Für meine Studie habe ich zunächst Prominin-1 aus dem Hund kloniert und als 
GFP-Fusionsprotein in MDCK-Zellen überexprimiert. Ich konnte zeigen, dass die 
genomische Struktur des Prominin-1 aus dem Hund der von Maus und Mensch ähnelt. 
Des Weiteren weist Prominin-1 aus dem Hund die allgemeinen Merkmale dieser 
Proteinfamilie auf, aber die Primärstruktur ist nur schwach konserviert. Ebenso wie das 
humane und murine Protein wird auch Prominin-1 aus dem Hund zur apikalen Membran 
transportiert, wo es sich spezifisch in den Mikrovilli und primären Zilien der MDCK-
Zellen anreichert. Durch immunzytochemischen Methoden, Durchflusszytometrie sowie 
Western Blot konnte ich nachweisen, dass keiner der angewendeten Antikörper gegen 
humanes oder murines Prominin-1 das Protein aus dem Hund erkennt. 
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3. INTRODUCTION 
3.1. Cell Polarity 
Cell polarization is the generation of cellular asymmetry in shape, structure and 
function. All cell types polarize, at least transiently, during division or to generate 
specialized shapes and functions. Hereafter, I will describe three classical examples. 
First, migratory cells, such as leukocytes and fibroblasts, can be activated by 
external stimuli. Thereupon, a plethora of signaling molecules at their membrane 
responds and subsequently activates the cellular motility machinery. As a result, cells 
develop a defined front called the leading edge (Fig. 1A), where actin polymerization and 
new surface attachment take place. In the rear of the cells, the uropod, adhesions are 
disassembled and stress fibers contract to pull the trailing edge for directed migration1, 2. 
Establishing a specific front and rear is crucial for cell motility and hence for processes 
such as embryonic development3, 4, wound healing5, 6 and immune responses7, 8.  
Second, polarized neurons assemble functional networks in the complex vertebrate 
nervous system (Fig. 1B)9, 10. They receive signals from neighboring cells at postsynaptic 
densities of multiple branched, cellular extensions called dendrites. The electric potential 
is integrated along the somatodendritic compartment to trigger an action potential that 
is further propagated along the axonal compartment to the synapse. There, the 
electrical signal is converted into a chemical signal by the release of synaptic vesicles 
containing neurotransmitter. They trigger either changes in membrane potential or 
initiate signaling cascades in the recipient neuron or effector cell (e.g., muscle or gland). 
Thus, the polarity of neurons facilitates directional flow of information, which is 
required for communication. 
Third, epithelial cells, on which I will focus in the following chapters, have a defined 
apicobasal polarity (Fig. 1C). Their apical membrane faces the outside of the body or the 
lumen of internal cavities. Their basolateral membrane contacts neighboring cells and 
the underlying extracellular matrix.11, 12 Junctional complexes form at the interface of 
these regions and are important for maintaining directional transport of nutrients, ions 
and waste products, as well as for secretory and protective functions of epithelial cells. 
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Fig. 1 Cell polarization. 
(A-C) Examples of polarized cells 
highlight the multiplicity of cell 
polarity. Cell polarization results 
from the coordinated regulation of 
several cell functions, most 
important actin and microtubule 
dynamics. (A) In a migrating cell, the 
actin cytoskeleton promotes 
extension of the leading edge and 
retraction of the rear of the cell 
(uropod). The microtubule system 
associated with the centrosome 
aligns along the direction of 
migration.13 (B) Neurons undergo 
complex morphological 
rearrangements to assemble into neuronal circuits and propagate signals. They start as round neuronal 
spheres that gradually adopt an elaborate structure by forming one long axon and several shorter 
dendrites to eventually connect to other neurons via synapses.14 (C) In differentiated epithelial cells, the 
entire cell organization is polarized and allows the segregation of apical and basolateral proteins and 
membrane domains separated by tight junctions (TJ). The intracellular organization is also characterized 
by polarized cytoskeletal structures and membrane traffic.15 
 
3.2. The Plasma Membrane 
The morphological polarization of the cells described in chapter 3.1 is the result of an 
asymmetric distribution of cellular components starting with lipids and proteins in the 
plasma membrane16-18. In order to understand these complex processes a preface on the 
structure and function of the plasma membrane is mandatory. 
The mammalian plasma membrane is about 5-10 nm thick and composed of a 
heterogeneous and dynamic mixture of lipids and proteins. Singer and Nicolson laid the 
basis for our understanding of its structure and function in 197219, 20. Grounded on their 
fluid mosaic model we comprehend the plasma membrane as a lipid bilayer composed of 
phospholipid molecules that constitute the matrix and alternate with peripheral and 
integral proteins (Fig. 2). The phospholipids consist of a head that is attracted to water 
(hydrophilic) and a tail that repels water (hydrophobic). Such molecules with two 
different affinities are called amphipathic. The phospholipid bilayer structure illustrates 
the combined effects of hydrophobic and hydrophilic interactions. The nonpolar fatty 
acid chains are sequestered together spontaneously to form bilayers. They are held 
together by van der Waals forces, thereby maximizing hydrophobic interactions19. In 
contrast, the head groups are in direct contact with the aqueous phase. They form 
INTRODUCTION 
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hydrogen bonds at the outside of the bilayer, thereby maximizing hydrophilic 
interactions. Integral proteins are also postulated to be amphipathic. For example, they 
can be comprised of a highly polar end with clustered ionic amino acids and covalently 
bound saccharides and a nonpolar region. The polar end will contact the aqueous phase 
while the nonpolar region will be embedded in the interior of the membrane21. Since 
biological membranes are held together only by noncovalent interactions, lipids and 
proteins can diffuse quickly in the plane of the membrane22-24. However, the mobility of 
membrane proteins is often limited by extracellular restrictions such as binding to the 
extracellular matrix, formation of large protein complexes or domains with high protein 
concentration. Additionally, transient confinement by the cytoskeleton can also 
immobilize proteins or contribute to directed movement25. 
The constituents of the plasma membrane will be described in greater detail in the 
context of epithelial cells in chapter 3.6 and 3.7.  
 
 
 
 
Fig. 2 Structure of the plasma membrane.  
According to the fluid mosaic model of Singer and Nicolson (1972) biological membranes can be 
considered as a two-dimensional liquid in which lipid and protein molecules diffuse more or less easily. 
The amphipathic phospholipids self-assemble into a bilayer that can contain different kinds of proteins, 
e.g., channels and receptors, responsible for various biological activities. Cholesterol is the essential 
structural component of all animal membranes. It is required for membrane integrity and rigidity. Plasma 
membranes also contain carbohydrates, predominantly glycoproteins and some glycolipids. Cytoskeletal 
components associated with the membrane can influence the mobility and distribution of membrane 
proteins.  
 
 
www.wikipedia.de 
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The plasma membrane serves as an important cellular barrier. At the same time, it is an 
active interface between the cell and its environment. Extracellular signals in the form of 
ions, hormones, enzymes, growth and motility factors are integrated via membrane 
components and subcellular cytoplasmic structures to initiate signaling processes. 
Therefore, the plasma membrane helps to selectively transmit signals and substances 
from the outside or adjacent cells while releasing signaling molecules and other factors 
into its microenvironment26. Simultaneously, it undergoes constant turnover of its 
constituents. Furthermore, the plasma membrane guides contacts and interacts with 
other cellular structures, maintains cellular polarity and mechanical properties.  
 
3.2.1. Epithelial Plasma Membrane 
Epithelia are ordered layers of uniformly polarized cells that line inner organs, blood 
vessels and the outer surface of animal bodies. They conduct various functions like 
secretion, selective absorption, protection, transcellular transport and sensing. Epithelia 
provide a paradigm of cell polarization and explicitly illustrate the intimate connection 
between morphology and function. Their formation is governed by the organization of 
individual cell membrane domains and cell-cell junctions via interactions of membrane 
proteins and the cytoskeleton. The acquisition of apicobasal polarity is essential for 
normal epithelial cell shape, proliferation, organization and function, as well as for the 
maintenance of tissue architecture27.  
The apical plasma membrane of epithelial cells contains unique proteins and lipids, 
such as partitioning defective (PAR) 3/6, atypical protein kinase C (aPKC), the Crumbs 
complex, gp135 and phosphatidylinositol 4,5-bisphospate (PIP2), which are not found on 
basolateral membranes12, 28. With its specific set of molecules this membrane mediates 
many functions specific to epithelial cells. The apical membrane is particularly robust due 
to its enrichment in sphingolipids and cholesterol29 and faces a constant and rapid 
turnover by endocytosis30, 31. Another characteristic is its compartmentalization into 
planar and protruding subdomains, namely primary cilia and microvilli, which will be 
described in section 3.3 and 3.4.  
The basolateral membrane also harbors specific lipids and proteins, such as the 
Scribble complex, insulin receptors, adenylate cyclase, Na+-K+-adenosine triphosphatase 
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(ATPase), Neurexin IV and phosphatidylinositol 3,4,5-trisphosphate (PIP3). It contacts 
neighboring cells and the underlying extracellular matrix through cell adhesion 
molecules such as cadherins, dystroglycans and integrin receptors.  
Specialized junctions occur at points of cell-cell and cell-matrix contact (Fig. 3A). 
Sealing junctions, i.e. tight junctions (septate junctions in invertebrates), are formed 
between the apical and basolateral domains. Epithelial cells also develop adherens 
junctions, which are based on calcium-dependent cell adhesion molecules (cadherins) 
and serve as bridges connecting the actin cytoskeleton of neighboring cells. 
Desmosomes connect the lateral membranes of adjacent cells. Specialized intercellular 
connections, called gap junctions, directly connect the cytoplasm of adjacent cells 
allowing various molecules, ions and electrical impulses to directly pass through. In 
addition, hemidesmosomes connect the basal face of a cell to the basal lamina by the use 
of integrins. They all limit the paracellular permeability of fluids and ions between the 
lumen and the interstitium32. These cell-cell interactions are particularly important for 
the establishment of polarity. Wang et al. have shown that cell-cell contact is sufficient 
to trigger the correct segregation of apical and basal proteins to their corresponding 
domains33.  
The development of epithelial polarity is conducted by multiple distinct but 
interacting groups of proteins, namely the PAR, Crumbs and Scribble complexes12, 34. In 
mammals, the PAR complex comprises two scaffold and adapter proteins that contain 
PDZ domains (PAR3 and PAR6), aPKC and GTPase Cell Division Control protein 42 
homolog (Cdc42). The Crumbs complex involves the transmembrane protein Crumbs 
and the scaffold proteins Protein Associated with Lin7 (PALS1) and PALS1-assosiated 
tight-junction protein (PATJ). The Scribble complex consists of Scribble, discs-large 
(DLG) and lethal giant larvae (LGL)12. While the PAR and Crumbs complexes define the 
apical membrane Scribble marks the basolateral domain (Fig. 3B). Interactions between 
these functional modules generate zones of mutual exclusion around tight junctions, 
thereby constituting the apicobasal polarity (see legend of Fig. 3)34. All of these 
complexes are also important for the formation and/or stabilization of cell-cell 
junctions35-39.  
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Fig. 3 Structure of a polarized epithelial cell (A) and protein complexes involved in 
establishing its polarity (B).  
(A) Features of a polarized epithelial cell and its diverse junctions are shown. The apical plasma membrane 
(blue), which harbors microvilli (MV) and a primary cilium (PC), is separated from the basolateral domain 
(pink) by tight junctions (TJ). Adherens junctions (AJ) bridge neighboring plasma membranes and are 
located more basal than TJ. Desmosomes (D) are spot-like adhesions randomly arranged on the lateral 
side of the plasma membrane. Gap junctions (GJ) directly connect the cytoplasm of adjacent cells, while 
hemidesmosomes (HD) attach the cell to the extracellular matrix.40 (B) The Crumbs (Crumbs-3, PALS1, 
PATJ), PAR (PAR3/6, aPKC) and Scribble (Scribble, LGL, DLG) complexes are responsible for initiating 
apical-basolateral polarity. First, Crumbs interacts via its PSD95/Dlg1/Zo-1 (PDZ)-binding domain with 
PALS1, which binds PATJ. PAR6 and PAR3 act as scaffolding proteins and bind one another via their PDZ 
domains. Interaction of PAR6 with Cdc42-GTP relieves the inhibition of aPKC enabling the kinase to 
phosphorylate PAR3. Upon phosphorylation PAR3 moves to the adherens junction and PAR6 is free to 
bind Crumbs or LGL. PAR6 binding to LGL also enables it to be phosphorylated by aPKC, which is 
important for its lateral membrane localization. Scribble and DLG are important for cell-cell adhesion via 
adherens junctions and play a significant role in regulating planar cell polarity41.  
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3.2.2. Epithelial Membrane Traffic 
To generate distinct apical and basolateral domains, epithelial cells are able to control 
the protein and lipid composition of their membrane in time, location and in response 
to signaling pathways. This polarity must be maintained during the lifetime of an 
epithelium, which faces constant membrane turnover and remodeling. The transport of 
lipids and proteins between internal membranes and the plasma membrane by polarized 
trafficking provides the basis for its heterogeneous and dynamic composition. The 
trafficking machinery is composed of secretory organelles, e.g., the endoplasmic 
reticulum (ER), Golgi complex and various endosomal compartments42-44. In general, 
newly synthesized proteins travel from the ER to the Golgi and through the trans-Golgi 
network (TGN), where they are sorted into distinct transport vesicles45-47(Fig. 4). The 
TGN is considered to be a major site for sorting apical from basolateral proteins48. 
However, some proteins, e.g., galectins, serglycin or ciliary polycystin-2, avoid the TGN 
entirely and are secreted by a non-canonical bypass pathway49, 50. The transport vesicles 
from the TGN are delivered to the appropriate cell surface domain, where their lipid 
and membrane protein content is incorporated into the plasma membrane and their 
internal cargo is released into the extracellular environment (exocytosis)51. Most of the 
proteins take a detour to one or more endosomal compartments that may also 
modulate their function or conformation52, 53. The decoding machinery that recognizes 
some of the sorting signals localizes to endosomes and ensures polarized delivery to the 
cell surface44. A direct route from the TGN to the cell surface is only known for 
basolateral proteins, but is also hypothesized for apically secreted soluble proteins54. 
In addition of being targeted directly to their sites of functional residence, proteins 
can also be randomly delivered and retained only in the correct compartment by 
interactions with cytoskeletal components or through other mechanisms that effectively 
immobilize the protein.  
Moreover, some proteins such as the polymeric immunoglobulin receptor or the 
neuron glia cell adhesion molecule are first delivered to the apical or basolateral 
membrane and resorted to the opposite membrane domain after endocytosis. This 
process is called transcytosis. The internalized proteins need to reach the recycling 
endosomes for resorting55. The recycling endosomes consist of different domains 
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involved in apical or basolateral targeting named apical and common recycling 
endosomes, respectively52.  
Endocytosis and the endocytic recycling pathways play important roles in epithelial 
polarization and the appropriate localization of key polarity proteins56. Upon 
internalization, proteins enter peripherally localized apical or basolateral early 
endosomes57. From there they are sorted for rapid recycling to the plasma membrane, 
for transcytosis or for transport to the lysosome and final degradation. 
 
 
 
Fig. 4 Membrane trafficking 
pathways in polarized epithelial 
cells. 
Newly synthesized proteins and lipids are 
transported from the endoplasmic 
reticulum (ER) to the trans-Golgi network 
(TGN, 1). From there, they take either 
direct routes to the apical (2) or 
basolateral (3) surfaces, or indirect routes 
via the apical recycling endosome (ARE, 4), 
the apical early endosome (AEE, 5a/b) or 
the common recycling endosome (CRE, 6). 
Proteins and lipids can also be internalized 
from the apical (7a) and basolateral (7b) 
membranes followed by delivery to AEE or 
basolateral early endosomes (BEE). 
Afterwards, they can recycle to the cell 
surfaces (8a/b) or travel to the CRE (9a/b). 
From the latter they can be sorted for 
transport to multivesicular bodies (MVB, 
10) for final transfer to lysosomes (not 
shown). CRE cargos can also be shuttled to 
the basolateral surface (11) or the ARE 
(12), from where they gain access to the 
apical surface.  
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3.2.3. Epithelial Cell Polarity and Disease 
Healthy tissues exist in a dynamic equilibrium of proliferation, cell death, tissue 
morphogenesis and differentiation. This complex balance can be perturbed by the failure 
to generate or maintain epithelial polarity, which is leading to altered function and to 
severe pathologies. In the following I will give a brief insight into well-studied examples.  
The loss of epithelial polarity by deregulated expression of polarity proteins can 
result in uncontrolled proliferation and loss of normal tissue organization, which are 
defined hallmarks of cancer58-60. For example, PAR6 is overexpressed in breast and lung 
cancer61. Overexpression of aPKC is observed in ovarian, pancreatic and lung cancers62. 
In contrast, PAR3 expression is significantly reduced or lost in esophageal cancer cells, 
glioblastoma and lung cancer patients59, 63. PATJ is downregulated in colon, breast and 
cervical cancers64. The Scribble proteins are consistently lost or mislocalized in multiple 
cancers including lung, prostate, breast and colon cancer62. Despite that, there are also 
many evidences that polarity proteins can act as tumor suppressors65-67 highlighting the 
context- and cell-specific roles of polarity proteins.  
In juvenile and adult cystic kidney diseases loss of epithelial polarity is a common 
issue. Cystic kidney disease appears in a heterogeneous group of genetic disorders that 
are characterized by dilated or cystic kidney tubular segments. These symptoms can be 
accompanied by a variety of abnormalities in the kidney or other tissues. The highly 
ordered apicobasal polarization of the epithelia lining renal tubules is essential for the 
unidirectional vectorial transport of ions and fluids. It provides the basis for appropriate 
regulated reabsorptive and secretory function of the normal kidney. The missorting of 
transporters, channels and receptors to the wrong cell surface membrane or their 
accumulation in the cytoplasm has been implicated in many diseases68-73. The Autosomal 
Dominant Polycystic Kidney Disease (ADPKD) is one of the most common of all 
inherited cystic kidney diseases and is caused by the reduction in normally functioning 
polycystin-1 or polycystin-2. In ADPKD, renal cystic dilation is due to increased cell 
proliferation accompanied by apical secretion of fluid. Furthermore, epithelia from 
patients with ADPKD show thickened basal membranes, alterations in matrix 
composition, and abnormal numbers of integrin receptors74. The polarity defects include 
mislocalization of normally basolateral situated membrane proteins to apical membranes 
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such as the activated epidermal growth factor receptors and Na+K+-ATPase-α-subunit. 
Furthermore, apical membrane proteins, like the Na+K+2Cl- cotransporter, are 
mislocalized to basolateral membranes. The trafficking and insertion of proteins into 
membranes can also be impaired and results in their intracellular accumulation as seen 
for epithelial (E)-cadherin and the β−1 subunit of Na+K+-ATPase. The junctional 
complexes such as adherens junctions, desmosomes and basal cell-matrix adhesions 
(focal adhesions) are also functionally and structurally abnormal. For instance, E-cadherin 
is lost from adherens junctions where it is replaced by its embryonic isoform, neural 
(N)-cadherin. In addition, E-cadherin is internalized and mislocalized to the apical plasma 
membrane. The protein composition of focal adhesions is also deficient in ADPKD 
epithelia due to loss of focal adhesion kinase from integrin/polycstin-1-containing 
macromolecular complexes. The loss of phosphorylation of these complexes leads to 
altered epithelial cell shape, adhesion and migration75. 
Hepatocytes are the main functional cells of the liver and perform an astonishing 
number of metabolic, endocrine and secretory functions. They have a unique 
polarization arrangement in which two adjacent cells contribute parts of their apical 
plasma membrane to form one or more capillary-like structures, the bile canaliculus. 
Tight junctions functionally seal the canaliculi. Microvilli project sparsely into bile 
canaliculi but are abundantly present on the face contacting the sinusoids, small blood 
vessels. Defects in hepatocyte polarization lead to major pathophysiological 
consequences. For example, disruption of tight junctions by mutations in tight junction 
protein-2 or claudin1 causes severe liver diseases. This is presumably caused by 
increased paracellular permeability resulting in bile regurgitation. Furthermore, many 
patients with mutations in the gene encoding Myosin 5b, which causes Microvillus 
Inclusion Disease, also manifest cholestasis and progressive liver disease. The 
mislocalization of ABCB11, a canalicular bile acid transporter, and Rab11a, an adaptor 
protein of the recycling endosome, might be responsible for this. Loss of function 
mutations in genes encoding recycling endosome-associated proteins such as Myosin 5b, 
VPS33B and VIPAR result in the Arthrogryposis, Renal dysfunction and Cholestasis 
syndrome. This demonstrates the importance of the recycling endosome for the 
establishment and maintenance of hepatocyte polarity.  
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3.3. Cilia 
In the last 15 years a complex plasma membrane protrusion, called the cilium, has 
emerged as a key organelle in numerous physiological and developmental processes. It is 
highly conserved between eukaryotes and exists in two different types – motile and 
non-motile or primary cilia. On the surface of eukaryotic cells, motile cilia generate 
external fluid flow. They can be present in large numbers or only as single cilium. For 
instance, the airway epithelia possesses many motile cilia, which beat in coordinated 
waves to transport the overlying mucus79. On cells of the ventral node, single motile cilia 
rotate to generate leftward movement, which is important for establishing the left-right 
asymmetry in mammals76, 77. Motile cilia also drive cell motility, e.g., of sperm or ciliates78, 
79. All cilia function as cellular antennae sensing extracellular signals, but the non-
motile/primary cilia seem to have developed to fulfill this one special function only. They 
harbor a wide variety of receptors and signaling molecules and play an important role in 
several signaling pathways such as Hedgehog80, wingless-Int1 (Wnt)81, platelet derived 
growth factor signaling82, planar cell polarity (PCP)83, sensory perception (rhodopsin84 
and odorant receptors localize to cilia85), and mechanical transduction (by polycystin-1 
and -286, 87). In the following I will focus on these exceptional organelles.  
 
3.3.1. Structure of Primary Cilia 
Non-motile cilia were first observed by Zimmerman more than a century ago88 and 
named ‘primary cilium’ by Sorokin in 196889. The average primary cilium is about 1-10 
μm long and its basic structure is conserved across species and cell types. It comprises a 
ciliary membrane, whose lipid and protein composition is distinct from that of the 
plasma membrane. The ciliary membrane is highly enriched in sterols, glycolipids and 
sphingolipids90, and accumulates various signaling receptors such as the SSTR3 isoform 
of the somatostatin receptor91, 92, the 5-HT6 serotonin receptor91, polycystin-193, 
polycystin-294, fibrocystin95 and smoothened96. It surrounds the axoneme that consists of 
a ring of 9 microtubule doublets nucleated at the basal body (Fig. 5). The basal body 
includes a mother centriole with 9 triplet microtubules and associated pericentriolar 
material. The triplets are converted into axonemal doublets, which are specialized 
structures composed of one complete microtubule (A tubule) linked to an incomplete 
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second microtubule with fewer protofilaments (B tubule; Fig. 5)97. In contrast to motile 
cilia (9+2 pattern) primary cilia lack the central pair of singlet microtubules (9+0 
pattern). Nevertheless, exceptions of this rule exist. For example, motile monocilia of 
the ventral node lack the central pair while kinocilia of hair cells contain the central 
microtubules, but are non-motile. Beyond its structural role, the axoneme serves as the 
track for the intraflagellar transport (IFT) system (Fig. 5)98. The IFT machinery harbors 
two modules named IFT subcomplexes A (for retrograde transport) and B (for 
anterograde transport). They bridge ciliary proteins to the motors kinesin-2 
(anterograde) and dynein-2 (retrograde) that actively transport them along the axoneme 
whereby anterograde IFT trains move along B-tubules, and retrograde trains move along 
A-tubules99. The IFT trains associate with the BBSome, a complex of seven Bardet-Biedls 
syndrome (BBS) proteins that are altered in the multi-organ syndrome of the same 
name. The BBSome facilitates the transport of key cargo within cilia by acting as an 
adaptor protein for the IFT complexes. Together the IFT and the BBSome mediate the 
dynamic trafficking of structural and signaling proteins of the primary cilium100.  
The transition zone (TZ) describes a complex that is characterized by a short 
repeating pattern of Y-shaped structures that connect the axoneme to the overlying 
‘ciliary necklace’, which is located distal to the basal body (Fig. 5)101. The ‘ciliary necklace’ 
designates the presence of particles circumferentially decorating the ciliary membrane, 
which was revealed by transmission electron microscopy102. Transition fibers at the 
proximal end of the TZ form a pin-wheel-like structure and make contacts with the 
base of the ciliary membrane helping to form, together with the TZ, a gate that prevents 
uncontrolled entry into the cilium (see chapter 3.3.2). Importantly, transition fibers also 
serve as docking sites for the IFT machinery and are positioned to accept incoming 
vesicle-bound signaling proteins prior to ciliary entry100, 103, 104. Vesicle docking and fusion 
occurs at the periciliary membrane (between TZ and basal body) or at the ciliary 
pocket, a curved invagination of the plasma membrane originating from the cytosolic 
biogenesis of the primary cilium (see chapter 3.3.3.)105. 
The detailed structure of cilia appears to be critically important for normal 
physiology and the timing of signaling since any alteration can lead to diverse disorders 
collectively called ciliopathies (see chapter 3.3.4.). 
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Fig. 5 Evolutionarily conserved 
components of a ciliary organelle. 
The centriole-derived basal body connects 
to the plasma membrane using transition 
fibers. These fibers serve as docking sites 
for the intraflagellar transport (IFT) 
machinery, which is critical for the 
formation and functional maintenance of 
cilia. The IFT machinery consists of one or 
more kinesin-2 anterograde motors that 
mobilize two ‘core’ IFT subcomplexes (IFT-
A and IFT-B), a BBSome complex and 
associated ciliary cargo. A dynein-2 motor, 
transported to the tip by the anterograde 
IFT machinery (not shown), brings the IFT 
components back to the base. The 
transition zone contains axoneme-to-ciliary 
membrane connectors (typically Y-shaped) 
and serves as a selective membrane diffusion 
barrier (‘gate’). Together, the transition 
fibers, transition zone and IFT machinery 
help to compartmentalize the ciliary 
organelle and dynamically maintain its 
composition. (Cartoon from Ref.106) 
 
 
 
 
 
 
 
3.3.2. Gated Entry into the Primary Cilium 
By organizing signaling components in supramolecular complexes in a highly ordered and 
concentrated microenvironment the cilium allows for rapid, regulatable, and highly 
sensitive signaling. Although the ciliary membrane is continuous with the plasma 
membrane it has a particular protein and lipid composition. Many receptors are 
concentrated in the membrane allowing the primary cilium to sense a wide array of 
signals including light, odors, growth factors and developmental morphogens97. It is also 
highly enriched in the phospholipid phosphatidylinositol 4-phosphat (PIP) in contrast to 
the rest of the apical membrane where PIP2 predominates
90. The enrichment is achieved 
by the inositol polyphosphate-5-phosphatase (Inpp5e) that specifically localizes to the 
primary cilium107. The composition of soluble proteins in the cilium is also unique108, 109. 
Furthermore, a high ciliary concentration of the heteromeric transient receptor 
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potential channel PKD1L1-PKD2L1 results in a ciliary resting calcium concentration that 
is approximately 7-fold higher than that of the cytoplasm110. Thus, gating mechanisms 
must exist to ensure a proper ciliary composition. Ciliary entry takes place at the TZ 
and different mechanisms are described for soluble and membrane proteins.  
The gating process for soluble proteins has been suggested to utilize, at least in 
part, the same molecules and mechanisms as gated entry into the nuclear 
compartment111. Specifically, it has been hypothesized that nucleoporins, the building 
blocks of the nuclear pore complex (NPC), form a ciliary pore complex at the TZ. The 
idea is based on the observation of a size-dependent permeability barrier at the base of 
the primary cilium in cultured mammalian cells112, 113. The entry is restricted for soluble 
proteins in the 40-70 kDa range, which is reminiscent of the molecular sieve function of 
NPCs. For the gating of large soluble proteins, a ciliary localization sequence (CLS), 
homologous to nuclear localization sequences, was identified for some proteins. For 
example, the kinesin-2 motor KIF17114 and the peripheral membrane protein retinitis 
pigmentosa 2 harbor such signal sequences115. Both CLS motifs are recognized by 
importin-β2 for transport across the ciliary barrier. A RanGTP/GDP gradient drives the 
directionality of transport with the ciliary compartment enriched in RanGTP114, 116.  
Proteins can be highly mobile within the ciliary membrane, but a septin-containing 
barrier restricts the diffusional passage of proteins between the plasma and the ciliary 
membrane117-120. The membrane protein composition is also regulated by a gating 
mechanism at the TZ, which is conducted by two complexes of ciliopathy-associated 
proteins, the nephronopthisis (NPHP) and Meckel-Gruber syndrome/Joubert syndrome 
(MKS/JBTS) modules104, 117, 121. The molecular basis of this gating mechanism is not yet 
completely understood. It has been speculated that the NPHP module helps to nucleate 
the assembly of the Y-shaped structures and to establish the position and appropriate 
length of the TZ. In the MKS module, Cep290 plays a central role in the assembly and is 
also essential for the formation of a functional gate. Loss of Cep290 causes proteins, 
which are normally found at the periciliary membrane, to accumulate abnormally within 
the cilium. Furthermore, ARL-13 enters the TZ and accumulates at the periciliary 
membrane in cep290 mutants. In contrast, ARL-13 is completely excluded from the TZ 
in wild type animals.122 
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3.3.3. Biogenesis and Disassembly 
Most cells assemble primary cilia when they exit the cell cycle and enter a differentiated 
or quiescent state123. Two distinct pathways for primary ciliogenesis are described. 
Cilium biogenesis can be initiated by the attachment of a Golgi-derived membrane 
vesicle on the distal end of the mother centriole. After axonemal growth inside the 
vesicle it fuses with the plasma membrane. Thereby, the cilium is partially released at the 
cell surface and a ciliary pocket is created at its base. Alternatively, the mother centriole 
can directly dock onto the plasma membrane with the help of distal appendage proteins 
of the mother centriole, especially CEP16489, 105, 124-126. The docking is followed by the 
formation of the TZ and the membrane-ensheathed axoneme. Recently, some negative 
modulators of ciliogenesis have been found to be destructed or dislocated from ciliary 
structures at the onset of ciliogenesis. For example, CP110, which localizes to the distal 
ends of centrioles and inhibits microtubule growth127, interacts with Cep290, a hub 
protein connecting a broad network of ciliary proteins. CP110 restrains Cep290 from 
promoting ciliogenesis in proliferating cells. When cells exit the cell cycle CP110 is lost 
and Cep290 released from inhibition128. Likewise, Orofaciodigital syndrome 1 (Ofd1), 
which localizes to centriolar satellites where it interacts with various proteins, promotes 
primary cilia formation when degraded by autophagy129-132. At the same time, trichoplein 
is removed from the mother centriole by the ubiquitin-proteasome system and thereby 
causes Aurora A inactivation leading to ciliogenesis133. 
Structural and functional components are synthesized by ribosomes and 
transported from the cytoplasm to the cilium. Therefore, axoneme assembly and 
elongation requires the coordination of motor-driven IFT, membrane trafficking and 
selective import of cilium-specific proteins97, 100. Multiple mechanisms of ciliary cargo 
delivery exist100, 134. One pathway that is crucial for the delivery of vesicles to the ciliary 
base requires Rab8, Rabin8 and Rab11. Briefly, Rab11 functions in membrane trafficking 
from the TGN and recycling endosomes. In its GTP-bound form it interacts with Rabin8 
and stimulates the guanine nucleotide exchange activity of Rabin8 toward the small 
GTPase Rab8. Rab8 localizes to the cilium and activates vesicle fusion to the ciliary 
pocket135.  
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The balance of ciliary assembly and disassembly determines steady-state ciliary 
length. A negative regulator of ciliary length is the nuclear distribution gene E 
homologue 1 (NdeI) that associates with a dynein light chain protein, named 
DYNLL1/LC8, at the basal body. LC8 is a component of the retrograde IFT. The NdeI-
mediated sequestration of LC8 at the basal body negatively regulates the ability of 
dynein to contribute to cilium formation136. Another protein required for maintaining 
proper ciliary length is the anaphase-promoting complex (APC), a key ubiquitin ligase 
that localizes to the basal body. In complex with Cdc20, the metaphase APC co-
activator, APC negatively regulates ciliary length by destabilizing axonemal microtubules. 
When fully activated this complex leads to ciliary shortening and resorption137.  
In many cells, primary cilia start to disassemble as cells re-enter the cell cycle. An 
important player in ciliary resorption is the Aurora A kinase. Aurora A can be activated 
by the human enhancer of filamentation 1 (HEF1), Pitchfork138 and Ca2+/calmodulin139. 
When activated Aurora A phosphorylates and activates the histone deacetylase 6 
(HDAC6). As a result, HDAC6 destabilizes the axoneme by deacetylating ciliary α-
tubulin leading to the disassembly of cilia140. HDAC6 can also be activated by the polo-
like kinase 1 (Plk1), a key cell cycle regulator. This interaction promotes ciliary 
deacetylation and resorption before mitotic entry141. Plk1 is also reported to stabilize 
HEF1, which enhances ciliary resorption by the HEF1–Aurora A–HDAC6 pathway142. 
Moreover, Plk1 can phosphorylate Kif2A, a member of the human kinesin-13 family 
proteins. The phosphorylation of Kif2A leads to the depolymerization of microtubules 
and the disassembly of the primary cilium143. Another player in the regulation of ciliary 
resorption is T-complex testis expressed 1 (Tctex-1), a light chain subunit of 
cytoplasmic dynein. When Tctex-1 dissociates from the dynein complex it activates local 
F-actin polymerization. These actin rearrangements might trigger a cascade of cellular 
events that coordinately resorb the cilia and modify the basal body144. The disassembly 
of primary cilia finishes with the release of the basal body, which is then free to function 
as spindle pole during mitosis145, 146. Another mechanism resulting in the loss of primary 
cilia is deciliation (deflagellation). It involves severing of the axoneme and its associated 
membrane distal to the TZ resulting in the detachment of the cilium from the cell 
body147, 148.  
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There seems to be an inverse relationship between ciliation and cell cycle 
progression. However, there are some exceptional examples of cells that retain cilia 
during cell proliferation. For example, many ciliated protozoans maintain their cortical 
cilia throughout cell division149. Riparbelli and colleagues150 also reported that 
spermatocytes in Drosophila melanogaster possess cilia during two meiotic divisions. 
Therefore, whether a primary cilium negatively controls cell cycle progression has been 
a topic of discussion for a long time. 
 
3.3.4. Ciliopathies 
The pervasiveness and importance of primary cilia for human development and 
physiology is highlighted by a wide spectrum of genetic disorders with ciliary defects. 
They are collectively called ciliopathies and show a variety of deficiencies in the assembly 
or function of the cilium. Abnormal cilia have been attributed to single gene mutations in 
more than 50 gene loci151. These mutations result in broad clinical manifestations from 
organ-specific disorders such as polycystic kidney disease (PKD) and nephronophthisis 
(NPHP) to broad pleiotropic phenotypes such as Bardet-Biedl (BBS) and Alström 
(ALMS) syndromes152. PKD and NPHP majorly result in renal dysfunction due to 
cystogenesis and fibrosis. Both ciliopathies are caused by mutations in ciliary proteins, 
namely PKD1 or PKD2 and nephrocystins, leading to the suppression of canonical Wnt 
signaling153, 154, which is required for normal renal development and maintenance. 
Affected NPHP genes are also often found associated with retinal abnormalities, in 
which the corresponding pathology is known as Senor-Løken syndrome (SNLS)155. 
Another syndrome with renal and retinal abnormalities is the BBS, which in addition 
exhibits obesity, polydactyly, male hypogonadism and learning disabilities152. Most of the 
BBS causative genes encode for proteins of the BBSome or for those required for its 
regulation and assembly. Mutations in these genes lead to perturbations in trafficking of 
cargoes across cilia. ALMS patients also present a number of phenotypes reminiscent of 
BBS, including retinitis pigmentosa, obesity and diabetes, but they can be distinguished 
by the development of significant sensorineural deafness and the absence of 
polydactyly152. Another well-studied ciliopathy is the Joubert syndrome (JBTS), a 
multiorgan disorder with a characteristic hindbrain malformation, along with ataxia and 
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cognitive dysfunction. JBTS is also frequently accompanied by renal and/or retinal 
symptoms. This syndrome is caused by disrupted ciliogenesis or trafficking of 
components essential for defining and maintaining the ciliary compartment 
characteristics155. The most severe multiorgan ciliopathy is the Meckel-Gruber 
syndrome (MKS), characterized by occipital encephalocele, perinatal lethality, renal cysts 
and hepatic ductual malformations. MKS proteins are involved in early ciliogenic events 
that involve establishment of the ciliary barrier or basal body docking156.  
 
3.3.5. Primary cilia and cancer 
Cancer cells are distinguished from normal cells by enhanced proliferation and 
metabolism, loss of polarity control and the potential to invade other tissues of the 
body. Primary cilia have the ability to influence the cell cycle by releasing the basal body 
freeing up the centrioles to function as spindle poles. Furthermore, they modulate a 
variety of signaling cascades. Therefore, dysfunction of cilia has been proposed as a 
prerequisite step of cancer development. In many human cancers, cilia are lost or their 
formation is compromised as in breast cancer, cholangiocarcinoma, melanoma, 
pancreatic cancer, prostate cancer and renal cell carcinoma157-159. These observations 
suggest that cilia might play a suppressive role in cancer development. Nonetheless, the 
relationship between cilia and tumor proliferation is complex and controversial. Some 
studies fail to support the correlation between loss of cilia and tumor development and 
proliferation160. One of the major arguments against a direct role of cilia in 
tumorigenesis is the lack of evident tumor predisposition in patients with classic 
ciliopathies such as SLNS and NPHP158. Perturbations of signal transduction in the 
primary cilium can also lead to cancer. For instance, dysregulated activation of the 
Hedgehog pathway contributes to basal cell carcinoma and medulloblastoma 
development161, 162. Upregulation of Wnt signaling has also been linked to 
tumorigenesis163. Thus, primary cilia can either drive or inhibit tumorigenesis depending 
on the initiating oncogenic event164. It is therefore conceivable that the cell origin, 
genetic background and impaired signaling of tumors must be taken into consideration 
when the relationship between cilia and tumor proliferation is examined160.  
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3.4. Microvilli 
Microvilli are common to all transporting and sensory epithelia, e.g., the inner ear, 
conjunctiva or placenta. Tightly packed microvilli homogeneous in length and width form 
the brush border of the intestine and proximal kidney. They harbor digestive enzymes 
and ion exchangers for the intense absorptive processes performed by intestinal and 
renal epithelia165, 166. Microvilli not only increase the cell surface, but also enable 
asymmetric localization of membrane transporters, cytoskeletal proteins and enzymes of 
various signaling and adhesion pathways (e.g., insulin signaling, dendritic–T cell 
interaction, lymphocyte extravasation, mechanosensation, gut host defense)167-169. Yet, 
little is known about their assembly and regulation. In contrast, their complex molecular 
composition and structure are well studied. Microvilli are thin protrusions consisting of 
20-30 actin bundles that are anchored in the terminal web of the cell. The actin 
filaments undergo constant treadmilling170, a process of polymerization with different 
growth rates at the tip and base. As a result, microvilli comprise a fast-growing plus end 
(tip) and a slow-growing minus end (base). Both ends show a difference in the critical 
concentration of monomers needed for polymerization171. Thus, at steady state a net 
loss of monomers from the base occurs, which is balanced by a net addition to the tip. 
Microvillar growth and shrinkage is controlled by actin-severing and -capping proteins 
such as cofilin172 and eps8173, respectively.174. Actin-bundling proteins including espin, 
villin and plastin-1175 connect actin filaments thereby increasing their structural rigidity 
(Fig. 6)176. The actin core is linked to the overlying membrane by one or more paralogs 
of the ezrin-radixin-moesin (ERM) protein family177, 178 as well as by myosin 1179, 180. ERMs 
are expressed in a developmental and tissue-specific manner, with many epithelial cells 
expressing predominantly ezrin and many endothelial cells expressing predominantly 
moesin178. Myosin I stabilizes microvilli and can exert plus-end-directed force on the 
apical membrane, thereby it promotes intramicrovillar trafficking of membrane lipids and 
proteins ultimately resulting in the release of vesicles from the tips169. The members of 
the myosin I family are widely expressed. For example, myosins 1c is expressed in 
kidney proximal tubules180, whereas myosin 1a is restricted to the gastrointestinal tract 
and inner ear179, 180. Moreover, an atypical molecular motor, myosin VI, can also localize 
to microvilli where it moves cargo from the periphery to the center of the cell181, 182.  
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Fig. 6 Architecture of a microvillus. 
Microvilli are dynamic structures with a lifetime of about 7-17 min183, 184. 
Their length ranges from 200 nm to 3 μm with a diameter of about 100 
nm. Microvilli are composed of actin core bundles (red) linked by espin, 
villin and plastin-1 (also known as fimbrin). The actin filaments are 
capped at their plus end by proteins such as CapZ185. The actin core 
structure is laterally anchored to the plasma membrane by myosin 1 
and ERM-proteins (ezrin, radixin, moesin). Ezrin is concentrated in the 
apical microvilli of epithelial cells177 and moesin is primarily found in 
endothelial cells and the brush border of the kidney proximal tubule177. 
Radixin is a constituent of stereocilia186 as well as of hepatocytes187.  
 
 
 
 
 
 
 
 
 
 
3.4.1. Pathological Implications 
Several pathologies associated with microvillar malfunctions have been described. For 
example, microvilli in the intestinal brush border of patients suffering from ulcerative 
colitis or coeliac disease show various defects due to a massive inflammatory response, 
which is involved in these conditions188, 189. In patients with the chronic autoimmune 
disease called Sjögren’s syndrome conjunctival epithelial cells show a significantly lower 
number of microvilli, which in addition are shorter, wider and often branched190. The 
microvillus inclusion disease (MVID), a rare genetic disorder of the small intestine, is 
directly linked to microvilli breakdown191, 192. MVID patients show partial to total 
atrophy of microvilli on mature enterocytes with highly characteristic inclusion bodies 
containing rudimentary or fully differentiated microvilli193. These enterocytic 
abnormalities result in a persistent life-threatening watery diarrhea leading to intestinal 
failure. 
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3.5. Lipid Rafts 
The lateral segregation of lipids and proteins into distinct domains facilitates diverse 
functions of the membrane. These lateral heterogeneities differ in lipid and/or protein 
composition from the surrounding membrane. This can result in domains of different 
sizes ranging from whole surfaces (apical vs. basolateral) to membrane protrusion (cilia 
and microvilli) to domains of a few nanometers. The latter are small highly dynamic 
assemblies and today known as lipid rafts. They are ordered structures characterized by 
the presence of sterols, sphingolipids and a specific subset of proteins such as 
glycosylphosphatidylinositol (GPI)-anchored proteins194. Some membrane proteins are 
surrounded by a “shell” of typical raft lipids, which might confer a higher affinity for 
rafts, in addition to or even in the absence of a raft-targeting motif280. Others possess 
raft-targeting modifications such as palmitoylation, cholesterol- or sphingolipid-binding 
domains281-285. Lipid rafts play a crucial role in a variety of membrane functions such as 
molecule sorting, vesicle trafficking, cell migration, cell polarity and signal processing.  
The history of lipid rafts started in 1987 when Simons and van Meer discovered 
that glycosphingolipids (GSL) cluster in the Golgi apparatus before being sorted to the 
apical surface of polarized epithelial cells195. Ten years later Simons and colleagues 
proposed the lipid raft theory196. It describes the membrane bilayer as a mixture of 
loosely packed lipids with unconfined diffusion (called liquid-disordered phase, ld) and 
lipids with a propensity to associate with each other, thus segregating from the ld phase. 
The latter include cholesterol, sphingolipids and saturated glycerophospholipids, which 
can be packed more tightly. As a result, they can establish a more ordered state, called 
liquid-ordered phase (lo), and form discrete microdomains interspersed in the 
continuous ld phase. Multiple forces can drive lipid domain formation: hydrogen bonding, 
hydrophobic entropic forces, charge pairing and van der Waals forces197, 198.  
Properties of lipid rafts were first examined in model membranes, which do not 
reflect the complexity of the lipid environment in a membrane or the interactions 
between lipids and proteins. For example, transmembrane proteins that associate with 
rafts in the plasma membrane are depleted from the tightly packed lo phase when 
reconstituted in model systems199, 200. This suggests that the lo phase is not identical to 
rafts in plasma membranes201, 202. Nonetheless, the immiscible liquid phase coexistence in 
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vitro was suggested as the physical principle underlying lipid rafts in vivo203. The 
application of various techniques such as electron microscopy, freeze-fracture replica 
labeling, fluorescence recovery after photobleaching, single fluorophore tracking or 
stimulated emission depletion microscopy to study membrane heterogeneity led to 
results that were consistent with the developed lipid raft concept204-209. These studies 
revealed a non-random distribution of cell surface molecules leading to a membrane 
organization that includes microdomains differing in terms of composition, size 
(between 2-20 nm), and spatial and temporal dynamics (half-lifes in the range of 10-20 
ms) (Fig. 7). They also confirmed the importance of cholesterol and sphingolipids in 
membrane domain formation.  
Interestingly, boundary lipids of raft domains exchange very rapidly (every 10-100 
ns) with the lipids in the bulk membrane, but the presence of transmembrane proteins 
can increase their boundary residency times. There is also a tendency to exclude 
cholesterol and unsaturated phospholipids from boundary lipids210. Furthermore, some 
studies indicate the existence of different subpopulations of lipid rafts211, 212 as well as a 
close interplay between actin-mediated and lipid raft-mediated events (e.g., endocytosis 
of GPI-anchored proteins). The letter suggests a stabilization of lipid-based domains by 
the cortical actin network213, 214. In addition, the dynamic nanoscale heterogeneity of the 
plasma membrane can be stabilized to coalesce into larger raft domains by specific lipid-
lipid, protein-lipid and protein-protein interactions (Fig. 7)215, 216. This can also happen 
upon stimulation, thereby facilitating interactions between sets of proteins that before 
where physically separated from each other217.  
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Fig. 7 Lipid rafts – 
subdomains of the 
plasma membrane. 
Lateral segregation of lipids 
and proteins in the membrane 
results in small highly dynamic 
assemblies. Different integral 
proteins, glycoproteins, lipids 
and oligosaccharides are 
represented by different 
colors. Where the membrane 
has been peeled-up to view 
the inner membrane surface 
cytoskeletal fencing is 
apparent that restricts the 
lateral diffusion of some but 
not all transmembrane 
glycoproteins and/or lipid 
rafts. Coalescence of different 
small rafts into larger ones 
are displayed as well as interactions between proteins such as membrane glycoprotein complex formation 
(seen in the membrane cut-away) or polysaccharide-glycoprotein associations (at the far top left), which 
can also lead to the formation of bigger rafts. (Modified from Ref.20) 
 
 
3.6. Membrane Lipids 
Lipid rafts are enriched in specific lipids, but eukaryotic cells generate thousands of 
different lipids218. Most of them are membrane lipids suggesting that each type may be 
important in determining membrane function, structure and/or dynamics. The lipid 
species differ in their head groups, length and saturation of fatty acid tails. Typically, the 
plasma membrane contains large amounts of phosphatidylcholines (PC) and 
phosphatidylethanolamines (PE), as well as phosphatidylserines (PS), sphingolipids (SL), 
phosphoinositides (PI), and cholesterol. The composition is highly asymmetric between 
the inner and outer leaflet and it has been suggested that lipid asymmetry plays a role in 
membrane bending and vesicle budding219. The inner leaflet contains PEs, PSs and PIs 
whereas the outer leaflet contains mostly PC and SL, with cholesterol residing in both 
leaflets220. The asymmetric distribution is a consequence of biophysical properties that 
dictate the ability of lipids to cross the bilayer spontaneously, retentive mechanisms and 
the dynamic membrane translocation machinery. The latter consists of flippases, 
floppases and scramblases. Flippases and floppases use ATP to move phospholipids from 
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the exoplasmic to the cytosolic face or vice versa. In contrast, scramblases are energy-
independent bidirectional transporters causing reversible equilibration of phospholipids 
between the two sides of the membrane221. Moreover, membrane lipids are unevenly 
and dynamically distributed in the membrane plane and certain lipids such as cholesterol 
can change the fluidity, dynamics and lateral structures. Cholesterol is the only sterol 
and most abundant lipid in cell membranes where it is enriched in the inner leaflet222, 223. 
It is particularly important for the formation of membrane domains and in the sorting of 
membrane proteins and lipids by promoting membrane thickness and stiffness. The main 
interaction partners for cholesterol are PCs and sphingomyelins (SM), which constitute 
more than 50% of the plasma membrane phospholipids (OPM database,224). The complex 
lipid composition might has been established to ensure a stable and robust plasma 
membrane that can cope with local changes in composition, osmolarity or pH due to 
physiological or pathological events.  
 
 
3.6.1. Phosphoinositides (PIs) 
As early as in the 1950s Hokin and Hokin observed the implication of PI turnover in 
cellular processes225. PIs constitute only 1% of total cell lipids, but they play many 
fundamental roles, e.g., in actin cytoskeleton remodeling, vesicle trafficking, as 
precursors of lipid messengers and as membrane docking sites for effectors of signaling 
cascades226. Seven phosphoinositide isoforms exist that differ in the location and number 
of phosphate groups in their inositol ring. PIs are spatiotemporally regulated by 
organelle-specific phosphoinositide kinases and phosphatases. Thus, individual PIs can act 
as unique lipid signatures for cellular organelle identity, e.g., PIP2 on plasma membranes, 
phosphatidylinositol-3-phosphate on early endosomes and PIP on the TGN227. Through 
their ability to recruit proteins that possess specific PI-binding modules, e.g., the 
pleckstrin homology (PH) domain or the FYVE domain228, they fine-tune the 
composition of the membrane-cytosol interphase and regulate membrane trafficking229. 
The interaction of proteins with PIs can also be mediated by a cluster of basic residues 
within unstructured regions such as those found in many actin regulatory proteins (e.g., 
in profilin)230. 
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The apical and basolateral plasma membrane of polarized epithelial cells are 
enriched in different PIs, namely PIP2 in the apical and PIP3 in the basolateral domain. 
This is crucial for the development and maintenance of epithelial polarity231. The 
phosphatase and tensin homologue (PTEN) phosphatase, which removes phosphate 
from position 3 of the inositol ring232, localizes to the apical domain and functions to 
segregate PIP2 from PIP3
233. PIP2 comprises less than 1% of the total phospholipids
234 and 
its total amount is relatively constant with local dynamic changes at sites of phagocytosis 
and actin-rich protrusions such as membrane ruffles. Interactions of PIP2 with various 
proteins at the membrane can cause its sequestration resulting in the formation of 
specific microdomains. They are important in the assembly of multimolecular complexes 
that control protein activity, organelle identity and regulate membrane trafficking and 
receptor signaling. Furthermore, PIP2 is considered to promote the formation of actin 
filament structures beneath the plasma membrane. PIP3 only comprises < 0.05% of the 
total phospholipids, but it also serves as a signal for stimulus-induced actin 
polymerization. Interestingly, Insall and colleagues suggest that PIP2 acts as a marker for 
the plasma membrane thereby restricting actin polymerization to the cortex of the cell. 
PIP3, on the other hand, might act as a switch controlling when and where actin 
polymerization is initiated235. In addition, both PIs are involved in the generation of 
intracellular second messengers, exocytosis and endocytosis236.  
Abnormal PI signaling is a hallmark of many cancers237. Moreover, an overabundance 
of PIP3 in the plasma membrane is a frequent cause of type 2 diabetes. In addition, 
pathogenic bacteria including Legionella pneumophila, Salmonella enterica, Shigella flexneri 
and Listeria monocytogenes harness the regulation of host cell phosphoinositides to 
facilitate their infection processes236. 
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3.6.2. Sphingolipids 
Sphingolipids are minor components of membranes, but their local concentration can be 
high. They are associated with the external leaflet of the plasma membrane and are 
particularly abundant in the vertebrate brain, specifically in the myelin sheath of 
neurons238. Spingolipids are involved in the regulation of membrane-originated events 
such as cell-cell recognition and adhesion, and signal transduction within caveolae239, lipid 
rafts215 or glycosphingolipid-enriched microdomains (also known as glycosynapses)240. 
The major sphingolipids in mammalian cells are SM and glycosphingolipids (GSLs).  
The enrichment of GSLs in the external leaflet of the plasma membrane with their 
oligosaccharide chains protruding toward the extracellular space facilitates interactions 
of their sugar residues with a wide variety of cell surface and extracellular molecules240. 
GSLs can modulate cell-cell recognition as well as signaling across the membrane by 
modifying functional properties of several membrane-associated proteins including 
enzymes, receptors and adhesion molecules (see below).  
 
3.6.3. Gangliosides 
GSLs with terminal sialic acids are called gangliosides. They have been discovered in 
neuronal membranes of ganglion cells by Ernst Klenk in the 1930s. Gangliosides show a 
massive heterogeneity in their lipid moieties and hydrophilic head groups resulting in a 
very large family of compounds. They are known as major players in the formation of 
lateral order within biological membranes241. Moreover, they can modulate membrane 
elasticity due to their long and extended hydrophobic chains that can interact with the 
opposing layer. Gangliosides also contribute to the deformability of their membrane 
environment, e.g., in the formation and stabilization of caveolae. Thus, gangliosides 
influence the geometry of their environment and can build curvature traps or 
conformational traps.242 In polarized epithelial cells they are located primarily in the 
apical plasma membrane243. Gangliosides join glycoproteins and proteoglycans in 
constituting the glycan-rich glycocalyx, wherein they occupy the region closest to the 
cell surface244. They are also present on nuclear membranes, where they are proposed 
to play important roles in intranuclear calcium homeostasis245. Gangliosides are 
ubiquitously found in tissues and body fluids, but are more abundantly expressed in the 
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nervous system, where they undergo major changes during brain development246. 
Recently, gangliosides are gaining increasing attention in the field of stem and cancer 
stem cell biology due to a number of unique ganglioside markers that have been 
identified247.  
Defects in ganglioside biosynthesis and catabolism cause fatal neurodegenerative 
diseases (so far almost exclusively observed in mouse models) and clinical forms of 
lysosomal storage diseases, respectively. The latter comprise gangliosidoses, which show 
abnormal storage of gangliosides in cells of the central and peripheral nervous system248. 
Gangliosides are also involved in the Guillain-Barré syndrome caused by an autoimmune 
response to cell surface gangliosides leading to acute quadriplegia (partial or total loss of 
use of all four limbs and torso)249. Furthermore, gangliosides are well known as 
receptors involved in the interaction of several viruses with the cell surface leading to 
the internalization of the virus. For example, the influenza A viruses recognize sialic acid 
residues of gangliosides and glycoproteins on cell surfaces for invasion of host cells. In 
the case of the SV40 virus, the capsid proteins bind to gangliosides facilitating the 
generation of inward tubules250.  
 
3.6.3.1. Monosialotetrahexosylganglioside (GM1) and trisialotetra-
hexosylganglioside (GM3) 
The two most studied gangliosides are GM1 and GM3. The first ganglioside structure that 
was elucidated was the one of GM1 by Kuhn and Wiegand in 1963
251. Through its 
interaction with different molecules GM1 drives a diverse set of cellular functions such 
as microdomain regulation, ion transport modulation, neuronal differentiation, immune 
cell reactivity and neurotrophin signaling244. In particular, GM1 was shown to be 
necessary for the membrane insertion and function of the tropomyosin-related kinase A, 
the protein kinase receptor for nerve growth factor that is situated in lipid rafts252. GM1 
also associates with tropomyosin receptor kinase B, the tyrosine kinase receptor for 
brain-derived neurotrophic factor. The activity of this receptor is modulated by the 
amount of GM1 in its membrane environment
253. A need for a tight regulation of the 
GM1 content in lipid rafts was shown by microdomain alterations due to its 
overexpression254. Moreover, alterations in GM1 content of lipid rafts also occur in 
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diverse diseases such as systemic lupus erythematosus, Alzheimer’s or prion disease255-
257. Furthermore, GM1 can be crosslinked, e.g., by galectins, which can cause co-
crosslinking of associated proteins (e.g., integrins) that can induce tyrosine 
autophosphorylation of linked kinases (e.g., focal adhesion kinase) with consequent 
signaling244. As mentioned before, gangliosides are implicated in calcium homeostasis. 
Specifically, an elevation of GM1 can induce a Ca
2+ influx across the plasma membrane via 
low-threshold voltage-dependent T type channels244. GM1 also modulates the reactivity 
of the Na+/Ca2+ exchanger in the inner membrane of the nuclear envelope with which it 
is associated258.  
GM3 is the simplest ganglioside and the main one of the human body. By studying a 
GM3-deficient mouse model a role for this ganglioside and its derivatives in the 
maturation of the cochlea early in development was suggested259. Furthermore, GM3 
interacts with insulin receptors in membrane microdomains thereby modulating their 
activity260. An increase of cellular GM3 levels results in the elimination of insulin 
receptors from microdomains leading to insulin resistance, which is a major cause for 
type 2 diabetes261. Several studies also indicate that GM3 has an inhibitory or suppressive 
effect on cancer development and progression by inhibiting growth factor receptors262. 
 
3.7. Membrane Proteins 
Biological membranes contain a huge number of proteins. Three classes of membrane 
proteins can be distinguished – integral, peripheral and membrane-associated proteins. 
Integral membrane proteins are intercalated into the membrane and tightly bound to it 
mainly by hydrophobic forces. Thus, they are important in defining the basic membrane 
microstructure. Integral membrane proteins interact with membranes in very different 
ways, e.g., by transmembrane domains (TMD), short hydrophobic amino acid sequences, 
palmitoylated or myristoylated amino acids or GPI-anchors263-265. They include 
transporters, linkers, channel, receptors, enzymes and many more. In contrast, 
peripheral proteins are only loosely bound to hydrophilic regions of the membrane by 
electrostatic or other non-hydrophobic interactions. They provide enzyme activities, 
protein attachment sites, scaffolding, tethering or membrane-supporting structures, 
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curvature-preserving components and attachment points for soluble enzymes and 
signaling molecules. Membrane-associated proteins are cytoskeletal and associated 
signaling proteins at the inner membrane surface as well as certain glycoproteins and 
linked glycosaminoglycans at the outer membrane surface. They immobilize membrane 
components to the extracellular matrix or the cytoskeleton, where they function as 
parts of adhesion structures or cell motility traction points. Membrane-associated 
proteins are involved in stabilizing the membrane, endocytosis, cell motility and cell 
spreading20.  
Many membrane proteins are not completely free to move in the plane of the 
membrane, but are locally impeded by various interactions within the membrane or 
across the membrane. Interactions across the membrane can reduce or restrict the 
lateral movement by anchoring proteins to the underlying cytoskeleton as well as by 
cell-cell and cell-matrix interactions266. On the other hand, they can also cause 
movement of proteins by their tethering to the actin or microtubule network via motor 
proteins213, 267, 268. Membrane proteins can also interact with one another resulting in the 
assembly of macromolecular complexes. This can decrease their motility due to steric 
restriction and molecular crowding269.  
Membrane lipids can also have a big influence on neighboring proteins. Some lipids 
are stabilizing components of the quaternary structure of transmembrane proteins or 
protein complexes, e.g., cholesterol for the beta 2 adrenergic receptor and cardiolipin 
for the cytochrome bc1 complex271-273. In addition, gangliosides are known to bind 
specifically to receptor tyrosine kinases274. The binding of lipids to receptors can induce 
conformational changes that can affect ligand binding as well as signaling pathways 
downstream of receptor activation275. For example, the ganglioside GM3 strongly inhibits 
the autophosphorylation of the human epidermal growth factor (hEGFR) receptor 
thereby preventing the allosteric structural transition from inactive to a signaling hEGFR 
dimer276. Lipid-protein binding can also influence the lateral organization of membrane 
components as in the case of caveolin-1, a typical scaffold-forming protein that binds 
strongly and specifically to cholesterol277, 278, which is essential for caveolae formation 
and maintenance279.  
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To reach their appropriate membrane domain, integral membrane proteins 
developed a diverse set of sorting signals. Some proteins can be sequestered in lipid 
rafts, which can act as a signal in membrane trafficking from the TGN to the apical 
plasma membrane216. Another sorting signal for transmembrane proteins is the length of 
their transmembrane domain (TMD). The membrane thickness and stiffness increases 
from the ER to the plasma membrane due to an elevation of the sterol content. In the 
ER, newly synthesized proteins of various TMD lengths are incorporated into the 
membrane and transported to the cis-Golgi. In the Golgi complex, cholesterol 
concentration increases toward the trans-side promoting sorting of shorter Golgi 
proteins from longer TMD proteins, which proceed toward the plasma membrane286, 287. 
This gradient of sterols (and sphingolipids) towards the cell surface is augmented by the 
exclusion of sterols and SM from the coat protein I (COPI) vesicles that transport 
proteins and lipids retrogradely in the Golgi complex and back to the ER288. Besides lipid 
raft association and TMD length, N- and O-linked glycosylation of the extracellular 
domain can serve as apical sorting signals54, 289, 290. Moreover, sorting determinants can 
also reside in the cytoplasmic or extracellular domain. Apical sorting signals show a 
great variety ranging from a few amino acids to up to 30 amino acid long stretches43. In 
addition, lectins have been implicated in apical transport. For example, galectin-9 
together with the Forssman glycolipid cycle between the TGN and the apical plasma 
membrane. The interaction of galectin-9 and Forssman glycolipid in the TGN may help 
to sort apical cargo components292. In contrast, basolateral sorting signals are relatively 
well defined. They are usually located in the cytoplasmic tail and include tyrosine-based 
YXXØ (e.g., in the transferrin receptor; X can be any amino acid and Ø is a bulky 
hydrophobic residue) and NPXY motifs (e.g., in the low density lipoprotein receptor) as 
well as dileucine-based sorting motifs (e.g., in the GLUT4 glucose transporter and 
vasopressin V2 receptor)293. These signals are similar to endocytic and lysosomal 
targeting determinants. The machinery responsible for their decoding involves clathrin 
and the heterotetrameric adaptor protein complexes AP1, AP3 and AP455. Clathrin is 
also involved in basolateral sorting of proteins that do not contain canonical endocytic 
sorting signals, e.g., the transferrin receptor with GDNS as a motif294 and cluster of 
differentiation 147 with a single leucine as sorting motif295.  
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3.7.1. Prominin-1 (CD133) 
Prominin-1 was simultaneous identified in 1997 by two independent studies, which 
concerned murine neuroepithelial cells296 and human hematopoietic stem and progenitor 
cells297, respectively. In the search of novel markers of neurogenesis in the vertebrate 
central nervous system Huttner and colleagues raised new monoclonal antibodies (mAb) 
against mouse neuroepithelial cells, the precursor cells of all neurons and macroglia298. 
One of them (mAb 13A4) was found to specifically label the apical plasma membrane. 
Within the apical membrane the 13A4 antigen was selectively associated with microvilli 
and absent from planar regions of the membrane. Due to its characteristic localization it 
was given the name ‘prominin’ from the Latin word prominere – to stand out, to be 
prominent296. In the other study, Buck and colleagues created a panel of mAb against 
human hematopoietic progenitor cells to facilitate their efficient isolation. This led to the 
identification and molecular characterization of the protein that bears the AC133 
epitope (CD133)299. Since this protein was found to be highly related to murine 
prominin-1 in sequence, membrane topology, tissue distribution and subcellular 
localization it was acknowledged as the human ortholog of murine prominin-1300, 301. 
Importantly, it was demonstrated that the AC133 immunoreacitvity diminishes upon 
differentiation302. Thus, the corresponding epitope is thought to be dependent on 
conformation and/or sensitive to changes in glycosylation.  
 
3.7.2. Membrane Topology And Interaction Partners 
Prominin-1 is the first member of the prominin family with approximately 850 amino 
acid residues, depending on the splice variant (see below). The amino acid sequence is 
poorly conserved among PROM1 gene products across species. For instance, primate 
and rodent prominin-1 exhibit an average identity of 60% and this number drops to 
about 45% in fish, amphibians and birds303-307. In invertebrates (e.g., worm, fly) less than 
25% of the mammalian residues are conserved300, 308. Prominin-1 does not show obvious 
sequence homology to other proteins nor does its sequence reveal motifs that could 
provide clues to its physiological role. The membrane topology of prominin-1 after the 
cleavage of the signal peptide is characterized by a N-terminal extracellular domain 
(EC1), five transmembrane domains (TMD), two small intracellular loops (IC1-2), two 
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large extracellular loops (EC2-3) and an intracellular C-terminal domain (IC3) (Fig. 8). 
The two extracellular loops contain more than 250 amino acid residues each and harbor 
eight potential N-glycosylation sites297. At least 20 different splice variants of prominin-1 
have been identified. Some of them appear to be ontogenetically regulated and/or tissue 
specific, but the significance of this variability is not yet understood. Remarkably, at least 
ten alternative C-termini can be generated by intron retention, exon skipping or the use 
of a cryptic acceptor site309. Furthermore, prominin-1 comprises a cysteine-rich region 
of as yet unknown function, which is located at the transition of the first transmembrane 
domain and the first cytoplasmic loop296, 297. It harbors six (seven in human) cysteine 
residues in the EC2 and EC3 domains, which are likely to form disulfide bridges. In 
addition, two ganglioside-binding sites are proposed within the EC1 and EC2 domains310. 
A consensus core sequence at the end of the EC3 domain and the beginning of TMD5 
was observed in prominin proteins: CXPX(12,13)CX(5)[P/S]X(4)WX(2)hX(4)hhXh (X 
stands for any residue; the number of X is indicated in parentheses; residues in brackets 
indicate alternatives for a given position, and h stands for any hydrophobic residue). 
Some prominin-1 gene products exhibit distinct potential PDZ-binding domains304, which 
may indicate unidentified cytoplasmic PDZ domain-containing interaction partners311. 
Moreover, Src and Fyn tyrosine kinases can phosphorylate prominin-1 at tyrosine 
residue 828312. Importantly, the phosphorylation of tyrosine828 mediates the direct 
interaction between prominin-1 and the phosphoinositide 3-kinase (PI3K) via its 85-kDa 
regulatory subunit (p85) resulting in the activation of PI3K/protein kinase B (Akt) 
pathway313. Prominin-1 also physically associates with the histone deacetylase 6 
(HDAC6) thereby inhibiting the trafficking of prominin-1 down the endosomal-
lysosomal pathway for degradation314. 
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Fig. 8 Membrane topology of prominin-1. 
Prominin-1 contains five transmembrane segments 
(blue cylinders) separating two small intracellular 
domains (IC1 and IC2) and two large extracellular 
loops (EC2 and EC3), which contain eight N-
glycosylation sites (forks). The N-terminal domain 
(EC1) is located extracellularly whereas the C-
terminal domain (IC3) faces the cytoplasm. The s2 
splice variant of prominin-1 contains an additional 
exon encoding 9 residues (red square). A 
conserved cluster of cystein residues (dashed green 
circle) is located at the transition of the first 
transmembrane domain and the first cytoplasmic 
loop. Distinct PDZ-binding motifs (green hexagon) 
are found at the C-terminus of certain prominin-1 
splice variants. Two ganglioside-binding sites are 
proposed within the EC1 and EC2 domains (orange 
and yellow cylinders). Lysine residue 129 (K129) is 
implicated in the association of prominin-1 with 
HDAC6 and tyrosine residue 828 (Y828) mediates 
the interaction of prominin-1 with the PI3K.  
 
 
3.7.3. Tissue Distribution  
Prominin-1 has become widely known as a cell surface antigen used for the isolation of 
stem and cancer stem cells from various tissues. Nevertheless, its expression is not 
restricted to stem or progenitor cells, but extends to several epithelial and non-
epithelial cell types. In a nutshell, prominin-1 is expressed in the kidney, colon, prostate, 
pancreas, liver, mammary glands, epididymis and major cephalic exocrine glands, i.e. 
salivary and lacrimal glands. In non-epithelial cells, prominin-1 is notably detected in 
photoreceptors, glial cells and developing spermatozoa309. 
 
3.7.4. Prominin-1 and Plasma Membrane Protrusions  
As mentioned earlier, prominin-1 has a remarkable subcellular localization. It is confined 
to specific subdomains of the cell surface. Although distinct in structure these 
subdomains have one feature in common, i.e. to protrude from the planar regions of the 
plasma membrane into the surrounding extracellular milieu. In epithelial cells, prominin-
1 is exclusively located in microvilli, motile and primary cilia, where it often appears to 
be concentrated at their tips211, 296, 302, 315, 316. The protrusion-based localization of 
prominin-1 presumably explains why prominin-1 retains its specific apical localization 
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when epithelial cells lose their tight junctions296, 315. In non-epithelial cells, such as 
Chinese hamster ovary cells or hematopoietic progenitor cells, prominin-1 is also 
enriched in microvilli-like protrusions302. Moreover, prominin-1 is concentrated in the 
plasma membrane evaginations present at the base of the outer segment of 
photoreceptor cells317. In the optic nerve, it is observed in the myelin sheath, which 
represents a specialized domain of the oligodendrocyte plasma membrane318. 
Furthermore, prominin-1-transfected fibroblasts show a concentration of the protein in 
microspikes, filopodia and the leading edge of lamellipodia296, 302. Thus, prominin-1 
exhibits a profound preference for any kind of plasma membrane protrusion. 
 
3.7.5. Prominin-1 and a Novel Type of Lipid Rafts  
The selective localization of prominin-1 in plasmalemmal protrusions does not seem to 
be accomplished by a direct interaction with the cytoskeleton. The deletion of the C-
terminal cytoplasmic domain of prominin-1, which is the most likely candidate to 
mediate this interaction, does not impair its concentration in protrusions315. Insight into 
the mechanism of its confinement to membrane protrusions came from a study 
comparing prominin-1 with another apical membrane protein, placental alkaline 
phosphatase (PLAP), in transfected epithelial cells319. The localization of PLAP, a GPI-
anchored protein, within the apical plasma membrane was found to be distinct from that 
of prominin-1, i.e. PLAP was largely excluded from microvilli (Fig. 9a). Huttner and 
colleagues showed that the differential localization of both proteins is due to their 
association with different lipid rafts. In the TGN, prominin-1 becomes associated with 
small lipid rafts that are soluble in Triton X-100 but insoluble in another non-ionic 
detergent, Lubrol WX. In contrast, PLAP is incorporated into Triton X-100-insoluble 
lipid rafts. Interestingly, cholesterol depletion resulted in the loss of the microvillus-
specific localization of prominin-1. Indeed, the cell surface form of prominin-1 interacts 
directly and specifically with cholesterol as shown by the use of a photoactivatable 
analogue of cholesterol319. Another lipid colocalizing with prominin-1 is the ganglioside 
GM1, which was found to share the same microdomain pattern in polarized epithelial 
cells as well as in hematopoietic stem cells211, 320. Precisely, in polarized epithelial cells 
prominin-1 colocalizes with GM1 on microvilli whereas another ganglioside, GM3, was 
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segregated from there. This suggests its localization in the planar region. Interestingly, 
both gangliosides as well as prominin-1 are found in the primary cilium (Fig. 9b)211. In 
migrating hematopoietic stem cells, prominin-1 and GM1 are enriched at the uropod
320. 
Recent investigations revealed that prominin-1 is involved in the biogenesis of microvilli-
like protrusions at the uropod (Doreen Reichert, unpublished data).  
 
 
Fig. 9 Distinct subtypes 
of membrane micro-
domains as building 
units of the apical 
membrane of epithelial 
cells. 
(A, B) Schematic repre-
sentation of two plasma 
membrane protrusions 
(microvillus, primary cilium) 
and planar regions of the 
apical domain with 
membrane microdomain sub-
types found therein. These 
subtypes are defined either 
by the segregation of 
membrane proteins (e.g. prominin-1 and PLAP) that have differential detergent extraction properties 
(Lubrol WX versus Triton X-100) (A) or the segregation of two membrane microdomain-associated 
gangliosides (GM1 and GM3) (B). Within the cilium, it remains to be determined whether GM1 and GM3 
are located in the same membrane microdomain (yellow) or are part of two distinct (red, green), but 
close, entities. (From Ref.321) 
 
 
3.7.6. Prominin-1 – Containing Vesicles  
Prominin-1 associates with small membrane vesicles and can be released into numerous 
body fluids including urine, saliva, seminal and cerebrospinal fluids322. In these vesicles 
prominin-1 retains its characteristic features, e.g., it also directly interacts with 
membrane cholesterol and associates with lipid rafts. The vesicles bud from the tip of 
microvilli and primary cilia by a molecular mechanism involving cholesterol-dependent 
microdomains (Fig. 10)323, 324. Depleting cells of cholesterol results in the enhanced 
release of prominin-1-containing vesicles and a dramatic change in the ultrastructure of 
microvilli from a tubular shape to a “pearling” state with multiple membrane 
constrictions324. Interestingly, the release solely occurs during and after cell 
differentiation322, 325. These observations led to the concept that prominin-1-containing 
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lipid rafts may host key determinants necessary to maintain stem cell properties and 
their reduction or loss may result in differentiation.  
The detection of prominin-1-containing vesicles may be highly instructive with 
regard to certain diseases. For example, Huttner and colleagues demonstrated that 
human cerebrospinal fluid contained a significantly increased amount of vesicle-
associated prominin-1 in patients with partial epilepsy326. 
 
 
 
 
Fig. 10 Two hypothetical mechanisms underlying the release of prominin-1-
containing membrane vesicles from microvilli. 
In model 1, small prominin-1-containing membrane microdomains (a, red) within the plasma membrane 
are converted into a larger one at the microvillar tip. This, in turn, may lead to phase separation (b) from 
the surrounding – more fluid – lipid microdomains. In the latter, membrane cholesterol is loosely packed 
(a, b, grey) and more sensitive to depletion by methyl-beta-cyclodextrin (mβCD, c). In model 2, an 
increased concentration of membrane cholesterol (a, red) toward the microvillar tip together with the 
local curvature may lead to fission by promoting a restricted area of fluid phase separation (b, blue). The 
latter phenomenon may be inducible by depleting membrane cholesterol (c). In both models, it cannot be 
excluded that prominin-1 itself plays a role either in the coalescence of particular membrane microdomain 
subtypes (model 1) or the concentration of membrane cholesterol (model 2). An active interplay between 
membrane constituents and the membrane-associated actomyosin system should be considered as well. It 
remains to be determined whether mβCD-induced membrane vesicles (c, pink) have the same 
biochemical characteristics as those released under physiological conditions (b, red). (From Ref.323) 
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3.7.7. Prominin-1 and Retinal Degeneration 
The most striking effects upon the loss of function of prominin-1 are observed in the 
visual system327. In 2000, Maw and colleagues investigated a consanguineous Indian 
pedigree that harbored a gene mutation associated with inherited autosomal recessive 
retinal degeneration317. The affected individuals were found to be homozygous for a 
single nucleotide deletion (nt 1878) in the human prominin-1 gene. This deletion is 
predicted to cause a frameshift resulting in a premature termination of translation. The 
expression of a corresponding murine prominin-1 deletion mutant in fibroblasts shows 
that the truncated form does not reach the cell surface317. In 2007, Zhang and colleagues 
identified a second prominin-1 mutation (nonsense mutation C1726 T), which causes a 
severe form of retinitis pigmentosa accompanied by macular degeneration328. This 
mutation was found in a consanguineous Pakistani pedigree. Furthermore, Pras and 
colleagues described a third mutation (homozygous insertion of T at position 1349) 
causing autosomal recessive cone-rod dystrophy and high myopia in a consanguineous 
Arab family329. Another autosomal recessive mutation in prominin-1 (C869 D), which was 
found in a consanguineous pedigree from Spain, causes a premature stop codon. As a 
result, approximately two-third of the protein is truncated330. Finally, a fifth mutation 
(C1117GC TGC) has been identified that results in a single amino acid substitution 
(R373C) generating three associated forms auf autosomal macular degeneration168, 331.  
In the retina, prominin-1 is expressed in photoreceptor cells. It is concentrated in 
the plasma membrane evaginations at the base of the outer segment317, 332. These 
membrane evaginations are essential precursor structures of the photoreceptive disks, 
which are constantly renewed throughout adult life333, 334. Mice lacking prominin-1 show 
an age-dependent deterioration of the photoreceptor structure. The disorganization and 
degradation of the cells starts at 6 month and ends with the total loss of the 
photoreceptor layer in older animals332. Furthermore, the expression of the human 
prominin-1 R373C mutant in transgenic mice results in an abnormal distribution of the 
protein throughout the photoreceptor layers. In addition, the cells harbor greatly 
overgrown and misoriented outer segment disk membranes. Altogether, these results 
suggest a role for prominin-1 in disc membrane morphogenesis168.  
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3.7.8. Prominin-2 
Two prominin genes are described in mammals, prominin-1 and prominin-2335. Their 
genomic structure is strikingly similar, i.e., their introns are concordant in position and 
phase. Furthermore, they are remarkably conserved across species suggesting an early 
gene duplication event304, 336. The amino acid identity between prominin-1 and -2 is low 
(< 30%), but they share the same membrane topology336. The expression of prominin-2 
appears to be restricted to epithelial cells with a high level in the adult kidney and along 
the digestive tract. In contrast to prominin-1, prominin-2 is not restricted to the apical 
domain of epithelial cells, but it is evenly distributed between the apical and basolateral 
membrane. Importantly, prominin-2 is not detected in the eye336, which might explain 
why loss-of-function mutations in the human prominin-1 gene cause retinal degeneration, 
but no other obvious pathological signs. Thus, prominin-2 might substitute for prominin-
1 in all epithelial tissues except for the retina. Similar to prominin-1, prominin-2 is 
selectively concentrated in membrane protrusions. It is also associated with detergent-
resistant membranes in a cholesterol-dependent manner suggesting its incorporation 
into specific membrane microdomains. Like prominin-1, it binds directly to plasma 
membrane cholesterol337. Interestingly, the overexpression of prominin-2 in human skin 
fibroblasts and Chinese hamster ovary cells causes the formation of extensive prominin-
2-associated protrusions. Finally, prominin-2 is also associated with small membrane 
vesicles that are released into the culture media. These vesicles are also found in 
physiological fluids such as the urine. Altogether, prominin-2 shares all characteristics 
with prominin-1. Therefore, it might have a similar role as prominin-1 – being a 
scaffolding protein involved in the cellular organization of membrane protrusions and 
the lipid rafts it resides in338.  
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3.8. Madin-Darby canine kidney (MDCK) cells  
In 1958, S.H. Madin and N.B. Darby established the MDCK cell line from a kidney of a 
cocker spaniel339. In 1964, they deposited the cell line at the American Type Culture 
Collection. Shortly afterwards, MDCK cells were reported to be susceptible to influenza 
virus infection and propagation340. They are used for vaccine production and the study of 
viral infections until today341-343. In 1966, MDCK cells were described for the first time in 
great detail by their growth rate, immunologic and cytogenetic characteristics and 
susceptibility to diverse viruses344. Up to the present day, MDCK cells are extensively 
used as a model for studying various properties of epithelia such as epithelial cell 
trafficking293, 345, polarity346, 347 and junction formation348, 349. MDCK cells show clear 
apicobasal polarity, well-defined junctions and a rapid growth rate. They are also suitable 
for diverse microscopic techniques and polarize in 2D and 3D cell culture. However, 
the MDCK cell line suffers from the disadvantage of its canine origin. Since commercially 
available antibodies and siRNAs are often raised against human or mouse sequences 
they rarely cross-react with canine proteins. When working with MDCK cell strains, it 
is also important to consider their clonal heterogeneity. At least nine unique MDCK 
strains exist, which differ in their morphology, migration and invasive behavior, trans-
epithelial resistance, junction and dome formation, protein expression, and viral 
susceptibility350. In the subsequently presented work MDCK cells of strain II were used 
(Fig. 11).  
 
 Fig. 11 Monolayer of MDCK cells. 
(A) MDCK cell monolayer observed by 
scanning electron microscope (SEM). (B) 
Overview of stably transfected MDCK 
cells expressing prominin-1-GFP (Prom1-
GFP, green). The primary cilia were 
marked with acetylated α-tubulin (ac Tub, 
red) and the cell nuclei were 
counterstained with DAPI (blue). PC, 
primary cilium; MV, microvilli. Scale bars, 
1 μm (A), 5 μm (B). 
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4. AIM OF THE THESIS 
Research on prominin-1 started with its identification and characterization in mouse 
neuroepithelium in 1997296. Simultaneously, the human ortholog was discovered in 
hematopoietic stem and progenitor cells297. Diverse studies revealed that prominin-1 
was selectively enriched in any kind of plasmalemmal protrusion irrespective of the cell 
type, e.g., microvilli, primary cilia, filopodia, lamellipodia, microspikes or the midbody211, 
296, 302, 315, 351. With the help of MDCK cells stably transfected with mouse prominin-1 the 
characteristics causing its exclusive localization have been elucidated. First, prominin-1 is 
sorted at the TGN and directly targeted to the apical membrane. It maintains its specific 
enrichment in apical microvilli even in the absence of tight junctions315. Second, the C-
terminal end of prominin-1 is not essential for its apical localization315. Third, the 
retention of prominin-1 in plasmalemmal protrusions relies on its direct interaction with 
membrane cholesterol and its association with a specific membrane microdomain. The 
integrity of which is dependent on its cholesterol content319. Fourth, the lipid raft-
associated ganglioside GM1 colocalizes with prominin-1 on microvilli and the primary 
cilium211. 
But, after almost two decades of intensive investigations on prominin-1 its 
physiological function still remains illusive. Experimental and clinical observations 
strongly support the theory that prominin-1, in association with other proteins and 
membrane lipids, provides a scaffolding mechanism for the maintenance and dynamics of 
plasma membrane protrusions.  
Therefore, I want to investigate the role of prominin-1 in the architecture and 
dynamics of apical plasma membrane protrusions. A detailed analysis of microvilli and 
primary cilia on MDCK cells that ectopically express human prominin-1 will help to 
decipher the implication of prominin-1. Furthermore, mutations that interfere with 
prominin-1 and its potential interaction partners such as HDAC6, PI3K and the 
ganglioside GM1 will be created to shed light on the underlying mechanisms. As basis for 
future knockdown experiments and antibody production, the canine prominin-1 will be 
identified and characterized.  
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5. MATERIAL AND METHODS 
5.1. Material 
5.1.1. Buffer 
Buffer Composition Purpose 
Blocking buffer I PBS, 0.3% Tween- 20, 5% milk powder Immunoblotting 
Blocking buffer II 
TBS (20mM Tris), 0.1% Tween 20, 3% bovine 
serum albumine 
Immunoblotting 
Blocking buffer III PBS; 1 mM CaCl2; 0.5 mM MGgCl2; 0.2 % gelatin 
Immunofluorescence 
staining 
Ca/Mg buffer PBS, 1 mM CaCl2; 0.5 mM MGgCl2 
Immunofluorescence 
staining 
D-PBS 
37 mM NaCI; 2.7 mM KCl; 8 mM Na2HP04; 1.5 mM 
KH2PO4 
 
EndoH buffer 
0.1 M Na-acetate buffer pH 5.5; 0.05 M EDTA; 2% β-
mercaptoethanol; 0.1% SDS; 2% Triton X-100 
EndoH digestion 
Laemmli buffer  Immunoblotting 
Lysis buffer 
20 mM Tris/HCl pH 7.5, 150 mM NaCl, 0.2% Triton 
X-100 
Immuno-isolation 
Permeabilization buffer PBS; 0.2 % gelatin; 0.2% saponin 
Immunofluorescence 
staining 
PNGase F buffer 
0.1 M Na-phosphate buffer pH 7.2; 0.05 M EDTA; 
2% β-mercaptoethanol; 0.2% SDS; 2% Triton X-100 
PNGase F digestion 
Running gel buffer 1.5 M Tris/HCL; 0.4% SDS; pH 8.8 SDS-PAGE 
Running buffer 0.25 M Tris, 1.9 M Glycin; 10 % SDS SDS-PAGE 
SDS buffer PBS; 0.2 % gelatin; 0.005% SDS 
Immunofluorescence 
staining 
Solubilization buffer 
1% NP-40; 0.5% deoxycholate; 0.1% sodium 
dodecylsulfate; 150 mM NaCl; 50 mM Tris-HCl; pH 
8.0 
Cell lysis 
Stacking gel buffer 0.5 M Tris/HC; 0.4% SDS; pH 6.8 SDS-PAGE 
Transferbuffer I 0.3 M Tris/HCl; 20% methanol; pH 10.4 Immunoblotting 
Transferbuffer II 0.025 M Tris/HCl; 20% methanol; pH 10.4 Immunoblotting 
Transferbuffer III 
0.025 M Tris/HCl; 20% methanol; 0.04 M 6-
Amiocproic acid; pH 9.4 
Immunoblotting 
Washing buffer I PBS, 0.3% Tween- 20 Immunoblotting 
Washing buffer II TBS (20mM Tris), 0.1% Tween Immunoblotting 
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5.1.2. Antibodies and other fluorescent reagents 
5.1.2.1. Antibodies 
Antibody Dilution Application Supplier 
Donkey anti-rat IgG Alexa Fluor 
488/546/633 
1:500 IF Life Technologies 
Goat anti-mouse HRP 1:5000 IB 
Jackson Immunoresearch 
Laboratories, Inc. 
Goat anti-rabbit IgG Alexa Fluor 
488/546/633 
1:500 IF Life Technologies 
Goat anti-rabbit HRP 1:5000 IB 
Jackson Immunoresearch 
Laboratories, Inc. 
Goat anti-mouse IgG1-Alexa Fluor 
488/546/633 
1:500 IF Life Technologies 
Goat anti-mouse IgG2b-Alexa Fluor 
488/546/633 
1:500 IF Thermo Fisher Scientific 
Mouse mAb acetylated α- tubulin 
(6-11B-1) 
1:1000 IF Sigma-Aldrich 
Mouse mAb actin (AC-40) 1:6000 IB Sigma-Aldrich 
Mouse α-tubulin (DM1A) 1: 10.000 IB Sigma-Aldrich 
Rabbit antiserum αhE2 
1:500 
1:1500 
IF 
IB 
Ref.352 
Mouse mAb β-actin (AC-74) 1:10.000 IB Sigma Aldrich 
Mouse mAb CD133/1 (AC133) 
pure / -PE/ -APC 
1:50 
1:100 
1:10 
IF 
IB 
FACS 
Miltenyi Biotec 
Mouse mAb CD133/2 (AC141)-PE 
1:50 
1:100 
1:10 
IF 
IB 
FACS 
Miltenyi Biotec 
Mouse mAb CD133/2 (293C3) 
pure / -APC 
1:50 
1:100 
1:10 
IF 
IB 
FACS 
Miltenyi Biotec 
Mouse mAb CD133 (80B258) 
10 μg/ml 
1:2000 
IF 
IB 
Ref.316 
Mouse mAb CD34-PE/ -APC 1:10 FACS BD Bioscience 
Mouse mAb CD34-PE 1:10 FACS BD Bioscience 
Mouse mAb CD34-APC 1:10 FACS BD Bioscience 
Mouse mAb p-Tyrosine (PY99) 1:330 IB Santa Cruz 
Rabbit polyclonal anti-HDAC6  1:50 IF Thermo Fisher Scientific  
Rabbit polyclonal anti-GFP  1:2000 IB ImmunoKontact 
Rat mAb 13A4 pure/-PE 
1:100 
1:500 
1:10 
IF 
IB 
FACS 
eBioscience 
Rat mAb 13A4-PE 1:10 FACS eBioscience 
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5.1.2.2. Others 
Name Dilution Application Supplier 
4’-6-diamidino-2-phenylindole 
(DAPI) 
1 μg/ml IF Sigma-Aldrich 
Cholera toxin subunit b-Alexa 
Fluor 488/546 
1:1000 IF Invitrogen 
Wheat germ agglutinin-
fluorescein/rhodamin 
1:400 IF Vector Laboratories, Inc. 
 
5.1.3. Reagents and Kits  
Reagent/Kit Supplier 
AmaxaTMNucleofector® Technology (Kit L) Lonza 
anti-FITC Microbeads Miltenyi Biotec 
β-glycerophosphate Sigma-Aldrich 
CD133 MicroBead kit, human, lyophilized Miltenyi Biotec 
cDNA from adult Beagle dog kidney tissue (# DD-901) Zyagen Laboratories  
CompleteTM protease inhibitor cocktail (with/without 
EDTA) 
Roche Molecular Biochemicals 
Protease/Phosphatase inhibitor cocktail Cell Signaling 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich 
DNA ladder 1 kb Promega 
DNA ladder 100 bp Thermo Scientific 
DNA ladder 50bp Serva 
DNAse ligation kit TAKARA 
dNTP mix Invitrogen 
EDTA  VWR International 
Endoglycosidase H (EndoH) Roche Diagnostics GmbH 
enhanced yellow fluorescent protein (EYFP)-N1 vector  BD Bioscience  
Fibronectin BD Bioscience 
gelatin VWR 
Glutaraldehyde 8% Polysciences Inc. 
loading dye 6x Promega 
LY294002 Sigma-Aldrich 
MACS® Columns (MS/LS) Miltenyi Biotec 
Mowiol 4.88 Merck 
MultiScribe™ reverse transcriptase  
(High-capacity cDNA reverse transcription kit) 
Applied Biosystems, Thermo Fisher 
Scientific 
Niltubacin AbMole 
One shot® Top 10 competent cells Invitrogen 
Paraformaldehyde (PFA) Riedel-de Haën 
pCR™4-TOPO® TA vector kit Invitrogen, Thermo Fisher Scientific 
pEGFP-N1 vector  Takara Bio Europe/Clontech 
Peptide-N-glycosidase F (PNGase F)  Roche Diagnostics GmbH 
Platinum® Taq DNA Polymerase Invitrogen 
PureLinkTM Quick Plasmid Miniprep Kit Invitrogen 
PureLinkTM HighPure Plasmid Maxiprep Kit Invitrogen 
QIAquick® Gel Extraction Kit Qiagen 
QuikChange II Site-Directed Mutagenesis Kit Agilent Technologies 
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Reagent/Kit Supplier 
RNeasy® Mini Kit Qiagen 
Saponin Panreac Applichem 
SMARTer™ RACE cDNA amplification kit  Takara Bio Europe/Clontech 
S.O.C. medium Media kitchen BIOTEC 
Sodium-dodecyl sulfate (SDS) Roth 
Sodium fluoride New England Biolabs 
Sodium orthovanadate New England Biolabs 
Taq polymerase Invitrogen 
TOPO TA Cloning® Kit for Sequencing Invitrogen 
Tubacin Sigma-Aldrich 
Wortmannin Sigma-Aldrich 
 
5.1.3.1. Western Blot reagents  
Gel Composition 
Running gel 7,5 % 
5ml running gel buffer, 5 ml Acrylamid-Bis, 9,9 ml H2O, 100 μl APS,  
10 μl Temed 
Stacking gel 3 % 
2,5 ml stacking gel buffer, 1,25 ml Acrylamid-Bis, 6,15 ml H2O, 100 μl APS,  
10 μl Temed 
 
Reagent Supplier  
Acrylamid-Bis Severn Biotech Ltd. 
Amonium persulfate (APS) Merck 
Temed Merck 
Enhanced chemiluminescence reagents  
ECLTM Western Blotting Detection Reagents 
GE Healthcare 
High performance chemiluminescence film GE Healthcare 
Whatman paper Whatman International 
Polyvinylidene difluoride (PVDF) membrane,  
pore size 0.45 mm 
Millipore  
 
5.1.3.2. Cell culture reagents  
Name  Supplier/Composition 
0.05% trypsin/0.5 mM EDTA GIBCO, Life Technologies 
8-well chamber (μ-Slide 8 Well) Ibidi 
Dulbecco’s Modified Eagle Medium (DMEM), 1x, 
1g/l D-Glucose, L-Glutamine, Pyruvate) 
GIBCO 
Fetal calf serum (FCS) PAA, GE Healthcare 
flexiPerm  Greiner Bio-One GmbH 
Geneticin (G418) GIBCO, Thermo Fisher Scientific 
Hepes PAA Laboratories 
MDCK cells (strain II) ATCC 
MEM non-essential amino acids 1x PAA Laboratories 
Penicillin/Streptomycin GIBCO 
Sodium butyrate Sigma-Aldrich 
T75-flask Nunc 
μ-Slide 8 well Ibidi 
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5.1.4. Restriction Endonucleases  
Endonuclease Supplier  
XhoI New England Biolabs 
NotI New England Biolabs 
SbfI New England Biolabs 
BamHI New England Biolabs 
SacI New England Biolabs 
 
5.1.5. Devices 
 
 
5.1.6. Primer 
 
Table 1. Oligonucleotide primers used in this study. 
 
 
No. Name Nucleotide (nt) sequence 
nt in 
cDNA§ 
 
Subcloning# 
1 Prominin-1.s1-XhoI 5’ 5'-GTTTGGAGGATCTCTCGAGCGATGGCCCTCGTAC-3' 17-50 
2 Prominin-1.s1-NotI 3’ 5'-GCAGTTTCAACGCGGCCGCTCAATGTTGTGATG-3' 2654-2622 
3 Prominin-1.s2-XhoI 5’ 5′-CCGCTCGAGCGTTGCTAGCTATGGCCCTC-3′ 29 [TT…]-46 
4 Prominin-1.s2-NotI 3’ 
5′-TAGTTTAGCGGCCGCATTCTTATTCAATGTTGTGATG 
GGCTTGTC-3′ 
2635 [TGA...] 
-2624 
 
Introduction of point mutations 
5 K129Q fw 5’- CGTTGCTGTAACCAATGTGGTGGAG-3’ 436-461 
6 K129Q rv 5’-CTCCACCACATTGGTTACAGCAACG-3’ 461-436 
7 P37A-Y41S fw 
5'-GGAATTATGAATTGGCTGCAACAAATTCTGA 
GACCCAAGACTCC-3' 
132-175 
8 P37A-Y41S rv 
5'-GGAGTCTTGGGTCTCAGAATTTGTTGCAGCCAA 
TTCATAATTCC-3' 
175-132 
9 Y828F fw 5’-GGATTCGGAGGACGTGTTCGATGATGTTG-3’ 2503-2531 
10 Y828F rv 5’-CAACATCATCGAACACGTCCTCCGAATCC-3’ 2531-2503 
Name Supplier 
Canon PowerShot A620 Canon 
Confocal laser scanning microscope LSM 700 Zeiss 
Critical Point Dryer CPD 300 Leica 
FACSCanto II System BD Bioscience 
film processor OPTIMAX Protec 
Scanning electron microscope JSM-7500F JEOL 
Semi-dry transfer cell system  Cti, Idstein 
Sputter coater (SCD 050) BAL-TEC GmbH 
Axiovert 40C Zeiss 
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§  Nucleotide position refers to the human or canine prominin-1 sequence deposited in Database      
  under the accession number AF027208.1 or KR758755, respectively. 
# The introduced enzyme restriction sites are shown in bold letters. 
  Numbers in parentheses refer to prominin-1 sequence absent in the sequence KR758755, but   
  appear in 5'-UTR (Fig. 27) and 3'-UTR (Fig. 28) sequences, respectively. 
 Fw, forward primer; rv, reverse primer.  
No. Name Nucleotide (nt) sequence 
nt in 
DNA§ 
Identification and molecular cloning of canine prominin-1 
Identification 
11 P1CL-F1 5’-TCCTCGGCTTCCTGCTGCTGCTGGA-3’ 73-100 
12 P1CL-F2 5’-GCTGGGACACCTCTGCCCTGGGGCC-3’ 106-130 
13 P1CL-F3 5’-TTTGGACACCCCATATTTACTAAAT-3’ 1646-1670 
14 P1CL-F4 5’-GTTCTGCTGGACGCAGCAGGAA-3’ 1890-1912 
15 P1CL-R1 5’- GGGGAAAGGATGGGGCTGCACCACTT -3’ 280-256 
16 P1CL-R2 5’- GTAGCTACATTATCGACCCTAT -3’ 365-341 
17 PICL-R3 5’-CTGAGGAGATGCGAGTTTGGAGG-3’ 2247-2268 
18 P1CL-R4 5’-ATAGGGTCGATAATGTAGCTAC-3’ 2440-2419 
 
cDNA amplification 
19 MDCK-P1_6 fw 5’-TGTTCCTCCAAGTGGTGCAG-3’ 247-266 
20 MDCK-P1_6 rv 5’-TGGTTGATAGTGCTCATTGACT-3’ 2158-2137 
21 RACE-3 fw 5’-CACCATGGCCAAGTCATGCCTTTGG-3’ 2109-2133 
22 RACE-1 rv 5’-TAGCCACTGGAGGGACAGAGCAC-3’ 1005-983 
23 RACE-4 rv (nested) 5’-CGATCCGGGTCCTCAGGTGGTG-3’ 627-606 
24 MDCKP1_2.1F 5’-CCCAAGGCTTCCAGAACCTCTGAG-3’ (-6)-18 
25 MDCKP1_4R 5’-AGAACTCGTGCCACGTTGGATCTG-3’ 
2626-(2650) 
 
 
Subcloning# 
26 5’UTR-Xho1 5’-CTCCTGTCTCACTCGAGGCTTCCAG-3’ (-17)-8 
27 5’UTR-SbfI-BamH1 5’-ATGGGGATCCACCACCTGCAGGAACA-3’ 247-272 
28 CP-Sbf1 5’-GCAAGTGTTCCTGCAGGTGGTGCAGCCCC-3’ 242-270 
29 CP-SacI-BamH1 5’-CCTGGATCCTTTGGTTGATAGAGCTCATTGAC-3’ 2138-2169 
30 3’UTR-Sac1 5’-GTCAATGAGCTCTATCAACCAAAG-3’ 2138-2161 
31 3’UTR-BamH1 5’-GTGCCACGTTGGATCCGTTTAAAACC-3’ 2618-(2643) 
32 3’del new 2.1 fw 
5’-
CCACTCAGACTGTAACAAAGGTTTTAACGGATCCACC-3’ 
2596-2636 
33 3’del new 2.1 rv 
5’-GGTGGATCCGTTAAAACCTTTGTTACAGTCTGAGTGG-
3’ 
2636-2596 
 
Deletion of created restriction sites for subcloning 
34 Sbf1-remove fw 5’-GTGCAAGTGTTCCTCCAAGTGGTGCAGCCCCA-3’ 240-271 
35 Sbf1-remove rv 5’-TGGGGCTGCACCACTTGGAGGAACACTTGCAC-3’ 271-240 
36 Sac1-remove fw 
5’-CTTTGGAACAGTCAATGAGCACTATCAACCAAAGTA 
TCAAG-3’ 
2128-2168 
37 Sac1-remove rv 
5’-CTTGATACTTTGGTTGATAGTGCTCATTGACTGTTCC 
AAAG-3’ 
2168-2128 
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5.2. Methods 
5.2.1. Plasmid Construction  
Human prominin-1 (hprom-1) splice variant 1 (s1; GenBank AF507034.1, cDNA clone 
MGC: 20041 IMAGE: 4644690) and 2 (s2; AF027208.1168) expression plasmids were 
constructed by introducing the full-length coding sequence of both proteins into the 
enhanced yellow fluorescent protein (EYFP)-N1 vector. XhoI and NotI restriction sites 
were used for directional cloning168. Note that XhoI/NotI digestion of pEYFP-N1 vector 
causes the excision of EYFP. 
The eukaryotic expression plasmid containing canine prominin-1 (cprom-1) splice 
variant 23 (s23) in-frame with GFP was generated by removing the terminal codon as 
well as one adenine residue using QuikChange® II Site-Directed Mutagenesis Kit with 
the oligonucleotide primers 14 and 15 (Table 1). A linker of 11 amino acids is located 
between the cprom-1.s23 and the GFP sequence. The eukaryotic expression plasmids 
containing either mouse prominin-1 (mprom-1) splice variant 1 or hprom-1.s2-GFP have 
been described previously296, 302, 353. 
In all cases, prominin sequences within the expression plasmids were sequenced in 
order to confirm the absence of any reading mistakes introduced by the DNA 
polymerase and/or subcloning steps. Sequencing reactions were performed using 
Applied Biosystems 3730 Genetic Analyzer at the Max-Planck-Institute of Molecular Cell 
Biology and Genetics (MPI-CBG, Dresden, Germany) sequencing facility. 
 
 
5.2.2. Site Directed Mutagenesis  
All point mutations were created using QuikChange® II Site-Directed Mutagenesis Kit 
according to the manufacturer’s instructions using primers listed in Table 1. The hprom-
1.s1/s2 plasmids were used as templates. All resulting plasmids were sequenced to 
confirm mutations.  
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5.2.3. Cell Culture and Transfection  
MDCK cells (strain II) were cultured in Dulbecco’s Modified Eagle Medium (DMEM, 1x, 
1g/l D-Glucose, L-Glutamine, Pyruvate, GIBCO) containing 10% fetal calf serum (FCS, 
PAA, GE Healthcare), 100 U/ml penicillin and 100 μg/ml streptomycin (GIBCO), 10 mM 
HEPES and MEM Non Essential Amino Acids (1x, PAA) at 37ºC in a humidified 5% CO2 
atmosphere as described previously315. They were stably transfected with expression 
plasmids encoding hprom-1.s1 or s2 (-GFP), their corresponding mutants (2M, K138Q, 
2M Y819/828F, Y819/828F), cprom-1.s23-GFP or mprom-1.s1296 by electroporation 
using AmaxaTM NucleofectorTM Kit L according to the manufacturer’s instructions. Two 
days after transfection, cells expressing the neomycin resistance gene were selected by 
introducing 500 μg/ml of geneticin into the culture medium and further expanded in a 
medium containing only 250 μg/ml of selective agent. Note that the microvillar 
morphology of cells cultured in medium without geneticin or in those containing low 
(0.5 M) or higher (1 M) concentrations does not change ruling out a direct effect of the 
drug on polyphosphoinositides354, 355.  
To enrich the cell population expressing recombinant hprom, cells were sorted 
using paramagnetic labeling with CD133 MicroBeads and LS columns following the 
manufacturer’s instructions. Under these conditions, 80-95% of cells expressed the 
human transgene. 50 and 70% of neomycin-resistant cells expressed cprom-1 and 
mprom-1, respectively. 
 
5.2.4. Sodium Butyrate Treatment  
To enhance the expression of the transgene, 10 mM sodium butyrate was added to the 
culture medium for 16 h prior to immunocytochemistry experiments315, 356.  
 
5.2.5. HDAC6 Inhibition  
Cells were incubated with 1 μM tubacin, niltubacin or DMSO (1:10 000) for 16 h. 
 
5.2.6. PI3K Inhibition  
Cells were incubated with 5 μM LY294002 or DMSO (1:2000) as control for 4 h.  
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5.2.7. Detergent Cell Extracts and Endoglycosidase Digestion  
Wild type and transfected MDCK cells (2 x 106) were grown in 6-well plates until 6 days 
post-confluence. Cells were harvested by trypsinization and centrifuged for 5 min at 300 
x g. Cell pellets were lysed in solubilization buffer supplemented with complete protease 
inhibitor cocktail for 30 min at 4°C. Lysates were centrifuged at 4°C (10 min, 10,000 x 
g) and the resulting supernatants were either used for endoglycosidase digestion or 
directly mixed with Laemmli sample buffer (with or without reducing agent; β-
mercaptoethanol) prior to analysis with SDS-PAGE.  
For endoglycosidase digestion, the detergent cell extracts were incubated for 6 h at 
37°C in the absence or presence of 1 unit PNGase F or 10 mU EndoH. 
 
 
5.2.8. Differential Centrifugation of Prominin-1-Containing Membrane 
Vesicles  
Transfected MDCK cells were grown in six-well dishes until 6 dpc. After gently washing 
with PBS they were supplied with fresh culture medium (2 or 3 ml) and incubated for 4 
or 16 h. Afterwards, conditioned media were collected, supplemented with complete 
protease inhibitor cocktail and subjected to differential centrifugation as follows: 5 min 
at 300 x g (P1); 20 min at 1,200 x g (P2); 30 min at 10,000 x g (P3) and 1 h at 200,000 x 
g (P4). Pellets were resuspended in Laemmli buffer. In parallel, adherent cells were 
harvested and centrifuged for 5 min at 300 x g. The resulting pellets were lysed in 
solubilization buffer supplemented with complete protease inhibitor for 30 min at 4°C. 
Detergent extracts were centrifuge at 4°C (10 min, 10,000 x g) and resulting 
supernatants were mixed with Laemmli buffer. All samples were analyzed by 
immunoblotting for prominin-1 and β-actin or α-tubulin. For quantification, we 
combined the prominin-1 immunoreactivity associated with cell extract, P1 and P2 
fractions and designated them as Cell fraction while materials found in P3 and P4 were 
referred to as Vesicle fraction. 
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5.2.9. Immunoblotting  
Proteins were separated by SDS-PAGE (7.5%, 1.5 h, 60 mA) under reducing or non-
reducing conditions and transferred to PVDF membranes using a semi-dry transfer cell 
system (60 min, 150 mA for 2 gels). After transfer, membranes were incubated in 
blocking buffer I overnight at 4°C. Incubation with primary antibodies was performed 
for 1 h at room temperature. As loading controls, mouse mAb against actin, β-actin or 
α-tubulin was used. All antibodies were diluted in blocking buffer I. For the analysis of 
immuno-isolated prominin-1, membranes were incubated in blocking buffer II overnight 
at 4°C prior to 1 h incubation with the antibodies against prominin-1 and phosphor-
tyrosine. Antibodies were diluted in blocking buffer II. In all cases, antigen-antibody 
complexes were detected using appropriate horseradish peroxidase (HRP)-conjugated 
secondary antibodies and visualized with enhanced chemiluminescence reagents. 
Membranes were exposed to films and developed using the OPTIMAX film processor. 
Fiji357 was used for the quantification of immunoblotting. 
 
5.2.10. Flow Cytometry  
Non-confluent wild type and transfected MDCK cells were harvested via treatment with 
0.05% trypsin/0.5 mM EDTA solution for 15 min at 37°C. Cells were centrifuged, and 
the pellet was resuspended in PBS containing 0.2% gelatin and 5 mM EDTA. Cell 
suspensions (2 x 105 cells in 100 μl) were incubated for 30 min at 4°C with 
fluorochrome-conjugated antibodies. Cells expressing prominin-1-GFP were examined 
using the fluorescein isothiocyanate (FITC) channel. Cells were washed with PBS 
containing 5 mM EDTA. After centrifugation, cells were resuspended and incubated for 
10 min in 4% PFA. After washing with PBS containing 5 mM EDTA, 20,000 events were 
acquired on a FACSCanto II System. Instrument settings and gating strategies were 
established using unstained or CD34-labeled MDCK cells. 
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5.2.11. Microscopy  
5.2.11.1. Immunofluorescence and Confocal Microscopy  
MDCK cells were grown on fibronectin-coated glass coverslips, in silicon eight-well 
chambers (flexiPerm) or μ-Slide 8 wells. They were rinsed with Ca/Mg buffer and 
incubated in blocking buffer III for 30 min at 4°C. For cell surface labeling, cells were 
incubated with a primary antibody in blocking buffer III for I h at 4°C, washed with PBS 
and then fixed in 4% PFA in PBS for 30 min at room temperature. Afterwards, they 
were rinsed with PBS and incubated for 10min in PBS containing 50 mM NH4CL prior 
to the incubation with secondary antibodies. For intracellular labeling, fixed cells were 
permeabilized and blocked with permeabilization buffer for 30 min at room 
temperature. Cells were incubated for 30 min with additional primary antibodies 
followed by the appropriate secondary antibodies (30 min each), all diluted in 
permeabilization buffer. For labeling with homemade antibodies (80B258 and αhE2), 
PFA-fixed cells were incubated in SDS buffer for 30 min at room temperature and 
washed with PBS containing 0.2% gelatin for 10 min. Cells were incubated with 
antibodies diluted in PBS containing 0.2% gelatin. Nuclei were counterstained with DAPI 
(1 μg/ml). Cells were washed two times with PBS, once with H2O and mounted in 
Mowiol 4.88. Cells seeded in flexiPerm chambers or μ-Slide 8 Wells were not mounted, 
but directly observed with Zeiss LSM 700 confocal laser scanning microscope (Jena, 
Germany). Micrographs in Fig. 11B, Fig. 21 G/H, Fig. 22, Fig. 24J and Fig. 30 A/D were 
prepared from data files using Volocity 3D Image Analysis Software (PerkinElmer) and all 
others were processed with Fiji357. 
 
5.2.11.2. Scanning Electron Microscopy (SEM) 
Samples for SEM analysis were prepared as described337. Briefly, MDCK cells grown on 
fibronectin-coated coverslips were fixed in 2% glutaraldehyde overnight at 4°C. After 
dehydration in an acetone gradient (25-100%) cells were critical point dried in a CO2 
system (CPD 300). Samples were mounted on aluminum stubs, coated with gold in a 
sputter coater and examined with a scanning electron microscope (JSM-7500F). 
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5.2.11.3. Transmission Electron Microscopy (TEM)  
Cells growing on 30-mm dishes were prefixed by the addition of 0.1 % glutaraldehyde 
into the cell culture medium and subsequently fixed in 1% PFA, 1% glutaraldehyde in 0.1 
M PIPES, pH 7.4, at room temperature. After washing steps, cells were postfixed in 1% 
aqueous osmium tetroxide for 1 h at room temperature. After washing with water, cells 
were incubated with 0.1 % tannic acid in water for 10 min and contrasted with 1% 
aqueous uranyl acetate for 30 min at room temperature. The samples were processed 
through a graded series of ethanol for standard plastic embedding in LX 112 resin 
(LADD Research Industries). Sheets of resin embedded cells were removed from the 
dishes by liquid nitrogen. Transverse sections were cut at 70 nm on an UCT 
ultramicrotome (Leica), and poststained with uranyl acetate and lead citrate. The 
samples were viewed in a Morgagni electron microscope (Thermo Fisher Scientific) and 
images acquired on a Morada CCD camera (EMSIS GmbH). 
 
5.2.11.4. Phase-Contrast Microscopy  
Cellular morphology was observed by phase-contrast microscopy using a high-resolution 
digital camera (Canon PowerShot A620) attached to a Zeiss Axiovert 40C microscope. 
Micrographs were processed using Adobe Photoshop. 
 
5.2.12. Protein Sequence Analysis  
The amino acid sequence deduced from cprom-1 cDNAs was compared with its mouse 
and human orthologs using CLUSTAL OMEGA358, 359. Pairwise sequence identity and 
similarity were analyzed using Sequence Identity And Similarity (SIAS) with BLOSUM62 
matrix (gap open and gap extend penalties at 10 and 0.5, respectively)360 on a Spanish 
server (http://imed.med.ucm.es/Tools/sias.html). The signal peptide and transmembrane 
domains were determined using the Consensus Constrained TOPology prediction web 
server (http://cctop.enzim.ttk.mta.hu)361. The Color Align Conservation program from 
Sequence Manipulation Suite (SMS; www.bioinformatics.org) was used to illustrate the 
output of the sequence alignment programs362. 
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5.2.13. Measurements  
Primary cilia were quantified using Huygens Professional Software (Scientific Volume 
Imaging, Hilversum, The Netherlands). After deconvolution of z-stack images the 
advanced object analyzer was used to obtain ciliary length. Mean intensity values were 
measured using Volocity 3D Image Analysis Software.  
 
5.2.14. Statistical analysis  
Analyses were performed using GraphPad Prism version 6.00 for Mac (GraphPad 
Software, La Jolla California USA, www.graphpad.com). Two-tailed Fisher’s exact test 
was applied for the evaluation of the absence/presence of prominin-1 in primary cilia, 
ciliary deficiencies and the microvillar phenotypes. Ciliary length, fluorescence intensity 
of ciliary tubulin, and the number of microvilli per cluster were analyzed using the two-
tailed Mann-Whitney test. The analyses of the number of microvilli and microvillar 
clusters; the prominin-1 immunoreactivity associated with membrane vesicles; dome 
formation; the nuclei numbers regarding proliferation or dome formation and the 
immunoreactivity ratio of prominin-1/β-actin were estimated using the two-tailed 
unpaired student’s t-est. Differences were regarded as significant if the calculated p-
values were ≤ 0.05, * = p < 0.05, ** = p < 0.01, *** p = < 0.005.  
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6. RESULTS 
 
6.1. Human Prominin-1 Localizes to Microvilli and the 
Primary Cilium at the Apical Membrane of MDCK Cells  
In order to study the influence of prominin-1 on the organization and dynamics of 
plasma membrane protrusions two different splice variants, s1 and s2, of human 
prominin-1 (hprom-1) were overexpressed in MDCK cells (Fig. 12A; done by Deimantė 
Šimaitė). They differ in the extracellular N-terminus, where exon 3 (Fig. 12A, red 
square) is absent in s1. This exon encodes for 9 amino acids (PETVILGLK). The 
expression level of both variants in the corresponding cell lines was similar (Fig. 12B) 
although differences in their expression patterns were detected. S1 was expressed in 
88% of the cells in a confluent monolayer while 95% were positive when transfected 
with splice variant 2 (Fig. 12C). Additionally, immunolabeled s1-expressing cells showed 
variations in signal strength ranging from weak to medium to strong. In contrast, the 
signal strength of s2-positive cells was more uniform (Fig. 12D). Next, I analyzed the 
localization pattern of both splice variants in polarized MDCK cells. At day 6 post-
confluence (dpc), the polarized cell monolayer was subjected to double 
immunofluorescence using anti-prominin-1 and anti-acetylated α-tubulin antibodies or 
WGA. Anti-acetylated α-tubulin was used to visualize primary cilia and WGA to mark 
the apical plasma membrane. Confocal laser scanning microscopy (CLSM) analysis 
revealed the colocalization of both variants with WGA at the apical plasma membrane 
(Fig. 12E). A punctate pattern was observed which is characteristic for microvilli-
associated antigens319, 363. Both splice variants were also detected in the primary cilium 
(Fig. 12F). No hprom-1 immunoreactivity was detected at lateral and basal membranes 
consistent with previous reports (Fig. 12G)315, 337. 
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Fig. 12 Hprom-1 splice variant s1 and s2 localize to apical plasma membrane 
protrusions upon overexpression in MDCK cells. 
(A) Cartoon illustrating the domain organization of hprom-1.s1 and s2 (s2, red square). TM, 
transmembrane domain. (B-G) MDCK cells stably transfected with s1 or s2 were analyzed by immunoblot 
(B), flow cytometry (C) and immunocytochemistry at 6 dpc (D-G). (B) Quantification of the expression 
levels of s1 and s2 upon normalization to β-actin expression. The levels were not significantly (n.s.) 
different as revealed by two-tailed unpaired student’s t-test (n = 6). Standard deviation is indicated. (C) 
Cells were directly incubated with PE-coupled AC133 antibody. The vertical dashed line indicates the cut-
off for cells positive for hprom-1. The cut-off was established using unstained cells or those labeled with 
the irrelevant anti-human CD34-PE antibody (Fig. 15C). (D) Maximum projection of cells surface-labeled 
for hprom-1 using AC133 antibody. w, weak, m, medium, s, strong. (E, F) Double immunofluorescent 
labeling with AC133 antibody and wheat germ agglutinin (WGA). (E) Maximum projection of 19 optical x-
y sections (0.3 μm-slices) of the apical plasma membrane. Insets and arrows highlight the colocalization of 
hprom-1 and WGA in a punctate-like pattern. (F) Single optical x-z-plane sections illustrating the absence 
of hprom-1 at lateral and basal membranes. Nuclei were counterstained with DAPI. (G) Maximum 
projection of 16 (s1)/13 (s2) optical x-y sections (0.3 μm-slices) of the primary cilium labeled with anti-
acetylated α-tubulin and AC133 antibodies. Both splice variants colocalize with the ciliary marker. White 
semicircle, ciliary base. Scale bars, 2 μm (D), 5 μm (E), 3 μm (F) and 2 μm (G). 
 
 
 
 
6.2. The Active Interplay of Prominin-1–Ganglioside 
Membrane Complexes, the PI3K and Cytoskeleton 
Components Regulates the Architecture and Dynamics 
of Microvilli  
With ongoing polarization, MDCK cells generate a highly specialized apical membrane 
domain, which is characterized by the presence of a primary cilium and a vast number of 
microvilli. The latter are thin plasmalemmal protrusions common to all transporting and 
sensory epithelial cells and are particularly present in the intestine and proximal kidney. 
For decades, microvilli have been viewed as passive cytoskeletal scaffolds that serve to 
increase the surface area. Therefore, their only ascribed function was the housing of 
various membrane transporters to enhance nutrient processing and absorptive capacity. 
However, McConnell and colleagues clearly demonstrated that intestinal microvilli are 
also able to release vesicles from their tips169. These vesicles were enriched in specific 
proteins to deploy catalytic activities into the intestinal lumen and are probably involved 
in communication with the lumenal environment. Until today, the significance of 
microvilli for the regulation of basic cell functions remains obscure. The specific 
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microvillar localization of vital membrane proteins such as glucose transporters, ion 
channels, ion pumps and ion exchangers indicates their importance and functional 
diversity. Besides their role as vesicle-generating organelle they might also be involved in 
calcium (Ca2+) signaling167. In this context, microvilli integrate important components of 
this pathway. The cross-linked actin filaments can act as an intracellular Ca2+storage and, 
simultaneously, serve as a diffusion barrier between the tip of the microvilli and the cell 
body. Additionally, Ca2+-permeable channels of the transient receptor potential type are 
located at the tip of microvilli. Lange also discussed the implication of microvilli in the 
regulation of glucose transport/energy metabolism, ion channel regulation, generation 
and modulation of the membrane potential, volume regulation and multidrug 
resistance167. Hence, their multifaceted role in regulating general cell functions may be 
totally underestimated. 
The specific localization of prominin-1 to plasma membrane protrusions and its 
proposed role as a scaffolding protein involved in their organization and dynamics 
prompted me to investigate the impact of hprom-1-ganglioside membrane complexes on 
the apical microvilli of MDCK cells. 
 
 
6.2.1. Distribution and Morphology of Microvilli on MDCK Cells  
First, I performed a high-resolution characterization of the apical membrane of wild type 
MDCK cells by scanning electron microcopy (SEM) at 6 dpc. The distribution of 
microvilli across the apical surface varied considerably between neighboring cells; 
ranging from densely packed (Fig. 13A, purple) to sparsely scattered (Fig. 13A, brown). 
Microvilli were not only present as individual units, but also formed clusters comprising 
about ten microvilli (Fig. 13A, beige). Note that these structures differ to those 
described by Lima et al. where microvilli cluster at their tips364. The mechanism 
underlying this microvillar arrangement is poorly characterized 173, 365-368. Interestingly, no 
microvilli were observed in the proximity of the primary cilium (Fig. 13A, pink) and an 
array of microvilli was always detected at the cell borders (Fig. 13A, dark green).  
The length of microvilli also varied from cell to cell (Fig. 13B). Some cells displayed 
short microvilli with a length < 200 nm (Fig. 13B, red) while other cells harbored 
microvilli of intermediate length (Fig. 13B, blue, 200-400 nm). Long microvilli with a 
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length of > 400 nm were rarely seen (Fig. 13B, yellow). Only a few cells showed 
membrane ruffles or branched microvilli (Fig. 13B, orange and green, respectively).  
Next, a quantitative analysis of microvillar phenotypes was conducted. Therefore, I 
randomly chose cells of the monolayer and assigned them to one of the defined 
categories: short, intermediate, long, branched or membrane ruffles. This analysis 
revealed that at early time points of polarization, e.g., day one or three postconfluence, 
numerous cells harbored membrane ruffles, a phenomenon that could be linked to 
different stages of cytokinesis (Fig. 13C; Table 2)369. Starting at 6 dpc normal and short 
microvilli were the most common phenotypes (about 95% of examined cells, Fig. 13C, 6-
12 dpc; Table 2). On rare occasions, long (1-3%) or branched (1-2%) microvilli or 
membrane ruffles (1%) have been observed.  
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Fig. 13 Distribution and morphology of microvilli at the apical plasma membrane of 
MDCK cells.  
 (A-C) Untransfected MDCK cells were grown on fibronectin-coated coverslips for 6 dpc (A, B) or as 
indicated (C) and analyzed by SEM. (A) The apical plasma membrane of cells in a monolayer harbored 
either densely packed (purple) or sparsely scattered (brown) microvilli, or clusters of them (beige). No 
microvilli were observed near the primary cilium (pink), while an array of microvilli (dark green) was 
found at the cell border. (B) Individual microvilli of neighboring cells within the same cell monolayer 
showed distinct shapes. Microvillar lengths ranged from short (red; < 200 nm) to intermediate (blue; 200-
400 nm) to long (yellow; > 400 nm). Rare cells harbored membrane ruffles (orange) or branched microvilli 
(green). Dotted line encircles the surrounding surface of the primary cilium (A) and dashed line marks the 
cell border (B). (C) Microvillar phenotypes during cell polarization. Pie charts present the percentages of 
cells harboring a given microvillar phenotype at the indicated time of culture (dpc). Each examined cell 
was assigned to one of the defined categories by the predominant shape of its microvilli. Data were 
acquired by SEM from six (1 to 8 dpc) or three (12 dpc) independent experiments. At least 100 cells per 
experiment were evaluated. Scale bars, 500 nm; except the low power view (A, cell border), 5 μm. 
 
 
 
 
 
Table 2. Microvillar phenotypes of untransfected MDCK cells at the indicated days 
post-confluence.  
Pie chart data shown in in Fig. 13C. Percentage of cells with a given phenotype is presented with the mean 
and standard deviation. At least 100 cells per experiment were evaluated. n = 6 (1-8 dpc) or 3 (12 dpc). 
 
 
 
 
 
The microvillar heterogeneity was less impressive when cells were not confluent. In 
that state, many cells did not form any microvilli (Fig. 14A), while others harbored short 
microvilli or membrane ruffles (Fig. 14B-D). No direct link between the observed 
phenotypes and the position of the cell in the growing monolayer (surrounded or not by 
neighboring cells) was noticed. On free cell borders different amounts of filopodia were 
formed (Fig. 14E and F). The array of microvilli along cell borders started to form (Fig. 
14G) but was still missing between many cells (Fig. 14A, B).  
 
 
 
Days 
Microvillar phenotype (%) 
 
Short Inter-
mediate 
Long Branched Knob-like Ruffled 
1      50 ± 5  23 ± 4    0    0 0 27 ± 3 
3      53 ± 12 24 ± 14    0    0 0 23 ± 12 
6      45 ± 7 50 ± 6 3 ± 3 1 ± 2 0   1 ± 2 
8      63 ± 7 34 ± 12 1 ± 1 2 ± 3 0      0 
12      54 ±7 42 ± 6 2 ± 3 2 ± 3 0      0 
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Fig. 14 Appearance of the apical plasma membrane of subconfluent MDCK cells. 
(A-G) Untransfected MDCK cells were grown on fibronectin-coated coverslips and analyzed by SEM. 
Different regions (A-G) of the subconfluent monolayer are displayed as illustrated in the cartoon (H). At 
this stage, adjacent cells displayed either no microvilli (A) or numerous uniformly distributed ones (B). On 
some cells the first microvilli-like structures appear (C) as well as membrane ruffles (D). At free cell 
borders, few (E) or numerous (F) filopodia were formed. The array of microvilli along the cell border 
(dashed yellow line) of adjacent cells is already forming (G), while it is still missing on others (A, B). Scale 
bars, 1 μm. 
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6.2.2. Mutations in the First Ganglioside-Binding Site of Hprom-I Do 
Not Alter its Microvillar Localization or Colocalization with GM1  
In 2000, Huttner and colleagues unraveled the mechanism underlying the localization of 
prominin-1 to microvilli319. They demonstrated that the apical membrane of polarized 
MDCK cells is composed of distinct cholesterol-based membrane microdomains (lipid 
rafts, see chapter 2.7.5). The cell surface form of prominin-1 interacts directly and 
specifically with cholesterol and the depletion of the latter resulted in the loss of 
prominin’s microvillus-specific localization319. Thus, the interaction of prominin-1 with 
plasma membrane cholesterol in a special type of lipid raft leads to its microvillar 
retention. Lipid rafts are also enriched in sphingolipids such as the gangliosides GM1 or 
GM3
196, 216. Interestingly, prominin-1 colocalizes with GM1 in microvilli and primary cilia 
of MDCK cells while it is excluded from GM3-enriched planar domains
211. This 
colocalization pattern has also been observed in microvillar-like structures of 
hematopoietic stem cells353, 370, 371. Furthermore, Taïeb et al. proposed two ganglioside-
binding sites in the structure of prominin-1310. The first one is located in the first 
extracellular domain of prominin-1 and specifically binds GM1 (Fig. 15A, orange cylinder). 
The second binding site was found in the second extracellular domain with less 
specificity in its binding partner (Fig. 15A, yellow cylinder).  
To investigate the interaction of GM1 and hprom-1 and its impact on the 
organization of membrane protrusions two amino acids in the first ganglioside-binding 
site of hprom were mutated (P37A and Y41S, Fig. 15A, green letters; done by Deimantė 
Šimaitė). These two amino acids, besides others (Fig. 15A, blue letters), provide key 
features of a glycosphingolipid-binding domain310. The mutants were named 2M. 
Initially, upon stable transfection, the expression levels of wild type and mutated 
hprom-1.s1 and s2 were checked by immunoblotting and no significant differences were 
found (Fig. 15B). Flow cytometry analysis revealed that s1 2M and s2 2M were 
expressed in about 87% and 90% percent of the cells; similar to their corresponding wild 
types (88% in s1 and 95 % in s2; Fig. 15C). 
Next, cells were subjected to double cell surface labeling with monoclonal anti-
hprom-1 antibody and fluorescent cholera toxin B subunit conjugates. The latter 
recognizes the ganglioside GM1. CLSM analysis revealed that the 2M mutations did not 
interfere with the characteristic punctate staining pattern of hprom-1 at the apical 
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plasma membrane (Fig. 15D). Additionally, a colocalization of GM1 and hprom-1 
irrespective of the splice variant or mutant was observed (Fig. 15D). Thus, the 2M 
mutations in the first ganglioside-binding side of hprom-1 neither affect its microvillar 
retention nor the colocalization with GM1. 
 
 
 
 
6.2.3. Overexpression of Hprom-1 Increases the Number of Microvilli  
Next, I analyzed the microvilli at the apical surface of MDCK cells upon overexpression 
of hprom-1 at 6 dpc by TEM (performed by Michaela Wilsch-Bräuninger) and SEM. TEM 
analysis confirmed the presence of microvillar clusters (Fig. 15E, yellow line) in addition 
to single microvilli, and suggested an increase in the number of microvilli in the 2M 
mutants. Using SEM micrographs, the quantification of microvilli of untransfected cells 
(MDCK) revealed an average amount of 95±33 microvilli per 12 μm2 of cell surface (Fig. 
15E, F). This number significantly increased by 25% upon the overexpression of both 
hprom-1 splice variants to 127±49 (s1) and 127±36 (s2). Cells expressing 2M mutants 
displayed an additional increase. Thus, s1 2M and s2 2M mutants harbored 168±56 and 
156±43 microvilli per 12 μm2 of cell surface, respectively (Fig. 15E, F).  
The examination of microvillar clusters on untransfected cells shows an average 
number of 10 clusters per 17.3 μm2 of cell surface (Fig. 15E, G). Each cluster comprised 
about 10±3 microvilli (Fig. 15H). Cells transfected with s1 or s2 showed a significant 
increase in the number of clusters (~25%) as well as in the number of microvilli per 
cluster. The 2M mutations exerted no additional effect on the amount of microvillar 
clusters (Fig. 15G). In contrast, the number of microvilli per cluster was further 
increased in both mutants, but only significant for s1 2M.  
In summary, the overexpression of both hprom-1 splice variants significantly 
increases the number of individual microvilli, microvillar clusters as well as microvilli per 
cluster on the apical surface of MDCK cells. The 2M mutants exert a strong influence on 
the number of single microvilli and a milder one on the number of microvilli per cluster.  
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Fig. 15 Overexpression of hprom-1 in MDCK cells increases the number of microvilli. 
(A) Schematic overview of the domain organization of hprom-1. The sequence of the first ganglioside-
binding site is displayed (orange). Amino acids implicated in the interaction with GM1 are marked in blue. 
Two of them were mutated (Pro37→Ala and Tyr41→Ser, green) in the 2M mutants. Blue cylinders, 
transmembrane domains (TM1-5); red square, exon3 in s2; orange and yellow cylinders, ganglioside-
binding sites. (B-G) MDCK cells stably transfected with s1 or s2 wild type or 2M mutants were analyzed 
by immunoblotting (B), flow cytometry (C), immunocytochemistry (D), TEM and SEM at 6 dpc (E-H). (B) 
Expression levels were evaluated by immunoblotting and quantified. Upon normalization to β-actin, the 
expression levels of 2M mutants do not differ significantly from each other or from their corresponding 
wild type protein (n.s.; two-tailed unpaired student’s t-test, n = 5). The mean±standard deviation is 
indicated. (C) Cells were directly incubated with PE-coupled AC133 antibody and analyzed by flow 
cytometry. The vertical dashed line indicates the cut-off for cells positive for hprom-1. The cut-off was 
established using unstained cells (PE) or those labeled with the irrelevant anti-human CD34-PE antibody. 
(D) Maximum projection of CLSM images of cells double-labeled with anti-hprom-1 antibody and cholera 
toxin b. Mutations in the GM1-binding site of hprom-1 did not inhibit its colocalization with the ganglioside 
(insets, arrows). (E) TEM and SEM micrographs show individual microvilli or clusters of them (yellow). (F-
H) Quantification of individual microvilli (F), microvillar clusters (G) or microvilli per cluster (H) of the 
indicated cell line. SEM micrographs were used for quantification. Numbers of individual microvilli or 
cluster of them were counted for a surface equivalent of 12.0 and 17.3 μm2, respectively. Five randomly 
taken cells within a confluent cell monolayer were analyzed per experiment (n = 6). Mean±standard 
deviation is indicated. Two-tailed unpaired student’s t-test (F-G), Mann-Whitney test (H). **, p < 0.01; 
***, p < 0.005. Scale bars, 5 μm (D), 500 nm (E, SEM) and 1 μm (E, TEM). 
 
 
 
6.2.4. Overexpression of Hprom-1 Alters The Architecture of 
Microvilli  
During the analysis of apical microvilli on hprom-1-transfected cells, a pronounced 
change in their shape was noticed (Fig. 16A, B). Therefore, I decided to conduct a 
quantitative analysis of microvillar phenotypes at 6 dpc using SEM. Examined cells were 
randomly picked and assigned to one of the following categories: short, intermediate, 
long, branched, knob-like (or irregular shape) microvilli or membrane ruffles. 25% of the 
cells expressing s1 or s2 wild type generated branched microvilli (Fig. 16 A-C, green; 
Table 3). This phenotype was scarcely observed in untransfected cells or those 
expressing an empty vector (3% and 0%, respectively). The expression of the 2M 
mutants led to a two-fold increase in cells with branched microvilli (49-53%). In addition, 
about 20% of the cells expressing s1 2M and s2 2M harbored microvilli with an irregular 
shape and/or knob-like structure at their tips (Fig. 16A-C, purple). These microvilli were 
rarely seen in unmutated cells (2% in s1 and 11% in s2) and have never been observed in 
untransfected cells or those carrying an empty vector. Furthermore, knob-like/irregular 
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microvilli often showed branching at the same time suggesting that both phenotypes are 
somehow linked (Fig. 16B, purple). 
Finally, microvilli with small protruding vesicle-like structures at their tips were 
observed in cells expressing 2M mutants indicating that the budding of membrane 
vesicles might be affected (Fig. 16A, purple, right panels).  
 
 
Table 3. Microvillar phenotypes of the indicated cell lines at 6 dpc.  
Pie chart data shown in Fig. 16C. Percentage of cells with a given phenotype is presented with the mean 
and standard deviation. At least 100 cells per experiment were evaluated. n = 5 
 
 
 
6.2.5. Mutations in the First Ganglioside-Binding Site of Hprom-1 
Decrease the Release of Prominin-1+ Vesicles  
Since microvilli are dynamic structures I examined the release of prominin-1+ vesicles 
from MDCK cells stably transfected with hprom-1.s1, s2 or their corresponding 2M 
mutants. Cells were cultured for 6 dpc, gently washed with PBS, supplied with fresh 
culture medium and incubated for 16 hours. The conditioned culture media were 
subjected to differential centrifugation followed by immunoblotting of recovered 
materials for hprom-1 and β-actin (Fig. 16D). The amount of hprom-1 immunoreactivity 
found in the vesicle fraction of s1 and s2 was comparable, 10±5% and 12±7%, 
respectively (Fig. 16E). The release of prominin-1+ vesicles by cells expressing 2M 
mutants was reduced by half irrespective of the splice variant (Fig. 16E; s1 2M: 5±2%, s2 
2M: 5±4%, n = 7). These results imply that the microvillar shape changes provoked by 
the expression of 2M mutants impair the correct budding and fission of vesicles from 
microvilli. The presence of small protruding vesicle-like structures at microvillar tips is 
consistent with such negative impact (see above). 
 
Cell line 
Microvillar phenotype (%) 
 
Short Inter-
mediate 
Long Branched Knob-like Ruffled 
MDCK 50 ± 9 46 ± 9 1 ± 2   3 ± 3          0   0 
Empty vector 64 ± 7 35 ± 6 1 ± 0      0          0   0 
s1 42 ± 9 29 ± 12 2 ± 1 24 ± 9       2 ± 2    1 ± 0 
s1 2M 15 ± 6 13 ± 6 1 ± 1 53 ± 9 17 ± 6    1 ± 1 
s2 37 ± 12 22 ± 10 2 ± 2 27 ± 4 11 ± 7    1 ± 1 
s2 2M 12 ± 9 14 ± 4 1 ± 1 49 ± 10 22 ± 11    2 ± 2 
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Fig. 16 Overexpression of hprom-1 leads to structural alterations of microvilli, which 
is enhanced by 2M mutations resulting in decreased vesicle release. 
(A-C) Untransfected MDCK cells (MDCK) and those stably transfected with an empty vector, hprom-
1.s1, s2 or their corresponding 2M mutants were grown until 6 dpc and analyzed by SEM and TEM. (A) 
High-power views of characteristic microvillar phenotypes. Almost all microvilli of untransfected cells and 
those carrying an empty vector are short (not shown) or intermediate (blue). Branched microvilli (green) 
were detected among hprom-1-expressing cells and irregular ones with knob-like structures (purple) 
among 2M mutant-expressing cells. (B) SEM overviews illustrating that the structural alterations appear as 
a general phenomenon affecting many microvilli of a given cell. Colored microvilli are selected as 
examples. (C) Percentages of cells harboring a given microvillar phenotype are shown in pie charts. Cells 
were quantified by SEM. Each examined cell was assigned to one of the defined categories by the 
predominant shape of its microvilli. Number of cells ≥100 per experiment. n = 5 (E-F) 16 h-conditioned 
media was subjected to differential centrifugation and adherent cells were harvested. The entire pellets 
and 1/40 of cell lysates were analyzed by immunoblotting for hprom-1 and β-actin. Molecular mass 
markers (kDa) are indicated. (F) Quantification of the release of hprom-1+ vesicles. Hprom-1 
immunoreactivity associated with cell lysates, P1 and P2 fractions were combined as cell fraction while 
materials found in P3 and P4 were referred to as vesicle fraction. n = 8. Two-tailed unpaired student’s t-
test, *, p < 0.05; **, p < 0.01. Scale bars, 100 nm (A) and 500 nm (B). 
 
 
 
6.2.6. Inhibiting the PI3K or its Interaction with Hprom-1 Reduces the 
Amount of Cells Harboring Modified Microvilli and Restores 
Vesicle Release Therefrom  
To unravel the mechanism underlying the morphological changes of microvilli we have 
to take a closer look at their structural organization. The family of phosphoinositides, 
including PIP2 and PIP3, play a tremendous role in the regulation of the actin 
cytoskeleton. Both are located in the inner leaflet of the microvillar membrane, but PIP2 
is much more abundant than PIP3
372. PIP2 strongly influences the organization of microvilli 
by inducing membrane-cytoskeleton connections via linker proteins such as myosin I or 
ezrin373-375. PIP3 is known activate the actin-related protein (Arp)2/3 complex leading to 
actin polymerization that creates branches from the side of existing filaments376, 377. 
According to Insall and Weiner, PIP2 and PIP3 are complementary signals carrying 
different messages to the cytoskeleton with PIP3 acting as a switch to turn on actin 
filament polymerization and PIP2 as marker of the plasma membrane to ensure growth 
at the right side and in the right direction235. The PI3K is the enzyme that converts PIP2 
into PIP3. It thereby initiates the reorganization of the underlying actin cytoskeleton
235, 
378-380. Importantly, the PI3K can be activated by phosphorylated hprom-1313. The 
phosphorylation of tyrosine residue 828 (in reference to splice variant 2; 819 in splice 
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variant 1) in the C-terminal region of hprom-1 mediates its direct interaction with the 
85-kDa regulatory subunit of the PI3K leading to its activation.  
Overexpression of hprom-1.s1/2 wild type, and particularly the 2M mutants, may 
cause an elevated activation of the PI3K. As a result, PIP2 could be transformed into PIP3 
thereby weakening the membrane-actin cytoskeleton links. Thus, the conversion of PIP2 
into PIP3 might favor the detachment of the membrane bilayer from the underlying actin 
cytoskeleton resulting in microvilli with irregular and/or knob-like phenotypes.  
To test this hypothesis, MDCK cells transfected with s1, s2 and the 2M mutants 
were incubated with the PI3K inhibitor LY294002. Furthermore, an additional mutation 
at residue 819/828 (Y819F/Y828F) was generated in the existing 2M mutants (Fig. 17A; 
performed by Vicente Bermúdez). In both approaches microvillar phenotypes and the 
release of hprom-1+ vesicles were analyzed. 
 
 
 
6.2.6.1. Inhibition of the PI3K Using LY294002  
The specific enzyme inhibitor LY294002 interacts directly with the ATP binding pocket 
of the PI3K and induces a conformational change in their catalytic domains381. MDCK 
cells expressing s1, s2 or 2M mutants were grown until 6 dpc, supplied with fresh 
culture medium containing 5 μM LY294002, or DMSO (1:2000) as control, and 
incubated for 4 hours. Afterwards, cells were examined by SEM (Fig. 17B) and their 
phenotypes were quantified (Fig. 17C). Incubating the cells with DMSO alone already 
had an impact on microvillar morphology, as reported earlier382. The main consequence 
was the enhanced formation of short microvilli, mainly on the expense of intermediate 
ones, irrespective of the splice variant or mutant (compare Fig. 17C and Fig. 16C). This 
phenomenon was observed in all cell lines except s2 2M (Table 4). Despite that, 
inhibition of the PI3K caused a dramatic decrease in the number of microvilli with 
structural alterations. The quantitative analysis revealed a reduction of knob-like 
microvilli by more than half (Fig. 17C, purple; Table 4). For example, in cells transfected 
with s1 2M or s2 2M the numbers dropped from 9±8% and 24±6% in DMSO-treated 
cells to 2±2% and 11±4% in LY294002-treated ones, respectively.  
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Interestingly, the number of branched microvilli was also significantly reduced (Fig. 
17C, green; Table 4). S1-transfected cells showed a small but significant reduction from 
27±11% to 20±15%. Astonishingly, cells expressing s1 2M only developed about half as 
much branched microvilli in comparison to DMSO-treated cells. A strong effect of 
LY294002 was also observed on cells expressing s2 and its corresponding mutant 
causing a decrease in the number of branched microvilli from 44±20% and 53±14% to 
16±9% and 31±13%, respectively.  
I also compared the release of hprom-1+ vesicles into the culture medium of 
untreated cells and those incubated with LY294002 or DMSO (Fig. 17D, E). The 
reduction of microvilli with structural alterations and the concurrent increase of short 
ones were reflected by an increase in the release of hprom-1+ vesicles in LY294002-
treated cells (Fig. 17D). The increase was not significant for cells expressing wild type 
hprom-1 but for those expressing 2M mutants. The latter showed a 3-5-fold increase in 
vesicle release. Although DMSO-treatment enhanced the number of cells with short 
microvilli it did not stimulate the release of hprom-1+ vesicles (Fig. 17E). This suggests 
that the appearance of short microvilli is not necessarily the result of extended release. 
 
 
 
Table 4. Microvillar phenotypes of the indicated cell lines upon treatment with 
LY294002 or DMSO at 6 dpc.  
Pie chart data shown in Fig. 17C. Percentage of cells with a given phenotype is presented with the mean 
and standard deviation. At least 100 cells per experiment were evaluated. n = 4 
 
Cell 
line 
 
Treatment 
Microvillar phenotype (%) 
 
Short Inter-
mediate 
Long Branched Knob-
like 
Ruffled 
s1 DMSO 59 ± 19   3 ± 3 0 27 ± 11 11 ± 12  0 
 LY294002 72 ± 20   3 ± 3 0 20 ± 15   5 ± 3 0 
s1 2M DMSO 61 ± 5   3 ± 2 0  27 ± 7   9 ± 8 0 
 LY294002 85 ± 8   1 ± 1 0 12 ± 6   2 ± 2 0 
s2 DMSO 47 ± 19   3 ± 3 0 44 ± 20   6 ± 2 0 
 LY294002 79 ± 7   3 ± 2 0 16 ± 9   2 ±3 0 
s2 2M DMSO 19 ± 15   4 ± 5 0 53 ± 14 24 ± 6 0 
 LY294002 51 ± 13   7 ± 7 0 31 ± 13 11 ± 4 0 
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Fig. 17 Interfering with the interaction of hprom-1 and PI3K or inhibiting the latter 
reduces the amount of structurally altered microvilli and enhances vesicle release. 
(A) Cartoon illustrating the domain organization of hprom-1 (for details see legend of Fig. 15) with 
mutations in the GM1-binding site (orange) and at tyrosine 819 (Tyr→Phe; in reference to splice variant 1, 
828 in s2). (B-H) Cells were stably transfected with s1 or s2, 2M or 2M Y828F mutants and examined at 6 
dpc. (B-E) PI3K was inhibited by incubating the cells for 4 h with LY294002 (5 μM), or DMSO (0.05%) as 
control. After treatment, cells were processed for SEM (B) and quantified (C) or subjected to differential 
centrifugation (D-E). (D, E) Quantification of the release of hprom-1+ vesicles. After differential 
centrifugation, samples were analyzed by immunoblotting for hprom-1. The data are presented as fold-
change values relative to DMSO-treated (D) or untreated cells (E) (=1, red line). n = 4 (F) SEM 
micrographs of knob-like microvilli on s1 2M mutant (purple). Introducing Y819F mutation resulted in 
enhanced formation of short and intermediate microvilli (blue). (G) Quantification of microvillar 
phenotypes. n = 5 (H) Differential centrifugation of 16 h-conditioned media analyzed by immunoblotting 
for hprom-1. For comparison, the vesicle fractions of 2M mutants are presented (magenta). n = 6 (C, G) Pie 
chart values are expressed as a percentage. Number of cells ≥100 per experiment. Two-tailed Fisher’s 
exact test. The p-values are indicated. (D, E, H) Two-tailed unpaired student’s t-test, *, p < 0.05; ***, p < 
0.005. Scale bars, 500nm. 
 
 
 
6.2.6.2. Impairment of the Interaction of PI3K and Hprom-1 by 
Introducing Y828F Mutation  
Next, I compared MDCK cells transfected with s1/2 2M with those carrying the 
additional Y819/828F mutation that would impede its phosphorylation, and hence the 
interaction of hprom-1 with the 85-kDa regulatory subunit of the PI3K313 (Fig. 17A). 
Changes in tyrosine phosphorylation of cell surface hprom-1 were demonstrated by 
immunoisolation using AC133 mAb-conjugated magnetic beads and immunoblotting with 
anti-phosphotyrosine antibody (Fig. 18A; performed by Jana Karbanová). Quantification 
revealed a significant reduction of phosphorylation in 2M Y819/828F mutants (Fig. 18A, 
B). The remaining phosphotyrosine signal can be attributed to the second 
phosphorylation site in hprom-1 (Y843/852)312. A slight, but not significant, increase of 
phosphorylated tyrosine in 2M mutants compared to their wild type proteins was 
detected. Nonetheless, the interaction of hprom-1 with the p85-kDa subunit of PI3K 
was strongly stimulated in cells expressing 2M mutants but not in those carrying the 
additional tyrosine mutation (Fig. 18C, D). These data suggest that mutations in the 
extracellular GM1-binding site of hprom-1 influence its interaction with a cytosolic 
enzyme (Fig. 18D). Due to this observation and the impact of Arp2/3 complex inhibitor 
on microvillar structure, materials recovered from immunoisolation of hprom-1 were 
probe for members of the Arp2/3 complex. Surprisingly, two subunits of this complex, 
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i.e. Arp2 and p34-Arc/ARPC2, were co-immunoisolated with hprom-1 (Fig. 18C, D). 
Again, 2M mutations increased the interactions while the additional Y819/828F mutation 
reduced them. 
The quantitative SEM analysis of microvillar phenotypes at 6 dpc revealed that cells 
expressing 2M Y819/828F harbored less microvilli with structural alterations compared 
to 2M mutants (Fig. 17F,G; done by Vicente Bermúdez). Notably, the knob-like 
phenotype was almost abolished. Only 2–5±1% of 2M Y819/828F-transfected cells 
developed microvilli of this phenotype (Fig. 17G, purple; Table 5). The amount of cells 
with branched microvilli also dropped from about 50±10% in s1/2 2M to 20-30±6% in 
s1/2 2M Y819/828F mutants. Thus, changing tyrosine 819/828 of s1/2 2M into 
phenylalanine impaired the effect provoked by the mutations created in the first 
ganglioside-binding site. As a result, the distribution of the microvillar phenotypes of 
cells expressing s1 2M Y819F resembled the one of those transfected with the 
corresponding wild type (compare Fig. 16C and Fig. 17G). In the case of s2 2M Y828F, 
the mutation caused a further decrease of ~10% in cells harboring microvilli with 
structural alterations compared to its wild type. In addition, mutating tyrosine 819/828 in 
cells carrying 2M mutations restored the release of hprom-1+ vesicles (Fig. 17H).  
Altogether, the data suggest that the interaction of hprom-1 with the PI3K is 
implicated in the structural organization of microvilli on MDCK cells.  
 
 
 
Table 5. Microvillar phenotypes of the indicated cell lines at 6 dpc.  
Pie chart data shown in Fig. 17G. Percentage of cells with a given phenotype is presented with the mean 
and standard deviation. At least 100 cells per experiment were evaluated. n = 10 (s1 2M/s2 2M) or 5 (s1 
2M Y819F/s2 2M Y828F) 
 
 
 
 
Cell line 
Microvillar phenotype (%) 
 
Short Intermediate Long Branched Knob-like Ruffled 
s1 2M 16 ± 5 15 ± 3    0 52 ± 6  17 ± 4 1 ± 1 
s1 2M Y819F 37 ± 2 23 ± 3 1 ± 1 33 ± 2    5 ± 1 1 ± 1 
s2 2M 13 ± 6 16 ± 2    0 50 ± 9  17 ± 3 3 ± 1 
s2 2M Y828F 46 ± 11 32 ± 13 1 ± 1 19 ± 6    2 ± 1    0 
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Fig. 18 Mutations in the first ganglioside-binding site of prominin-1 stimulate its 
interaction with PI3K, Arp2/3 and syntenin-1.  
(A-F) MDCK cells expressing either prominin-1.s1 (A, B) or s2 (A-F) and their corresponding mutants (as 
indicated) were subjected to immunoisolation using magnetic beads conjugated to mAb AC133 (AC133) 
or anti-fluorescein isothiocyanate (FITC) antibody as control. Bound fractions were analyzed by 
immunoblotting using mAbs against either prominin-1 (80B258), phosphotyrosine (pY) (A) or ezrin (E) or 
antisera against p85 subunit of PI3K, Arp2, p34-Arc/ARPC2 (p34) subunit of Arp2/3 complex (C), 
syntenin-1 or ubiquitin (Ubi) (E). Unbound fraction (UF) of ezrin is shown. The ratios of pY (B), p85, Arp2 
and p34 (D) or Ubi and syntenin-1 (F)/prominin-1 immunoreactivities were quantified. 3-6 independent 
experiments were performed. The arrow and open arrowhead indicate the plasma membrane and 
endoplasmic reticulum-associated forms of prominin-1, respectively. Molecular mass markers (kDa) are 
indicated. 
 
 
  
 
6.2.7. Arp2/3 Complex Inhibition Reduces the Amount of Cells 
Harboring Modified Microvilli  
PIP3 is a tightly regulated membrane lipid known to stimulate the assembly of branched 
actin networks by the Arp2/3 complex376, 377. Following my hypothesis that the 
overexpression of hprom-1.s1/2, and particularly the 2M mutants, activates the PI3K 
PIP3 levels in the microvillar membrane would increase and activate Arp2/3 complex-
mediated actin nucleation resulting in branched microvilli. A coarse analysis of 
microvillar branches from SEM micrographs revealed an angle (64.7±12.5°, n = 21) 
highly reminiscent of the one formed by Arp2/3 complex-nucleated branches in actin 
networks (70°)383. 
To evaluate the potential role of the Arp2/3 complex in the formation of branched 
microvilli, cells were incubated for 16 h with the inhibitor CK-666 or its inactive 
analogue CK-689 (200 μM). DMSO was used as vehicle control and again provoked an 
increase in short microvilli in all cell lines except s2 2M. The distribution of microvillar 
phenotypes of cells treated with DMSO or the inactive analogue CK-689 were 
comparable (Fig. 19B). The analysis further revealed that inhibiting the Arp2/3 complex 
reduces the number of microvilli with structural alterations (Fig. 19A, Table 6). In cells 
expressing splice variant 2 or its 2M mutant, the number of branched microvilli 
decreased from 29±5% and 54±20% to 10±6% and 26±17%, respectively (Fig. 19B, 
green). The decrease was even more pronounced in cells transfected with s1 or its 2M 
mutant, where the amount of branched microvilli dropped to one-fifth of the amount 
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measured in cells treated with the inactive analogue. Surprisingly, the amount of knob-
like microvilli was also reduced (Fig. 19B, purple). Only 2-4±4% of the cells transfected 
with s1 or its 2M mutant developed this phenotype. In s2 or s2 2M mutant-transfected 
cells, the number was decreased by half from 16±7% and 26±14% to 9±5% and 12±8%, 
respectively (Table 6).  
Thus, this data suggest that the interaction of hprom-1 with the PI3K might also 
activate the Arp2/3 complex resulting in the formation of branched microvilli.  
 
 
 
Table 6. Microvillar phenotypes of the indicated cell lines upon treatment with CK-
666, CK-689 or DMSO at 6 dpc.  
Pie chart data shown in Fig. 19B. Percentage of cells with a given phenotype is presented with the mean 
and standard deviation. At least 100 cells per experiment were evaluated. n = 3 (DMSO) or 6 (CK-
689/CK-666) 
 
 
 
 
 
 
 
 
Cell 
line 
 
Treatment 
Microvillar phenotype (%) 
 
Short Inter-
mediate 
Long Branched Knob-like Ruffled 
s1 DMSO   71 ± 10   4 ± 2 0 19 ± 10   6 ±1 0 
 CK-689   74 ± 5    7 ± 3 0 11 ± 2   8 ± 4 0 
 CK-666   72 ± 9 24 ± 6 0   2 ± 2   2 ± 1 0 
s1 2M DMSO   41 ± 14   5 ± 1 0 36 ± 10 18 ± 2 0 
 CK-689   41 ± 9    5 ± 3 0 38 ± 8 16 ± 6 0 
 CK-666   59 ± 16 30 ± 13 0   7 ± 4   4 ± 4 0 
s2 DMSO   51 ± 8   6 ± 4 0 25 ± 3 18 ± 4 0 
 CK-689   50 ± 7    5 ± 1 0 29 ± 5 16 ± 7 0 
 CK-666   41 ± 7 40 ± 11 0 10 ± 6   9 ± 5 0 
s2 2M DMSO   19 ± 22   6 ± 8 0 43 ± 19 32 ± 19 0 
 CK-689   16 ± 10   4 ± 1 0 54 ± 20 26 ± 14 0 
 CK-666   34 ± 24 28 ± 5  0 26 ± 17 12 ± 8 0 
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Fig. 19 Decrease in modified microvilli by Arp2/3 complex inhibition is amplified 
when combined with PI3K inhibition.  
Stably transfected MDCK cells were incubated for 16h with Arp2/3 complex inhibitor CK-666 (200 μM), 
its inactive analog CK-689 (200 μM) or DMSO (1:500), processed for SEM (A) and their microvillar 
phenotypes and were quantified (B). n = 3 (C-F) After 16h-incubation with CK-666, CK-689 or DMSO, 
the PI3K inhibitor LY294002 (LY, 5 μM) or DMSO (0.05%) was added for 4 h prior to microvilliar 
analyzes. (C) Quantification of microvillar phenotypes. n = 4. Pie chart values are expressed as a 
percentage. Number of cells ≥ 100 per experiment. (D-F) Quantification of individual microvilli (D), 
microvillar clusters (E) or microvilli per cluster (F) of the indicated cell line treated with DMSO (-) or CK-
666 and LY294002 (+). SEM micrographs were used for quantification. Numbers of individual microvilli or 
cluster of them were counted for a surface equivalent of 12.0 and 17.3 μm2, respectively. Eight randomly 
taken cells within a confluent cell monolayer were analyzed per experiment. Mean±standard deviation is 
indicated. n = 4 (B-C) Two-tailed Fisher’s exact test. P-values are indicated. (D-E) Two-tailed unpaired 
student’s t-test, (H) Mann-Whitney test. *, p < 0.05; **, p < 0.01; ***, p < 0.005. 
 
 
6.2.8. Combined Inhibition of PI3K and Arp2/3 Complex Almost 
Abolishes Microvilli With Structural Alterations  
The individual inhibition of PI3K and Arp 2/3 complex resulted in a decrease of both 
branched and knob-like microvilli pointing to a cooperative interaction of both pathways 
in the formation and/or maintenance of microvilli. Therefore, the impact of combined 
inhibition on microvillar architecture was examined. To this end, cells were incubated 
for 16 h with Arp2/3 complex inhibitor CK-666, or its inactive analogue CK-689 (200 
μM). Thereafter, cells were additionally incubated for 4 h with CK-666 or CK-689 and 
the PI3K inhibitor LY294002 (5 μM). Again, DMSO was used as control and provoked 
an increase in short microvilli in cells expressing s1 or its 2M mutant but not in those 
expressing splice variant 2 or s2 2M. 
As expected, the incubation of MDCK cells stably transfected s1, s2 or their 
corresponding 2M mutants with CK-689 and LY294002 resulted mainly in a decrease of 
knob-like microvilli (Fig. 19C, Table 7). A slight decrease in branched microvilli was also 
observed. However, the combined inhibition of PI3K and the Arp2/3 complex almost 
abolished all microvilli with structural alterations. Only 1-3±2% of all cells harbored 
knob-like microvilli irrespective of the splice variant or mutant. Furthermore, cells 
transfected with s1 or its 2M mutant only showed branched microvilli in 2±2% of the 
cases. This number was only slightly higher in splice variant 2 and its 2M mutant (5-
6±4%). Interestingly, the number of individual microvilli and clusters of them was also 
significantly reduced (Fig. 19D, E) whereas the number of microvilli per cluster remained 
similar (Fig. 19F). 
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In sum, the data suggest that multiple interactions of hprom-1 with regulatory 
enzymes such as PI3K and Arp2/3 complex are implicated in the structure and dynamics 
of microvilli. 
 
 
Table 7. Microvillar phenotypes of the indicated cell lines upon treatment with 
DMSO or CK-666/CK-689 and LY294002 (LY) at 6 dpc.  
Pie chart data shown in Fig. 19C. Percentage of cells with a given phenotype is presented with the mean 
and standard deviation. At least 100 cells per experiment were evaluated. n = 4  
 
 
 
6.2.9. Ubiquitination of Prominin-1 and its Interaction with Syntenin-1 
are Stimulated in 2M Mutants 
As previously described in384, hprom-1 is subjected to ubiquitination and interacts with 
the adaptor protein syntenin-1. These two processes are involved in the recycling of 
hprom-1 in the endocytic pathway and its degradation314, 325, 385, 386. Thus, hprom-1 and its 
mutants were probed for ubiquitin and syntenin-1 upon immunoisolation. Both the 
ubiquitination of cell surface hprom-1 and its interaction with syntenin-1 were 
significantly increased in 2M mutants (Fig. 18E, F). The additional mutation at tyrosine 
819/828 reduced both interactions suggesting that 2M mutations in the ganglioside-
binding site of hprom-1 can trigger its recycling (Fig. 18E, F). In contrast, no interaction 
was observed for hprom-1 and ezrin, an adaptor protein of the ezrin/radixin/moesin 
(ERM) family (Fig. 18E), which is in line with the previous study384. 
 
Cell 
line 
 
Treatment 
Microvillar phenotype (%) 
 
Short Inter-
mediate 
Long Branched Knob-
like 
Ruffled 
s1 DMSO 64 ± 7 11 ± 6 0 16 ± 1   9 ±3 0 
 CK-689 + LY 79 ± 5   7 ± 1 0 11 ± 3   3 ± 3 0 
 CK-666 + LY 84 ± 7 13 ± 6 0   2 ± 1   1 ± 1 0 
s1 2M DMSO 54 ± 13 19 ± 9 0 17 ± 6 10 ± 4 0 
 CK-689 + LY 66 ± 8 14 ± 6 0 16 ± 3   4 ± 1 0 
 CK-666 + LY 81 ± 12 16 ± 9 0   2 ± 2   1 ± 1 0 
s2 DMSO 31 ± 9 21 ± 12 0 32 ± 3 16 ± 9 0 
 CK-689 + LY 64 ± 15 15 ± 7 0 16 ± 7   5 ± 2 0 
 CK-666 + LY 65 ± 13 28 ± 13 0   5 ± 3   2 ± 2 0 
s2 2M DMSO   4 ± 2 17 ± 1 0 55 ± 10 24 ± 14 0 
 CK-689 + LY  15± 3 19 ± 3 0 55 ± 7 11 ± 4 0 
 CK-666 + LY 55 ± 9 36 ± 11  0 6 ± 4   3 ± 2 0 
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6.2.10. Mutating Cytoplasmic Tyrosine 819/828 of Hprom-1 Results in 
Short Microvilli 
Does the inhibition of tyrosine phosphorylation of hprom-1 affect the architecture of 
microvilli? To address this, I analyzed their morphology in MDCK cells expressing s1 or 
s2 variant carrying solely a mutation at tyrosine 818 or 828, respectively. This mutation 
impeded the phosphorylation of hprom-1 as well as its interaction with p85 subunit of 
PI3K and Arp2/3 complex (Fig. 18A-D). CLSM analysis revealed that s1/2 Y819F were 
concentrated at the apical plasma membrane of polarized cells as observed for wild type 
proteins and 2M mutants (Fig. 20A, left panels). Nonetheless, the hprom-1–
immunoreactive signals seemed to be narrower in cells expressing Y819/828F mutants 
(Fig. 20A, right panels), which prompted me to analyze the appearance of microvilli by 
SEM. Unexpectedly, the majority of the cells, 74±9% in s1 Y819F and 76±7% in s2 
Y828F, harbored short microvilli that were often sparsely scattered over the cell surface 
(Fig. 20B, C, Table 8). In both splice variants, only ~25% of the cells developed microvilli 
of intermediate length. Interestingly, the release of hprom-1+ vesicles into the culture 
medium was only slightly stimulated by the Y819/828F mutation (Fig. 20D). This 
confirms that the appearance of short microvilli is not necessarily the result of extended 
release as seen before in DMSO-treated cells. 
 The appearance of short microvilli may reflect a high turnover of cells, and thus I 
evaluated their proliferation. At 7dpc, the number of cells expressing Y819/828F 
mutants was significantly higher than the one of untransfected MDCK cells or those 
expressing wild type hprom-1 (Fig. 20E, left panel). At 14 dpc, s1/2 Y819/828F mutants 
showed the same number of cells in contrast to untransfected cells or those transfected 
with s1/2 that showed either an increase or decrease. This suggests that the Y819/828F 
mutants extensively proliferate during the first seven days with finally reaching a plateau 
phase. Consistent with this, primary cilia, which dissemble during cell division387, 
appeared significantly shorter in these cells in comparison to untransfected cells (Fig. 
20F, G, Table 9).  
Thus, by blocking the phosphorylation of hprom-1 at tyrosine 819/828 cells develop 
short microvilli and short primary cilia confirming that the interaction of PI3K with 
hprom-1 plays an important role in the formation of microvilli and suggesting a role for 
hprom-1 in ciliary development and/or maintenance influencing cell proliferation. 
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Table 8. Microvillar phenotypes of the indicated cell lines at 6 dpc.  
Pie chart data shown in Fig. 20C. Percentage of cells with a given phenotype is presented with the mean 
and standard deviation. At least 100 cells per experiment were evaluated. n = 4 
 
 
 
 
Table 9. Average ciliary length of indicated cell lines at 7 and 14 dpc. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Average ciliary length with standard deviation is shown. P-values for comparison of 
ciliary length of untransfected (MDCK) and mutated (Y819/828F) cells are 
indicated. 
  
 
Cell line 
Microvillar phenotype (%) 
 
Short Intermediate Long Branched Knob-like Ruffled 
s1 55 ± 8 26 ± 5 0 16 ± 4   3 ± 2 0 
s1 Y819F 74 ± 9 25 ± 9 0   1 ± 1      0 0 
s2 28 ± 11 29 ± 9 0 23 ± 9 20 ± 5 0 
s2 Y828F 76 ± 7 24 ± 6 0      0      0 0 
Cell line Average ciliary length  
(μm) 
Mann-Whitney test  
p-value 
7 dpc 
MDCK 2.5 ± 1.17  
s1 Y819F 1.7 ± 0.81 < 0.001 
s2 Y828F 1.7 ± 0.68 < 0.001 
14 dpc 
MDCK 2.1 ± 1.06  
s1 Y819F 1.6 ± 0.72 < 0.001 
s2 Y828F 1.6 ± 0.60 < 0.001 
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Fig. 20 Mutating tyrosine 819/828 of hprom-1 induces short microvilli. 
MDCK cells transfected with s1 Y819F or s2 Y828F were grown for 7 or 14 dpc and analyzed by 
immunocytochemistry (A, E, G), SEM (B, C, F) or differential centrifugation (D). (A) Single optical x-z-
plane sections of cells labeled with anti-hprom-1 antibody. Note that hprom-1 immunofluorescence 
appears narrower in Y819/828F mutants then in wild type cells (yellow bars). Nuclei were counterstained 
with DAPI. (C) Quantification of microvillar phenotypes. Pie chart values are expressed as a percentage. 
Number of cells ≥ 100 per experiment. n = 4 (D) Quantification of the release of hprom-1+ vesicles by 
differential centrifugation of 16 h-conditioned media analyzed by immunoblotting for hprom-1. n = 5 (E) 
The number of cells after 7 and 14 dpc was quantified for the given surface area and is displayed as box-
and-whisker plot. The boxes represent data from 25th-75th percentiles and 100% within the whiskers. n 
= 4 (G) The length of acetylated α-tubulin-labeled cilia was evaluated by CLSM (see chapter 6.3.2.). 
Number of analyzed cilia is displayed in brackets. Two-tailed unpaired student’s t-test. N.s. not significant; 
*, p < 0.05; **, p < 0.01 ***; p < 0.005. Scale bars, 5 μm (A, left panels), 1 μm (A, right panels) and 500 nm 
(B, F).   
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6.3. Hprom-1 Influences the Length of the Primary Cilium 
via its Interaction with HDAC6  
Mutations in the prominin-1 gene are associated with various forms of retinal 
degeneration388 that can be mimicked in genetically modified mice carrying either a null 
allele or a mutated form of prominin-1168, 332. Both mouse models show a severe 
disorganization of photoreceptor outer segments, which are specialized sensory cilia. 
Together with the presence of prominins in different types of cilia, e.g., primary and 
motile ones316, 337, 351, these morphological evidences indicate a conserved involvement of 
prominin-1 in the formation and/or maintenance of the ciliary structure and function. 
 
6.3.1. Characteristics of Hprom-1 Localization at the Primary Cilium  
During the localization studies of hprom-1 in MDCK cells (chapter 6.1.) I noticed that 
not all primary cilia were positively labeled (Fig. 21A). Therefore, I started a detailed 
analysis of the abundance of hprom-1 at this specific cellular compartment. In cells 
expressing s1, 61±9% of the analyzed cilia were positive for hprom-1. In contrast, s2 
localized to the primary cilium in only 36±4% of the cilia (Fig. 21B). Since cells within the 
same monolayer showed different expression levels of hprom-1 (Fig. 21D, E) I defined 
three categories: weak, medium and strong. Irrespective of the expression level, splice 
variant 1 showed a higher abundance at the primary cilium than s2 (Fig. 21C).  
Surprisingly, hprom-1 immunoreactivity in cilia was often asymmetrically distributed 
(Fig. 21G, H). Quantification of the vertical and horizontal localization revealed its 
enrichment in ciliary subcompartments (Fig. 21F). S1 was concentrated either at the 
base or the tip of cilia in 11±9% and 18±5%, respectively. In 71±12% hprom-1 was 
distributed over the entire cilium. Splice variant 2 showed a stronger enrichment at the 
base and the tip (18±9% and 30±6%, respectively). As a result, only 52±3% of the cilia 
showed a localization of hprom-1 along the entire cilium. Furthermore, cilia enriched in 
splice variant 1 displayed a concentration of hprom-1 on one side in 24±12% of the 
cases. Interestingly, s2 localized twice as often to this specific subcompartment (54±9%). 
The reason for this phenomenon remains to be identified, but it might be related to the 
coexistence of distinct membrane micro- or nanodomains in the ciliary membrane211. 
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Fig. 21 Localization characteristics of hprom-1 splice variants at the primary cilium. 
(A, D, G, H) Hprom-1-transfected MDCK cells were subjected to double immunofluorescent staining 
with anti-hprom-1 and acetylated α-tubulin at 6 dpc. (A) Single z-planes of the primary cilium from 
underneath the microvilli (top left corner) to the tip of the cilium (bottom right corner). Hprom-1 either 
colocalized with the ciliary marker (presence, top panel) or only localized to microvilli (absence, bottom 
panel). (B, C, F) Quantitative analysis of the localization of hprom-1 to the primary cilium. Number of 
analyzed cilia is indicated in brackets. Two-tailed Fisher’s exact test, *, p < 0.05; ***, p < 0.005 (B) Splice 
variants 1 and 2 differ significantly in the presence (blue)/absence (orange) of hprom-1 at the primary 
cilium. n = 5 (C) Presence or absence of hprom-1 at primary cilia is not influenced by its expression level. 
n = 5 (D) Extended focus image of 44 optical x-y sections (X/Y) and z-projection (Z) of MDCK cell 
monolayer illustrating different expression levels of hprom-1. The z-projection displays the cells 
corresponding to the orange line in the extended focus image. (E) Flow cytometry analysis of cells 
incubated with PE-coupled anti-hprom-1 antibody. Dashed line, negative control. (F) Quantification of 
vertical and horizontal asymmetry of hprom-1 localization at the primary cilium. n = 3. (G, H) 3D-
reconstructions of CLSM images spanning the apical plasma membrane. (G) Asymmetric distribution of 
hprom-1 along the primary cilium. (H) Concentration of hprom-1 at one side of the primary cilium. Scale 
bars, 3 μm (A), 10 μm (D) and 2 μm (G, H). Expression levels: W, weak; M, medium; S, strong. 
 
 
 
 
6.3.2. Hprom-1 Modulates the Length of Primary Cilia  
To investigate whether hprom-1 can alter the architecture of primary cilia a method for 
3D-measurement of ciliary length was developed. This method prevents the 
underestimation of ciliary length occurring with measurements from 2D maximum 
projection images where any cilium that does not lie completely parallel to the plane of 
focus would not appear at full length. Cilia were labeled with anti-acetylated α-tubulin 
and optimized image stacks were taken by CLSM (Fig. 22A). Using Huygens Professional 
Software, the stacks were subjected to deconvolution and subsequently the length of 
cilia was measured. Our method is comparable with the one published by Saggese et 
al.389, who proved it to be accurate for length measurements of cilia.  
For the analysis of ciliary length I defined three categories: short (< 3 μm), 
intermediate (3-5 μm) and long (> 5 μm) (Fig. 22B). At 6dpc, in untransfected MDCK 
cells or those transfected with an empty vector 65-70% of the cilia were shorter than 3 
μm (Fig. 23B). Only 30%-35% of them developed a length of 3-5 μm or longer. Thus, 
they had an average ciliary length of 2.8±0.95 μm and 2.7±1.03 μm (Table 10), 
respectively, resembling findings of other groups389.  
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Fig. 22 Analysis of the length of primary cilia. 
(A) 3D-reconstruction of optical sections taken from the apical surface of a MDCK cell monolayer 
transfected with hprom-1.s2 at 6 dpc. Cells were subjected to double immunofluorescent staining 
with anti-hprom-1 and acetylated α-tubulin (top panel). The latter was used to visualize and 
measure the length of cilia (bottom panel). Scale, 1 Unit = 10.18 μm. (B) Measured cilia were 
categorized into three groups: short (< 3 μm, top panel), intermediate (3-5 μm, middle panel) and 
long (> 5μm, bottom panel). White semicircle, ciliary base. Scale bar, 1μm. 
 
 
 
Interestingly, the overexpression of hprom-1 significantly increased ciliary length, 
irrespective of the splice variant (two-tailed Mann-Whitney test, p < 0.005). S1-
transfected cells had an average length of 3.1±1.44 μm (Table 10, pooled data). Those 
transfected with splice variant 2 exhibited an average length of 3.4±1.39 μm. 
Consequently, the number of shorter cilia (< 3 μm) was reduced concomitantly with an 
increase in longer ones, particularly those with a length of over 5 μm (Fig. 23B).  
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Table 10. Average ciliary length of indicated cell lines at 6 and 14 dpc. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The ciliary length of hprom-1+ and hprom-1- cilia as well as the pooled data are presented. 
Average ciliary length with the standard deviation are shown.  
 
Cell line Average ciliary length (μm) Mann-Whitney test 
 
Pooled data Hprom-1+ Hprom-1- 
Hprom1+ vs Hprom-1- 
p-value 
6 dpc 
MDCK 2.8 ± 0.95    
Empty vector 2.7 ± 1.03    
s1 3.1 ± 1.44 3.2 ± 1.28 3.0 ± 1.36 0.0762 
s1 2M 3.3 ± 1.82 3.8 ± 1.95 3.0 ± 1.65 < 0.005 
s2 3.4 ± 1.39 3.6 ± 1.55 3.3 ± 1.28 0.0013 
s2 2M 3.1 ± 1.65 3.4 ± 1.73 2.9 ± 1.58 0.0003 
14 dpc 
MDCK    2.6 ± 1.0    
s1 3.1 ± 1.30 3.1 ± 1.19 3.1 ± 1.46 0.6741 
s1 2M 3.3 ± 1.42 3.3 ± 1.38 3.2 ± 1.50 0.5981 
s2 3.0 ± 1.25 3.0 ± 1.30 2.9 ± 1.22 0.5940 
s2 2M 3.2 ± 2.01 3.4 ± 1.53 3.1 ± 2.18 0.0544 
RESULTS       
 
100 
 
RESULTS       
 
101 
Fig. 23 Mutations in the GM1-binding site of hprom-1 affect ciliary length.  
Untransfected MDCK (MDCK) cells or those transfected with an empty vector, hprom-1.s1/2 or 2M 
mutants were cultured until 6 dpc (A-D, F-H) or 14 dpc (E). Cells were subjected to double 
immunofluorescent staining with anti-hprom-1 and the ciliary marker acetylated α-tubulin. (A) Single z-
planes of the primary cilium additionally labeled with cholera toxin b as marker for ganglioside GM1. Scale 
bar, 1 μm. (B-E) Histograms of ciliary length distribution of indicated cell lines at 6dpc. (B) Histogram 
shows pooled data of hprom-1+ cilia (C, green) and hprom-1- cilia (D, red). n = 7 (E) Ciliary length 
distribution at 14 dpc. n = 4 (F-H) Quantitative analysis of the ciliary localization of 2M mutants. For 
comparison, data of wild type proteins are presented. (F) Analysis of the absence (orange) or presence 
(blue) of hprom-1 at the primary cilium. Two-tailed Fisher’s exact test, p, *** < 0.005. n = 5 (G, H) 
Quantification of the vertical and horizontal asymmetry of hprom-1 in primary cilia. Number of analyzed 
cilia is displayed in brackets. n = 3 
 
 
 
 
 
 
6.3.3. The 2M Mutations in the First Ganglioside-Binding Site of 
Hprom-1 Influence the Length of the Primary Cilium  
Given that hprom-1 influences the length of primary cilia and that it colocalizes with 
ganglioside GM1 therein (Fig. 23A, top panels), I investigated the effect of mutations 
created in its GM1-binding site.  
First, cells stably transfected with 2M mutants were subjected to cell surface 
labeling with anti-hprom-1 antibody, anti-acetylated α-tubulin and fluorescent cholera 
toxin B subunit conjugates recognizing ganglioside GM1. CLSM analysis revealed that the 
2M mutations did not interfere with the colocalization of hprom-1 and GM1 at the 
primary cilium (Fig. 23A, bottom panels). 
At 6 dpc, 2M mutations led to an increase in ciliary length compared to 
untransfected cells but provoked opposite effects in the two splice variants. Cells 
expressing s1 2M showed an increase in the average length (3.3±1.82 μm, Table 10, 
pooled data) compared to its corresponding wild type (3.1±1.44 μm). In contrast, the 
ciliary length of cells transfected with s2 2M (3.1±1.65 μm, Table 10, pooled data), was 
significantly shorter than the one of those expressing s2 wild type (p < 0.001). The 
amount of cilia with a length of over 5 μm did not change in s2 2M mutants, but they 
harbored 15% more cilia with a length below 3 μm.  
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Since not all cilia of hprom-1-expressing cells were positive for hprom-1 (Fig. 21A), 
I was curious to know if the presence of hprom-1 at the cilium might influence its length. 
The individual analysis of hprom-1+ and hprom-1- cilia revealed that all cilia positive for 
hprom-1 were longer compared to their negative counterparts (Fig. 23C, D, Table 10).  
To determine if the length modifications were permanent or might change with 
proceeding polarization I repeated length measurements at 14 dpc (Fig. 23E). Primary 
cilia of untransfected MDCK cells maintained their average length (2.6 ± 1.0 μm) as well 
as their distribution pattern. Cells transfected with hprom-1, irrespective of the splice 
variant or mutant, still showed a significant increase in ciliary length compared to 
untransfected cells (Table 10, p < 0.01). Note that the average length and the length 
distribution of s2 wild type changed considerably. However, at 14 dpc, the 2M mutations 
exhibited no significant effect on the average length compared to their corresponding 
wild types (Table 10).  
As described in chapter 6.3.1, the abundance of hprom-1 in the primary cilium 
differs between splice variant 1 and 2 with s1 being more frequent than s2 (Fig. 21B and 
Fig. 23F). Do mutations in the GM1-binding site of hprom-1 affect its presence in the 
primary cilium? The analysis of s1 2M showed a significant reduction in hprom-1+ cilia 
(44±7.7%) compared to its corresponding wild type (61±8.8%, p < 0.001). No difference 
was observed between s2 2M and its wild type (36±4.2% and 39±7.4%, respectively, p > 
0.05). The horizontal and vertical distribution of s1 2M and s2 2M along the primary 
cilium was comparable to the one of the corresponding wild type (Fig. 23G, H).  
In summary, at 6 dpc, 2M mutations in the GM1-binding site of hprom-1.s1 caused 
an increase in ciliary length. Interestingly, the length distribution of s1 2M hprom-1+ cilia 
strongly resembled the one of s2. The occurrence of s1 2M in primary cilia dropped by 
about 20% to a level comparable to the one of s2. The horizontal and vertical 
distribution of s1 2M in cilia also seems to approximate to the one of s2. On the other 
hand, introducing 2M mutations in splice variant 2 resulted in a significant decrease in 
ciliary length and no obvious changes in its ciliary localization. At 14 dpc, the opposing 
effect on ciliary length was abolished and the 2M mutants of both splice variants 
harbored more cilia with a length of over 5 μm than their corresponding wild types.  
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6.3.4. A Point Mutation in the HDAC6-Binding Site of Hprom-1 
Reduces Ciliary Length  
In various cancer cell lines hprom-1 physically interacts with HDAC6 and thereby 
creates a ternary complex with β-catenin, a central molecule of the canonical Wnt 
signalling pathway314. This complex stabilizes hprom-1 and prevents its trafficking down 
the endosomal-lysosomal pathway for degradation. In the context of ciliary length 
control the interaction of hprom-1 and HDAC6 is very interesting because α-tubulin 
deacetylation by HDAC6 is necessary and sufficient for the destabilization and 
resorption of primary cilia390. To evaluate the impact of hprom-1– HDAC6 interaction 
on ciliary length we mutated lysine 129 (in reference to splice variant 1, K138 in s2) in 
the HDAC6-binding site of hprom-1 into glutamine (Fig. 24A, K129/138Q)314. This 
mutation neutralizes electric charge and mimics lysine acetylation.  
The distribution pattern and average ciliary length (2.5±0.98 μm) of untransfected 
MDCK cells confirmed our previous data (Fig 24B, Table 11). Due to the pooling of 
data, the numbers for s1 and s2 wild type in Fig. 23B and Fig. 24B are the same.  
Surprisingly, the impact of K129/138Q mutation on ciliary length was divergent. 
Cells stably transfected with s1 K129Q showed no difference in average length (3.0±1.2 
μm, p > 0.05) or length distribution compared to s1 wild type (3.1±1.44 μm, Fig. 24B, 
Table 11). In contrast, K138Q mutation not only impaired the effect provoked by s2 
overexpression but completely abolished cilia with a length of over 5 μm (Fig. 234B). As 
a result, the average ciliary length dropped to 2.3±0.79 μm. Thus, primary cilia of s2 
K138Q mutants were significantly shorter in comparison to those observed in s2 wild 
type (p < 0.001, Table 11). 
Why the overexpression of K129/138Q mutants results in an opposing effect on 
the length of primary cilia needs further investigation. Since the function of different 
splice variants is unknown I can only speculate that s2 might be more important in the 
formation and/or maintenance of the primary cilium in MDCK cells than splice variant 
s1. Following this hypothesis, I decided to investigate ciliary alterations of hprom-1.s2 
wild type and K138Q mutant in greater detail. 
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Fig. 24 Mutation in the HDAC6-binding site of hprom-1.s2 reduces ciliary length. 
(A) Cartoon illustrating the mutation of HDAC6-binding site (K129/138Q) in the first cytoplasmic domain 
of hprom-1. Red square, exon 3 in splice variant 2; TM, transmembrane domain. (B, C) Histogram of 
ciliary length distribution (black) and quantitative analysis of cilium deficiency (red) at 6 (B) or 14 dpc (C). 
Two-tailed Fisher’s exact test; ***, p < 0.005. Number of analyzed cilia (black) or cells (red) is indicated in 
brackets. n = 7 (s1, s2), n = 3 (MDCK, empty vector, K129/138Q) (D) Maximum projection of 30-40 
optical x-y sections (0.38 μm-slices) of primary cilia labeled with acetylated α-tubulin and anti-HDAC6 
antibody. (E, F) Box-and-whisker plots with boxes representing data from 25th-75th percentiles and 100% 
within the whiskers. (E) Mean fluorescence intensity of HDAC6 in primary cilia was quantified upon 
normalization to acetylated α-tubulin at 6dpc. Two-tailed unpaired student’s t-test; *, p < 0.05, n = 3, 30 
cilia analyzed. (F) Mean fluorescence intensity of acetylated α-tubulin in cilia at 6 dpc. The extended focus 
image of a representative cilium for each cell line is depicted. Two-tailed Mann-Whitney test; ***, p < 
0.005 (G) SEM micrographs illustrating ciliary length of hprom-1.s2 and K138Q mutant. Primary cilia with 
a length of > 5 μm were rarely observed on cells expressing K138Q mutant and displayed an irregular 
shape with constrictions along their distal part (arrows). Some cilia displayed large bulbs of 200-500 nm 
(arc). (H) Ciliary length analysis of K138Q mutants-transfected cells grown until 6 dpc and treated for 16 
h with 1 μM tubacin, 1 μM niltubacin or DMSO (1:1000). Fold changes relative to the ciliary length of 
untreated control (red line) are shown. Points represent the means and bars indicate the standard 
deviation. No significant (n.s.) difference between any of the experimental conditions was observed. Two-
tailed Mann-Whitney test; p > 0.05. (I) Maximum projection of 25-35 optical x-y sections (0.38 μm-slices) 
of the apical part of K138Q mutant-transfected cells labeled with anti α-acetylated tubulin. Only tubacin-
treated cells showed a significant increase in the acetylation of cytoplasmic microtubules. (J) SEM image of 
an untransfected MDCK cell with a primary cilium harboring a large bulb (left panel). 3D-reconstructions 
of CLSM images of the primary cilium and microvilli of a s2-transfected cell (right panels). Hprom-1 
immunoreactivity seems to associate with the observed protuberances. Scale bars, 500 nm (G, J), 1μm (F, 
I) and 2 μm (D). 
 
 
 
 
Table 11. Average ciliary length of indicated cell lines at 6 and 14 dpc. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Average ciliary length and standard deviation are shown. Mann-Whitney test 
was used to calculate statistical significance.  
 
 
 
Cell line Average ciliary length 
(μm) 
Mann-Whitney test  
p-value 
6 dpc  
 
 
 
 
 
 
 
 
 
 
MDCK 2.5 ± 0.98 
s1 3.1 ± 1.44 
s1 K129Q 3.0 ± 1.20 
s2 3.4 ± 1.39 
s2 K138Q 2.3 ± 0.79 
14 dpc 
MDCK 2.5 ± 0.89 
s2 3.1 ± 1.42 
s2 K138Q 2.4 ± 0.81 
0.5477  < 0.001  
< 0.001  
< 0.001  
< 0.001  
< 0.001  
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6.3.5. K138Q Mutation Influences Ciliogenesis, Ciliary HDAC6 Levels 
and α-Tubulin Acetylation  
To exclude that the observed ciliary modifications upon overexpression of K138Q 
mutant were the result of declined ciliogenesis ciliary length was measured at 14 dpc 
(Fig. 24C). The obtained data were comparable to those at 6 dpc. Untransfected cells 
showed the same length distribution and average length (2.5±0.89 μm, Table 11). The 
overexpression of s2 wild type still led to a significant increase in ciliary length (3.1±1.42 
μm, p < 0.001). The K138Q mutation also impaired the ciliary effect of s2 
overexpression at 14 dpc resulting in an average length of 2.4±0.81 μm. Consequently, 
primary cilia of K138Q mutants were significantly shorter in comparison to those 
observed on s2 wild type-transfected cells at 14 dpc (p < 0.001, Table 11). In addition, 
the number of cells without a primary cilium was three times higher in the K138Q 
mutant compared to s2 wild type at 6 and 14 dpc (Fig. 24B, C, red). Furthermore, 
quantitative immunofluorescence image analysis revealed an increase in HDAC6 (Fig. 
24D, E) as well as a reduction of α-tubulin acetylation (Fig. 24F) in K138Q mutant cilia. 
These results are consistent with enhanced deacetylation activity of HDAC6 and the 
subsequent destabilization and disassembly of primary cilia. Since acetylated α-tubulin 
labeling was used to determine ciliary length, I wanted to rule out that the decrease in 
length was solely reflecting the loss of acetylation and not a physical reduction. 
Therefore, I performed a SEM analysis. Again, most of the K138Q mutant cilia were 
short (Fig. 24G, two left panels) and cilia with a length of over 5 μm were observed very 
rarely. The latter displayed an irregular ultrastructure with membrane constrictions 
along their distal part (Fig. 24G, two right panels, arrows). The size of each individual 
constriction was highly reminiscent of small membrane vesicles, which can be released 
by primary cilia (see chapter 6.3.6)351. Hence, the remaining longer cilia might have been 
captured in a transitional form with vesicular precursor structures before they were 
able to release vesicles and thereby reducing their size.  
The K138Q phenotype could not be rescued by the addition of tubacin, a potent 
HDAC6 inhibitor. Tubacin specifically inhibits the deacetylation of α-tubulin by binding 
to the α-tubulin catalytic domain of HDAC6391. Tubacin-treated cells showed a 
significant increase in the acetylation of cytoplasmic microtubules (Fig. 24I) without any 
RESULTS       
 
107 
specific effect on the length of primary cilia (Fig. 24H). This is in line with a previous 
report392. Neither the vehicle control (DMSO) nor the inactive analogue of tubacin 
(niltubacin) increased tubulin acetylation (Fig. 24I). Thus, this single point mutation in the 
HDAC6-binding site of hprom-1 led to an increase in α-tubulin deacetylation and 
seemed to promote the pearling of cilia. This in turn might lead to the budding and 
fission of vesicles therefrom resulting in the reduction of ciliary length. 
During the SEM analysis of primary cilia, the appearance of large bulbs (200-500 nm) 
was noticed in some of them (Fig. 24J, left panel, arc). These bulbs were observed in cilia 
of wild type cells as well as in those transfected with s2 or K138Q mutant. Fascinatingly, 
hprom-1 immunoreactivity seems to associate with these protuberances (Fig. 24J, right 
panels). Further studies are needed to decipher their identity.  
 
 
6.3.6. K138Q Mutation Increases Vesicle Release  
The observed pearling morphology of some K138Q cilia points to an enhanced release 
of membrane vesicles. This issue was addressed by differential ultracentrifugation of 16 
h-conditioned culture media followed by immunoblotting of recovered material for 
hprom-1, acetylated α-tubulin and β-actin (Fig. 25A). Acetylated α-tubulin was observed 
in the 10.000 and 200.000 x g pellet (vesicle fraction), which is in agreement with the 
release of hprom-1+ vesicles from cilia351. Interestingly, the amount of hprom-1 
immunoreactivity recovered in the vesicle fraction was significantly higher in cells 
expressing K138Q mutant. The quantitative analysis revealed that 23% of total hprom-1 
immunoreactivity (cells + vesicles) was found in the medium in comparison to 12% from 
cells expressing s2 wild type (Fig. 25B; n = 11 for s2, n = 3 for K138Q; two-tailed 
unpaired student’s t-test, p < 0.05). Microvilli also release hprom-1+ vesicles and they 
easily outnumber the primary cilium. Microvillar phenotypes of K138Q mutant resemble 
the one of untransfected MDCK cells or those transfected with an empty vector 
(compare Fig. 25C and Fig.16C, Table 12 and 3). Almost no microvilli with altered 
architecture were observed. Thus, the reduction in ciliary length is concomitant with 
enhanced vesicle release. In addition, normal and short microvilli might contribute to the 
increase in hprom-1+ vesicles in the medium.  
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Table 12. Microvillar phenotypes of indicated cell lines at 6 dpc.  
Pie chart data presented Fig. 25C. Percentage of cells with a given phenotype is presented with the mean 
and standard deviation. At least 100 cells per experiment were evaluated. n = 11 (s2), n = 3 (K138Q)  
 
 
 
 
 
 
 
 
 
Fig. 25 Mutation in the HDAC6-binding site of hprom-1.s2 increases vesicle release 
and causes short microvilli. 
MDCK cells stably transfected with s2 or K138Q mutant were cultured for 6 days and examined by 
differential centrifugation or processed for SEM. (A, B) 16 h-conditioned medium was subjected to 
differential centrifugation and analyzed by immunoblotting against hprom-1, acetylated α-tubulin and β-
actin. (A) All three proteins were detected in the vesicle fraction suggesting hprom-1-containing 
membrane vesicles were released from microvilli and primary cilia. (B) Quantitative analysis of hprom-1 
immunoreactivity in Cell and Vesicle fractions revealed a significant increase in the release of hprom-1+ 
vesicles in cells expressing K138Q mutant. Two-tailed unpaired student’s t-test, *, p < 0.05. n = 11 (s2), n 
= 3 (K138Q) (C) Analysis and quantification of microvillar phenotypes of K138Q mutant by SEM. Pie chart 
values are expressed as percentage. Number of cells ≥ 100 per experiment. Scale bar, 500 nm. n = 3 
 
 
 
 
 
 
Cell line 
Microvillar phenotype (%) 
 
Short Intermediate Long Branched Knob-like Ruffled 
s2 28 ± 11 29 ± 9 0 23 ± 9 20 ± 5   0 
K138Q 58 ± 10 38 ± 8 0   3 ± 4   1 ± 1   0 
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6.3.7. The Formation of Domes is enhanced in K138Q Mutant Cells  
Densely confluent MDCK cells are able to spontaneously form multicellular hemispheres 
known as domes (Fig. 26A)393. This property is not unique to MDCK cells but also 
characterizes epithelial cell cultures from diverse types of fluid-transporting epithelia 
such as urinary bladder394, mammary gland395, oral tissues396, ventral prostate397 and 
retinal pigment epithelium398. Domes result from fluid accumulation between the cell 
monolayer and the culture dish due to specialized, unidirectional ions and water 
transport as well as secretory properties399. They can rise and collapse at random 
suggesting that different foci of cells in the monolayer can be randomly recruited into 
domes. They are thought to arise by differentiation and are regulated by cyclic AMP 
levels400. Selective fluid accumulation in focal regions, rather than uniformly beneath the 
entire cell layer, suggests that functional, architectural, or biochemical properties of cells 
in a dome may differ from those cells in the surrounding monolayer401, 402. Since dome 
formation requires various physiological functions such as Na+/K+-ATPase activity, 
continuous protein synthesis and cytoskeletal organization393 I was interested if the 
length of primary cilia also has an impact on their formation.  
Untransfected MDCK cells or those transfected with s2 or K138Q mutant were 
grown until 7 dpc and the number of domes per 600 mm2 cell monolayer was 
determined. The overexpression of s2 significantly increased the formation of domes 
compared to wild type cells (Fig. 26B), which was further enhanced by the introduction 
of K138Q mutation even though their cell density was significantly decreased (Fig. 26F). 
At 14 dpc, when cell density was similar in all cell lines (Fig. 26F), differences in dome 
formation were even more apparent (Fig. 26C). When examining SEM images, I first 
noticed a variation in the number of cells composing a dome (Fig. 26D, top panel). 
Therefore, I conducted a quantitative analysis of domes of comparable size by CLSM 
using DAPI-labeled nuclei (Fig. 26D, E). The analysis revealed that domes of cells 
transfected with s2 harbored significantly more cells compared to those of wild type or 
K138Q-expressing cells.  
The data suggest that ciliary length influences dome formation. Changes in ciliary 
length may alter ciliary protein composition, which might cause the differences in dome 
formation. This aspect requires further investigation. 
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Fig. 26 Enhanced dome formation in K138Q mutant. 
Untransfected MDCK cells (MDCK) or those transfected with hprom-1.s2 or K138Q mutant were grown 
until 7 (A, B, D-F) or 14 dpc (C) and their spontaneous dome formation was analyzed. (A) Phase-contrast 
image of domes (4X magnification). (B, C) Box-and-whisker plots show the number of domes per 600 
mm2 cell monolayer. The boxes represent data from 25th-75th percentiles and 100% within the whiskers. 
Experiments were performed in triplicates. n = 4. (D, E) Analysis of the number of cells per dome. (D) 
SEM (top panel) and CLSM images (bottom panels) show a representative dome for each cell line. In the 
SEM images, each dome cell is labeled with a number (yellow). The CLSM images show DAPI-labeled 
nuclei in three different planes of the dome: bottom, center and top. Scale bars, 20 μm. (E) CLSM images 
were used to determine the number of cells in domes of comparable size. Mean and standard deviation 
are indicated. 15 domes per experiment were examined. n = 3. (F) Cell density was determined by 
counting DAPI-labeled nuclei per 0.1 mm2 of cell monolayer at day 7, 10 and 14 after seeding. n = 4. Two-
tailed student’s t-test; *, p < 0.05; **, p < 0.01; ***, p < 0.005. 
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6.4. Canine Prominin-1 Shows No Cross-species 
Immunoreactivity  
To study the molecular mechanisms underlying the role of prominin-1 in the 
architecture and dynamics of epithelial protrusions I was investigating exogenously 
expressed hprom-1 in MDCK cells. A reason for not investigating endogenously 
expressed protein is the absence of specific antibodies against canine prominin-1 
(cprom-1). Despite, studies investigating the expression of prominin-1 in dog tissues or 
cells derived therefrom have been conducted. The dog is an interesting alternative as a 
large animal model, particularly to study stem cell-based regeneration and cancers403, 404. 
Indeed, close similarities to human physiology and anatomy make the dog an attractive 
model to study various organ systems. Moreover, dogs develop cancers that share 
numerous features with human malignancies405. All studies on cprom-1 rely on 
antibodies directed against its human and murine orthologs (Table 13). For instance, 
mAbs 13A4 and AC133, which were used to identify and clone murine prominin-1 
(mprom-1) and hprom-1, respectively296, 299, were utilized to characterize prominin-1–
expressing canine cells. 
These studies raise the question if there is any antibody generated against mprom-1 
or hprom-1 that recognizes the canine protein? This question is of interest because the 
amino acid identity between mammalian prominin-1 orthologs is modest and discordant 
immunoexpression patterns of anti-hprom-1 antibodies suggest that prominin-1 
immunohistochemistry data should be interpreted with caution316, 406, 407. Furthermore, 
cross-reactivity of an anti-hprom-1 antibody (i.e. AC141 mAb) with cytokeratin 18 was 
reported408.  
To investigate this issue, I cloned prominin-1 cDNA from a beagle dog and the 
MDCK cell line and ectopically expressed it in the latter as an engineered green 
fluorescent protein (GFP) fusion protein. With the help of this tool, the 
immunodetection of cprom-1 was monitored while testing commercially available and 
custom-made antibodies.  
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Table 13. Studies on canine tissues and/or cell lines using anti-prom-1 antibodies. 
* FC, flow cytometry; IC, immunocytochemistry; IHC, immunohistochemistry; and WB, western blot. 
§ As stated by the seller; 1, eBioscience; 2, Miltenyi Biotec; 3, R&D Systems; 4, Abcam; 5, BioLegend; and 6, 
Santa Cruz Biotechnology. 
¶ pa, polyclonal antibody; ma, monoclonal antibody. 
‡ m, mouse; h, human. 
** Data not shown. 
 
 
 
 
 
 
 
Study/year Ref. Canine tissues or cell lines investigated 
Appli-
cation* 
Antibody 
(name/clone§) 
Host/ 
clonality¶ 
Immuno- 
gen‡ 
Lamerato-Kozicki 
et al., 2006 
409 Hemangiosarcoma cell lines Blood samples 
FC 
IC** 13A4
1 Rat/ma m 
Wu et al., 2006 410 Bone marrow-derived endothelial progenitors 
IC 
FC 
hCD1332 
hCD1333 Mouse/ma h 
Valenzuela et al., 
2008 
411 Skin-derived neuroprecursor cells from biopsies IC unspecified4 Rabbit/pa h 
Xia et al., 2009 412 Circulating endothelial progenitors FC 
AC1332 
(CD133/1) Mouse/ma h 
Cocola et al., 
2009 
413 Primary mammary cells from spontaneous breast cancers WB K-186 Goat/pa h 
Stoica et al., 2009 414 Glioblastoma tissues Primary tumor cells 
FC 
IHC 
IC 
13A41 Rat/ma m 
Turner et al., 
2010 
415 
Remodeled small intestinal 
submucosa-extracellular 
matrix implants 
IHC unspecified4 Rabbit/pa h 
Cogliati et al., 
2010 
416 Hepatocellular carcinoma Cholangiocellular carcinoma IHC ab198984 Rabbit/pa h 
Ito et al., 2011 417 
Lymphoid progenitor cells 
from B-cell lymphoma 
biopsies 
FC 13A41 Rat/ma  m 
Blacking et al., 
2012 
418 Various cancer cell lines Primary osteosarcoma FC 13A41 Rat/ma m 
Walton et al., 
2013 
419 
Primary neural stem and 
progenitor cells  
Brain tissues 
IHC AC133
2 (CD133/1) 
293C32 (CD133/2) Mouse/ma h 
Moulay et al., 
2013 
420 
Prostate carcinoma cell lines 
Prostate cyst-derived cell 
lines 
FC 
13A41 
315-2C115 
Rat/ma 
 
Rat/ma 
m 
Fujimoto et al., 
2013 
421 Hepatocellular carcinoma cell lines FC 13A41 Rat/ma m 
Guth et al., 2014 422 
Tumor biopsies from 
melanoma and osteosarcoma 
Osteosarcoma cell lines 
Melanoma cell lines 
FC AC133
2 
(CD133/1) Mouse/ma h 
Gorden et al., 
2014 
423 Hemangiosarcoma cell lines FC AC133
2 
(CD133/1) Mouse/ma h 
Tanabe et al., 
2014 
424 Lung adenocarcinoma cell line WB 13A41 Rat/ma m 
Michishita et al., 
2014 
425 Hepatocellular carcinoma cell line FC 13A41 Rat/ma m 
Liu et al., 2015 426 Prostate adenocarcinoma cell line ct1258 FC 13A41 Rat/ma m 
Suzuki et al., 2015 427 Lingual granular cell tumors IHC ab198984 Rabbit/pa h 
Fernandez et al., 
2016 
428 Glial tumors Kidney tissues IHC ab198984 Rabbit/pa h 
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6.4.1. Identification of Endogenously Expressed Prom-1 in MDCK Cells  
First, nucleotide sequences of hprom-1 and mprom-1 (GenBank accession numbers 
AF027208 and F026269, respectively) were used to search the nucleotide and protein 
databases at the National Center for Biotechnology Information (NCBI). Basic Local 
Alignment Search Tool (BLAST)429 network services were applied. A predicted cprom-1 
sequence (transcript variant X1, #XM_845738.4) derived from whole genome shotgun 
sequence of chromosome 3 of canis lupus familiaris breed boxer (#NW_003726054.1) 
was obtained. Based on this information, I designed various oligonucleotide primers 
(Table 1, primer Nr. 11-18, B) to identify cprom-1 by polymerase chain reaction (PCR, 
Fig. 27A). A cDNA pool from total RNA of MDCK cells was prepared as a template. 
Additionally, cDNA pools originating from kidneys of adult beagles were used. The 
kidney was chosen as mRNA source because prom-1 has strong renal expression in 
rodents and humans296, 352.  
The use of different primer pair combinations on both templates resulted in 
fragments of expected lengths (Fig. 27A). No band was observed with primers 11 and 16 
using the cDNA pools of dog kidney (Fig. 27A, right panel, blue). This might be due to 
the location of primer 16 in exon 3, which is only present in splice variant 2 (referring to 
hprom-1). Thus, this splice variant might not be expressed in beagle dog kidney. More 
likely, its expression level might be low and therefore undetectable by the PCR settings 
that were used. Why no band was detected with primer pair 14 and 17 in beagle dog 
kidney (Fig. 27A, right panel, beige) needs further investigations. The double band from 
MDCK cell cDNA (Fig. 27A, left panel, beige) hints to different splice variants with 
consequences for this DNA section.  
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6.4.2. Molecular Cloning of Cprom-1  
PCR was used to obtain cprom-1 cDNA sequence from adult beagle dog kidney using 
primers 24 and 25 (Table 1, Fig. 27B; done by Clara Hayn). This fragment contained the 
whole sequence from start to stop codon and was cloned into a pCR™4-TOPO® TA 
vector. Following the nomenclature of prominin-1 splice variants304, 306 – and with regard 
to the absence of exon 3 – we named the new cprom-1 splice variant 22. 
Cprom-1 from a pool of MDCK cell cDNA was amplified by PCR with primer 19 
and 20 (Table 1), which resulted in a 1.9-kb fragment (Fig. 27B). However, this fragment 
did not contain 5’- and the 3’-ends. The missing extremities were amplified by 5’- and 3’-
rapid amplification of cDNA ends (RACE) revealing two alternative exons within the 5’-
UTR (named A and B, Fig. 27C). A third alternative 5’-UTR is predicted (Fig. 27C, C). 
This is in agreement with the existence of various 5’-UTR isoforms of hprom-1430, 431 that 
are tissue-specific in humans and can vary with certain diseases (e.g., gliomas, colon 
cancers; reviewed in Ref.432). Resulting PCR DNA fragments were gel extracted and 
subcloned into pCR™4-TOPO® TA vectors. The three overlapping cDNA fragments 
from RACE and initial PCR were combined using oligonucleotide primers carrying 
different specific restrictions sites for amplification (Table 1, Nr. 26-31). Briefly, 5’-RACE 
cDNA fragment was subcloned into the pEGFP-N1 vector opened with XhoI and BamHI 
enzymes. The 1.9-kb fragment was ligated to the 5’-end after digestion with SbfI and 
BamHI enzymes. 3’-RACE cDNA fragment was then inserted in the same way using 
introduced SacI and BamHI restriction sites. All restriction sites introduced for 
subcloning were removed with oligonucleotide primers Nr. 34-37 (Table 1). The 
obtained sequence is identical to splice variant 22 except for the presence of exon 3 and 
was named splice variant 23. Note that the open reading frame (ORF) of cprom-1.s23 is 
not in-frame with the GFP.  
All DNA fragments and final sequences were verified by sequencing to confirm the 
absence of any reading mistake introduced by DNA polymerases. The resulting 
sequences were deposited in GenBank database under the accession numbers 
KJ654317.1 and KR758755.1. 
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Fig. 27 Identification and cloning strategy of endogenous cprom-1. 
(A) Identification of endogenous cprom-1 expressed by MDCK cells (left panel) or dog kidney tissue (right 
panel). Amplified fragments obtained by PCR applying cprom-1-specific oligonucleotide primers (Nr.11 to 
18) in different combinations are displayed. Sizes are indicated in base pairs (bp) and colors correspond to 
triangles in the cartoon below. (B) Cartoon depicts cprom-1 as blue box (coding region) with single thick 
lines at the left and right representing 5’- and 3’- UTR, respectively. The A in parentheses indicates the 
presence of a poly-A tail. Dark blue zones highlight transmembrane domains 1-5. Cprom-1-specific 
primers 11 to 18 (colored triangles above) and 19 to 25 (black triangles below) are schematically 
presented. They were applied alone or in combination with linker-specific adaptor primers (blue and 
green triangles) for the amplification of the 5’ and 3’ cDNA ends. The lines between the primers illustrate 
the amplified cDNA fragments and their size is indicated in bases (b). Red lines mark overlapping regions 
between PCR products. Names of cDNA clones are indicated. Clone CP4-A4 contains facultative exon 3 
(purple). (C) Alternative exons in 5’-UTR of cprom-1. Three 5’-UTR exons (A, B and C) were 
alternatively spliced prior to exon 1 (green), which encodes the initial codon. Their sequences are 
displayed as well as the names of corresponding clones or predicted ones (X1 and X2) found in database 
(GenBank entries are indicated in parentheses).  
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6.4.3. Identification of Different Splice Variants of Cprom-1  
Following in silico analysis and cloning approaches, distinct splice variants of cprom-1 
have been identified. Predicted cprom-1 transcripts were also found in NCBI database 
(GenBank entries: XM_845738, XM_005618555 and XM_005618556). All sequences 
were compared with the corresponding prom1 gene sequence located on chromosome 
3 using the BLAST program revealing that all introns are conserved in position and 
phase with human and mouse prom1 genes (Fig. 28A and Table 14). All exon/intron 
boundaries in the canine ortholog conform to the GT-AG rule (Table 14).  
The ORF of cprom-1 showed an alternatively spliced exon 3 in the extracellular N-
terminal domain that encodes for a 9-amino acid stretch (PENVVLTLK). This is in 
accordance with alternatively spliced prom-1 variants s1 and s2 in human and mouse301, 
433 (Fig. 28A). I also found one cDNA clone lacking another exon, namely exon 22, in the 
third extracellular domain of cprom-1 (Fig. 28A and D). Two other exons (11a and 19), 
located in the second and third extracellular domains, respectively, are predicted to be 
facultative (Fig. 28A and Table 14). Interestingly, mini-exon 11a (residues ALP), which is 
located between exons 10 and 11 according to human (or mouse) gene structure, is also 
reported in amphibians and fish, but not yet in mammals305, 306. Strikingly, exon 27 in dog 
harbors a stop codon generating a truncated cytoplasmic C-terminus that has not been 
found in any other species until now (Fig. 28A and Fig. 29A). This exon contains the 
entire 3’-UTR and a polyadenylation consensus sequence (AAUAAA) 12 nucleotides 
upstream of a poly(A) tract (B, top panel). The analysis of prom1 gene further revealed 
the presence of a facultative exon 26a (SSVLGTWHFTL) between exons 24 and 27 (Fig. 
28B, bottom panel, red), which was found in mprom-1.s3 to s6 variant and is predicted 
for human and rat (Fig. 28C)434. The use of this exon creates a different cytoplasmic C-
terminal end. Exons 25, 26b and 28 reported in mouse and/or human prom1 genes have 
not yet been identified in dog (Fig. 28A and Table 14). 
 In sum, these data suggest complex gene regulation of cprom-1 as reported 
for its counterparts in humans and mice. The functional significance of alternatively 
spliced variants is unknown, but it indirectly points to various interactions with other 
proteins – particularly by its alternative cytoplasmic C-terminal domain. 
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Table 14. Exon-intron boundaries of canine prom1 gene. 
Exon-intron boundaries were determined by comparing cprom-1 cDNA sequences (GenBank Accession Nos. 
KJ654317, KR758755, XM_005618555, and XM_845738) with canine whole genome shotgun sequence 
(Accession No. NW_003726054.1). 5’-UTR A, B and C refer to alternative exons within 5’-unstranslated regions 
of cprom-1 cDNA clones as indicated in brackets, while exons numbered 1 to 27 refer to the open reading frame. 
The nucleotide (nt) position is annotated according to sequence XM_845738 except for 5’-UTR A and C, which 
refer to our isolated cDNA clones (100/5 and 10) and XM_00561855 sequences, respectively. 5’ and 3’ ends of 
each exon appear as uppercase characters with adjacent intron 3’ acceptor site and 5’ donor site as lowercase 
letters. 
*Facultative exons. 
§Mini-exon predicted in cprom-1 but not reported yet in other mammalian prominin-1336. 
Exons in brackets are absent in canine transcripts in comparison to hprom-1 and/or mprom-1 sequences while 
the exon in braces is predicted from the genomic sequence309. 
 
Exon No. 3’ splice site 5’ splice site 
nt in cDNA 
(XM_845738) 
5’-UTR A 
(clones 100/5 and 10) 
AAATT CACCAgtaag 1-159 
5’-UTR C 
(XM_005618555) 
GTGTG AGAATgtaag 1-144 
5’-UTR B 
(clone R4-B7 and 
XM_845738) 
TCAGA CCCAGgtgag 1-136 
1 accagGGATG CGAAGgtaag 137-615 
2 cccagATATT ATAAGgtaat 616-671 
3* cacagCCAGA TGAAGgtaaa 672-698 
4 tgcagATTAT ATAAGgcaag 699-904 
5 tgcagTGTGG CAGCGgtaaa 905-1025 
6 tttagCAAAT GGATAgtgag 1026-1089 
7 tttagATATT TGAAGgtaag 1090-1179 
8 tacagCAATC GTCAGgtgag 1180-1397 
9 ttcagCTCCC AAAAGgtatg 1398-1472 
10 tctagGGCTA ATCAGgtgag 1473-1536 
11a*§ tgcagCCTCC CCCTgtaag 1537-1545 
11 ttcagATGTC TACAGgtgag 1546-1705 
12 accagGTGGC ATGGTgtgag 1706-1859 
13 tccagCGGAG TCCAGgttaa 1860-1982 
14 tctagATTTT TACAGgtata 1983-2086 
15 cacagTGACT AGGAGgtaag 2087-2171 
16 tgcagCATGC CAGAGgtgtg 2172-2318 
17 tgtagATGGG ATCTGgtgag 2319-2390 
18 tgcagCCCCA CAATGgtaac 2391-2482 
19* ccaagAAATA CGAGGgtaag 2483-2501 
20 accagAGCAC TGAGGgtaag 2501-2555 
21 tccagGTGAA TCAAAgtaag 2556-2636 
22 tccagGAAAG TCTCAgtaag 2637-2705 
23 catagATTAC CTATGgtaag 2706-2798 
24 cctagAATTT GATGAgtaag 2799-2914 
[25] – – – 
{26a} tgcagTTCCT TAACTgtttt – 
[26b] – – – 
27 tacagTATGG TCTGA 2915-3351 
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Fig. 28 Splice variants of cprom-1. 
(A) Genomic organization of human (h) and mouse (m) PROM1 genes is shown and compared to the 
canine equivalent (top panel). Vertical lines indicate exon boundaries and dark blue zones highlight the 
position of transmembrane segments. Exon numbering begins with the one bearing the start codon. 
Facultative exons included in the coding sequences are depicted in different colors. Amino acid sequences 
of exons 3, 11a and 19 are indicated in parentheses. New cprom-1 splice variants (s22, s23) and two 
additional predicted ones (X1, X2) including their GenBank accession numbers are presented (bottom 
panel). The presence (+) or absence (−) of an exon and the consequential protein sequence length 
(number of amino acids) are indicated. T represents the stop codon within exon 27. (B) Identification of 
exon 26a. Exons 24 and 27 from cDNA clones are displayed in green and blue, respectively. Exon 26a 
from the genomic clone (Accession No. NW_003726054.1) is depicted in red (bottom panel). The 
corresponding deduced amino acid sequences are indicated above. Donor and acceptor splice sites 
(GT/AG) are indicated in boxes and the polyadenylation signal (AAUAAAA) is underlined. The poly-A tail 
is shown (top panel). (C) Alternative exon 26a is conserved among mammalian species. Amino acid 
sequences deduced from dog, rat and human genomes are shown in italics whereas the sequence 
translated from murine mRNA appears in regular font (red)434. Arrowhead, exon boundary. (D) Exon 22 
(brown) at the end of the second extracellular loop of cprom-1 (GenBank Accession No. KR758755) is 
skipped in one clone amplified by 3’-RACE resulting in the in-frame deletion of 23 residues as indicated.  
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6.4.4. Amino Acid Sequence of Mammalian Prom-1 is Poorly 
Conserved  
In mammals, two PROM genes have been described with a strikingly similar genomic 
structure that is remarkably conserved across species304, 309, 336. Despite this genomic 
feature, the amino acid sequence is poorly conserved among PROM1 gene products.  
To investigate the conservation of specific characteristics of the prominin-1 family a 
multiple sequence analysis of cprom-1 with its human and mouse orthologs was 
conducted. It revealed that common characteristics of this pentaspan membrane 
glycoprotein family are conserved (Fig. 29A)303. For instance, six cysteine residues in the 
first and second extracellular loop that are likely to form disulfide bridges are found in 
all species (Fig. 29A, letter C in red). The extra cysteine (residue 624) in hprom-1 is 
absent in the canine sequence like in mouse and rat. The cysteine-rich sequence at the 
transition of the first transmembrane domain and the first cytoplasmic loop is also 
present in cprom-1 (Fig. 29A, asterisks). Lysine 138 within the cysteine-rich domain, 
which is implicated in the interaction with HDAC6, is also conserved (Fig. 29A, yellow 
box)314. This holds true for tyrosine 829 (828 in hprom-1) that can be phosphorylated by 
Src and Fyn tyrosine kinases in hprom-1 (Fig. 29A green box, P)312. Cprom-1 harbors 
nine N-glycosylation sites in its extracellular domains (Fig. 29A, symbol #). Only two of 
them are conserved in position with human and mouse proteins. The cytoplasmic C-
terminal domain of cprom-1 is significantly different due to the presence of a stop codon 
in exon 27. 
Next, a pairwise sequence comparison was performed showing that cprom-1 
exhibits an overall amino acid identity of 66% and 57% with its human and mouse 
orthologs, respectively. The amino acid sequences of hprom-1 and mprom-1 were 
identical in 61%. The similarity of cprom-1 with human and mouse proteins reaches 74% 
and 66%, respectively. Although the two small cytoplasmic loops display a significant 
amino acid identity between mammalian prom-1 (79 to 95%), the three large 
extracellular domains are only moderately conserved (Fig. 29A). Precisely, only 60% of 
the residues exposed to the extracellular milieu are conserved between canine and 
human proteins, and this number decreases to 45-55% in the murine sequence.  
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Fig. 29 Comparison of cprom-1 with its human and mouse orthologs. 
(A) Cprom-1.s23 sequence determined in this study (GenBank Accession No. KR758755; top) was aligned 
with hprom-1.s2 (AF027208; middle) and mprom-1.s2 (NM_001163577; bottom). Black and grey 
backgrounds indicate identical and similar amino acid residues, respectively; dashed line, putative signal 
peptide; solid blue lines, predicted transmembrane segments; solid red line, exon 3; asterisk stretch, 
cysteine-rich region; red C, conserved cysteine residue in extracellular domains; #, potential N-
glycosylation site in cprom-1; yellow box, conserved lysine potentially involved in the interaction with 
HDAC6; green box, conserved Src/Fyn phosphorylation (P) site; arrowhead, exon boundaries. (B) The 
percentage of amino acid identity of each structural domain of cprom-1 (c) with its corresponding 
counterparts in human (h) and mouse (m) orthologs is presented. 
 
 
 
 
6.4.5. Cprom-1 is Targeted to the Apical Membrane of MDCK cells  
For further characterization, cprom-1.s23-GFP was ectopically expressed in MDCK 
cells. The splice variant 23 was used since it has the same extracellular domains as 
hprom-1.s2, which is recognized by commercial and homemade mAbs (see below). The 
cprom-1-GFP fusion protein allowed the monitoring of its expression in the absence of 
specific antibodies. It was previously demonstrated that the addition of GFP in-frame 
with the cytoplasmic C-terminal domain of hprom-1 or mprom-1 did not interfere with 
their membrane topology nor their proper intracellular trafficking and targeting to a 
specific subdomain of polarized cells (see also below)351, 353. 
To determine the distribution of cprom-1-GFP in polarized epithelial cells, MDCK 
cells were grown for 6 dpc and analyzed by CLSM. The fusion protein was present at 
the apical domain in a punctate staining pattern typical for microvilli (Fig. 30A-D, mv). 
Cprom-1-GFP was also found in primary cilia (Fig. 30A-D, pc). The single x-z (Fig. 30B) 
and x-y sections (Fig. 30C) indicate a fluorescent signal in cytoplasmic vesicles consistent 
with intracellular transport of cprom-1-GFP en route to the apical plasma membrane 
(asterisks). No significant GFP-fluorescence was observed at the basolateral domain (Fig. 
30B-D). The same distribution pattern was observed upon the overexpression of 
hprom-1-GFP fusion protein (Fig. 30A, C).  
Thus, cprom-1 is targeted to the apical plasma membrane of polarized epithelial 
cells and is concentrated in plasmalemmal protrusions found therein, as previously 
reported for hprom-1 and mprom-1211, 302, 315, 316.  
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Fig. 30 Cprom-1-GFP is found in microvilli and the primary cilium at the apical 
domain of polarized epithelial cells. 
(A-D) Stably transfected MDCK cells expressing either canine (c) or human (h) prom-1-GFP (Prom1-GFP, 
green) were immunolabeled for acetylated α-tubulin (ac Tub, red) and their nuclei were counterstained 
with DAPI (blue). (A) Overviews and (D) high-power view in are presented as 3D-reconstructions of 32 
or 20 optical x-y sections (0.6 or 0.3 μm slices), respectively. (B) A single x-z section is shown. (C) Three 
single x-y sections (1-3) located as illustrated in the cartoon above. They reveal the presence of prom-1-
GFP at the apical plasma membrane with fluorescent signals characteristic of microvilli (mv) and the 
primary cilium (pc, arrow) as well as in intracellular structures such as the endoplasmic reticulum (ER, 
asterisk). Tj, tight junction. Scale bars, 5 μm. 
 
 
 
 
  
 
 
6.4.6. Antibodies Do Not Recognize Cprom-1 by Immunocyto-
chemistry, Flow Cytometry or Immunoblotting  
To evaluate if any antibody directed against hprom-1 and mprom-1 can cross-react with 
the canine protein, three different approaches were applied – immunocytochemistry, 
flow cytometry and immunoblotting. Cells transfected with cprom-1-GFP were used as 
control. In addition, stably transfected MDCK cells expressing hprom-1.s2 and mprom-
1.s1 were established as positive controls. These splice variants were chosen because 
they are recognized by mAbs directed against human (i.e. clones AC133, AC141 and 
293C3) and mouse (clone 13A4) prom-1296, 299. The CD133/1 (recognized by AC133 
antibody) and CD133/2 (recognized by AC141 and 293C3 antibodies) epitopes are 
found in the second extracellular loop of hprom-1435, 436. In mprom-1, the same domain 
contains the 13A4 epitope317. The structural domains of both extracellular loops, in 
terms of exons, are conserved within cprom-1. Moreover, our laboratory has developed 
a mouse mAb and rabbit antiserum against hprom-1 named 80B258 and ahE2, 
respectively316, 352. They were generated using a fragment of the first extracellular loop of 
hprom-1 corresponding to amino acid residues 240-388 of splice variant 2 as antigen 
(Fig. 29A). This region exhibits 59% amino acid identity and 68% similarity between 
hprom-1 and cprom-1. Only 49% amino acid identity is observed with the mouse 
ortholog. 
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 First, cell surface immunostaining of untransfected MDCK cells with the above 
mentioned antibodies revealed that none of them detected cprom-1 (Fig. 31A). More 
strikingly, the overexpressed cprom-1-GFP was also not recognized by any tested mAb 
(Fig. 31A). In contrast, antibodies detected either hprom-1 or mprom-1. To rule out 
that cprom-1-GFP did not reach the cell surface but instead localized to vesicular 
structures underneath the plasma membrane, we repeated the staining with the 
commercially available antibodies upon cell permeabilization via a low concentration of 
saponin. Again, the anti-prom-1 antibodies failed to detect the endogenous and 
ectopically expressed cprom-1 (Fig. 31B). 
Next, to investigate if the addition of GFP at the cytoplasmic C-terminal domain of 
prom-1 influences the tertiary structure, particularly the second extracellular loop, 
thereby impeding epitope accessibility, immunocytochemistry was repeated using a 
hprom-1-GFP fusion protein where GFP was also added at the C-terminus. In contrast 
to cprom-1-GFP, the human fusion protein was detect with all tested mAbs (i.e. AC133, 
AC141 and 293C3; Fig. 31C). This indicated that the protein tag did not influence the 
accessibility of the corresponding epitopes.  
The lack of immunodetection of cprom-1 could result also from other molecular 
constrains, notably the incorporation of prom-1 in ganglioside GM1-enriched membrane 
microdomains when epithelial cells are grown as a polarized monolayer211, 352, 437, 438. 
Thus, MDCK cells were analyzed by flow cytometry with commercially available 
antibodies that were directly coupled to a fluorochrome. None of these antibodies 
cross-reacted with endogenous prom-1 or cprom-1-GFP, although the anti-hprom-1 and 
anti-mprom-1 antibodies highlighted their respective antigen (Fig. 32A). No positive cells 
were observed without primary antibody or with an irrelevant antibody, i.e. anti-human 
CD34 antibody (Fig. 32B, C).  
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Fig. 31 Antibodies fail to detect cprom-1 by immunocytochemistry. 
(A-C) MDCK cells stably transfected with hprom-1 or mprom-1, cprom-1-GFP or hprom-1-GFP as well 
as wild type cells (MDCK) were analyzed by immunocytochemistry using commercially available mAbs 
AC133, AC141, 293C3 and 13A4, homemade mAb antibody 80B258 and rabbit antiserum αhE2. Cells 
were either surface-labeled in the cold (A, C) or permeabilized with saponin after fixation (B) followed by 
the appropriate Alexa555-conjugated secondary antibody (red). (C) MDCK cells stably transfected with 
hprom-1-GFP showed a positive staining for mAbs AC133, AC141 and 293C3 demonstrating that the 
GFP tag did not impede immunodetection of prom-1-GFP fusion protein. Insets show enlargement of the 
apical plasma membrane where a double staining was observed. The punctate staining pattern is typical for 
microvilli (arrowheads). As negative control only the secondary antibody was used, and cells were 
counterstained with DAPI (A, B). Scale bars, 30 μm (A, B) and 15 μm (C). 
 
 
 
 
 
 
Finally, I investigated whether any of the available antibodies can detect cprom-1 by 
immunoblotting. Proteins in detergent lysates prepared from the established MDCK cell 
lines were separated by SDS-PAGE under reducing condition (i.e. in presence of β-
mercaptoethanol) and analyzed by blotting. As expected from the immunocytochemistry 
and flow cytometry, none of the antibodies directed against hprom-1 and mprom-1 
detected the endogenous prom-1 of MDCK cells or its overexpressed GFP fusion 
protein (Fig. 33A). The latter was observed using an anti-GFP antibody and showed the 
expected higher molecular weight. The two-band pattern of recombinant prom-1 is 
consistent with its overexpression as demonstrated earlier296, 315, 434. The immunoreactive 
band with an apparent molecular mass of ≈115-120 kDa (or ≈160-170 kDa in the case of 
GFP-fusion protein) represents proteins at the plasma membrane (Fig. 33A, arrow). The 
≈100-105 kDa (≈150 kDa for prom-1-GFP) forms are found in the endoplasmic 
reticulum and/or early Golgi compartment (Fig. 33A, arrowhead). The antibodies also 
failed to detect cprom-1 under non-reducing conditions (Fig. 33B). MAbs AC133 and 
293C3 detected a faint band at ≈190 kDa (Fig. 33B, asterisk) suggesting the formation of 
dimers or multimers. 
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Fig. 32 Antibodies fail to detect cprom-1 by flow cytometry. 
(A-C) MDCK cells stably transfected with hprom-1 or mprom-1, cprom-1-GFP as well as wild type cells 
(MDCK) were directly incubated with fluorochrome (PE or APC)-coupled mAbs as indicated. Cells 
expressing cprom-1-GFP were examined using the FITC channel. Vertical dashed lines indicate the cut-off 
for cells positive for a given prom-1. Color code indicates the corresponding cell line used, and the 
percentage of positive cells is specified in each panel. (B, C) Instrument setup and flow cytometry 
controls. Cells were incubated without (B) or with anti-human CD34 antibody conjugated either to PE or 
APC fluorochrome (C) and analyzed by flow cytometry using the appropriate channel. Unstained cells and 
those labeled with an irrelevant fluorochrome-conjugated antibody were used to set up the cut-off for 
positive cells. 
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To confirm that the protein tag did not influence the accessibility of the 
corresponding epitopes, as proven for immunocytochemistry, the immunoblotting of 
lysates from MDCK cells expressing hprom-1-GFP was also performed. Again, anti-
hprom-1 antibodies recognized human, but not canine, fusion protein under reducing as 
well as non-reducing conditions (Fig. 34C and E, respectively). The expression levels of 
human and canine GFP-fusion proteins were comparable (Fig. 33F). 
Because of the debate about the role of glycosylation in the recognition of certain 
hprom-1 epitopes, notably CD133/1439, N-glycans were removed by PNGase F 
treatment of detergent extracts from cells expressing cprom-1-GFP prior to 
immunoblotting under reducing conditions. The recombinant fusion protein seems to be 
glycosylated as observed by the shift of molecular mass from ≈150/170 to 115 kDa (Fig. 
33G, black arrowhead) after PNGase F treatment. This is consistent with the presence 
of nine N-glycosylation sites (Fig. 29A). However, the removal of sugar moieties did not 
unmask any detectable epitope. So again, none of the anti-hprom-1 or anti-mprom-1 
antibodies was able to recognize cprom-1 (Fig. 33G). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS   
 
131
 
RESULTS   
 
132 
Fig. 33 Antibodies fail to detect cprom-1 by immunoblotting. 
(A-E, G) Detergent lysates prepared from MDCK cells stably transfected with hprom-1 or mprom-1, 
hprom-1-GFP or cprom-1-GFP as well as wild type cells (MDCK) were analyzed by SDS-PAGE under 
reducing (A, C, D, G) and non-reducing (B, E) conditions. For immunoblotting, mAbs AC133, AC141, 
293C3, 13A4, 80B258 and rabbit antiserum αhE2 or polyclonal antibody against GFP was used. β-actin 
and α-tubulin were used as loading controls. As negative controls, only the secondary antibody (as 
indicated) was used (D). (A, B) Immunodetection of canine, human or mouse prominin-1 and cprom-1-
GFP. Arrow and open arrowhead indicate plasma membrane-associated form and endoplasmic reticulum-
associated form of prom-1, respectively. Asterisk indicates potential disulfide-bridged prom-1 dimers or 
multimers. (C, E) Immunodetection of hprom-1-GFP fusion protein proved that the GFP tag did not 
impede the detection of cprom-1-GFP. GFP and prom-1 immunoreactivities are indicated (green and black 
bracket, respectively). Filled circle, hprom-1 degradation fragments. (F) The expression levels of hprom-1-
GFP and cprom-1-GFP were quantified upon normalization to the α-tubulin expression. They were not 
significantly (n.s.) different as revealed by unpaired two-tailed student’s t-test, n = 3. (G) Lysates from 
cprom-1-GFP transfected cells were incubated with (+) or without (–) PNGase F prior to immunoblotting 
with anti-GFP antibody or others (as indicated). The black arrowhead shows deglycosylated prom-1. 
Molecular mass markers (kDa) are indicated. 
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7. DISCUSSION  
7.1. The Active Interplay of Prominin-1–Ganglioside 
Membrane Complexes, PI3K and Cytoskeleton 
Components Regulates the Architecture and Dynamics 
of Microvilli  
In this work, I made use of MDCK cells, an epithelial model cell line that was established 
in 1958 by S.H. Madin and N.B. Darby339. MDCK cells are able to build an ordered 
monolayer of uniformly polarized cells, and hence, they are extensively used as a model 
for studying various properties of epithelia such as cell trafficking293, 345, cell polarity346, 347 
and junction formation348, 349. One important feature of their polarization is the 
development of an organized apical plasma membrane with microvilli as predominant 
structures. Here, I described in detail the morphology and distribution of microvilli as 
well as their dynamics and the impact of the cholesterol-binding protein prominin-1 on 
these structures. In contrast to highly ordered brush border microvilli of the small 
intestine and the kidney proximal tubule165, considerable variations exist in the number, 
length and morphology of microvilli between adjacent MDCK cells in a confluent 
monolayer in vitro. Their length can be categorized as short (< 200 nm), intermediate 
(200-400 nm) or long (> 400 nm). Irrespective of their length, the diameter of microvilli 
was uniform ranging from 90-100 nm. Some cells harbored clusters of microvilli, a 
phenomenon that has also been reported for other cell types and seems to be induced 
by the phosphorylation of the ERM-binding phosphoprotein of 50-kDa/Na+/H+ 
exchanger regulatory factor (EBP50/NHERF1) by protein kinase C363-365, 367. Another 
apparent characteristic is the array of microvilli along the cell-cell border. Whether 
these microvilli differ from the ones distributed over the rest of the cell surface, as 
reported for human choriocarcinoma JEG-3 cells365, has to be investigated. Occasionally, 
I observed branched microvilli. 
The analysis of the temporal and spatial occurrence of microvilli on MDCK cells 
revealed that at early time points of polarization (1-3 dpc) numerous cells harbored 
membrane ruffles. They are described as highly dynamic structures183, 440 and could be 
linked to different stages of cytokinesis369, since cell division still occurs at early stages of 
DISCUSSION 
  
134 
cell culture441. Interestingly, half of the cell population displayed short microvilli at any 
time of culture (from 1 to 12 dpc) but those of intermediate length became more 
frequent at later stages (> 6 dpc). Like membrane ruffles, short microvilli are observed 
on mitotic cells442 and might be present on MDCK cells at early stages of polarization. 
Furthermore, as described for Xenopus kidney A6 cells183, short microvilli might be in a 
state of formation or retraction while microvilli of intermediate length could resemble 
steady states. Since microvilli are dynamic structures it is tempting to speculate that 
short microvilli might develop into those of intermediate length and vice versa.  
The cholesterol-binding protein prominin-1 is selectively enriched in protruding 
subdomains of the plasma membrane, where it colocalizes with the lipid raft marker 
GM1
211 (reviewed in Ref.443). This remarkable subcellular localization together with its 
lipid raft association319 and the fact that raft lipids are involved in the formation and/or 
stabilization of microvilli on MDCK cells363 prompted me to investigate the role of 
ganglioside GM1-prominin-1 complexes in the architecture and dynamics of cellular 
protrusions. Therefore, two point mutations (2M, Pro37→Ala and Tyr41→Ser) in the 
GM1-binding site of hprom-1.s1 and s2 were created. The mutants, as well as their 
corresponding wild types, were ectopically expressed in MDCK cells. All hprom-1 
proteins showed similar expression levels and were targeted to microvilli and the 
primary cilium confirming previous reports211, 296, 302, 315.  
Upon overexpression of hprom-1.s1 and s2, the number of individual microvilli, 
microvillar clusters and microvilli per cluster were increased compared to untransfected 
cells. Interestingly, the 2M mutants further enhanced the amount of single microvilli and 
also showed a tendency to significance in the number of microvilli per cluster. Although 
some transmembrane proteins may stimulate the formation of cell surface 
protrusions444-448, the ultrastructural analysis of microvilli on hprom-1-transfected cells 
revealed that many of them had an altered architecture, which rather might affect their 
turnover.  
The structural alterations prompted me to thoroughly examine the distinct 
phenotypes. Besides microvilli of varying length, about 25% of the hprom-1-transfected 
MDCK cells developed branched microvilli, a phenotype that was only rarely seen in 
untransfected cells. Except for surface enlargement, the functional relevance of 
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branching microvilli needs still to be determined. This special microvillar morphology 
has been reported for various mammalian pathological and non-pathological cell types 
such as epithelial cells of mesothelioma and adenocarcinoma449-452, the respiratory 
tract453-455 and the conjunctiva (especially in chronic graft-versus-host disease)456, 457, 
principal and clear cells in the epididymis458 as well as the placental 
syncytiotrophoblast459. They were also observed in diseases such as microscopic 
enteritis and celiac disease 460, 461. Interestingly, the treatment of intestinal epithelia of 
chick embryos with cytochalasin B generated similar effects, i.e. complex branching of 
microvilli, suggesting a certain defect in actin organization462. The branching of microvilli 
is not restricted to mammals but also commonly occurs in the small intestine of 
salamanders463. Moreover, some epithelial cells of invertebrates also harbor branched 
microvilli, e.g., the epidermis of the starlet sea anemone Nematostella vectensis, the free 
surface of optical tentacles of the snail Helix aspersa and the external body-wall of the 
slug Arion hortensis as well as the intestine of the free-living nematode Halicephalobus 
gingivalis.  
Branching actin filaments are poorly characterized in microvilli, but are intensively 
studied in lamellipodia at the leading edge of migrating cells and neuronal growth 
cones464, 465 as well as in neuronal actin patches, the precursor cytoskeletal structures of 
dendritic and axonal filopodia466-468. It might be more than a coincidence that prominin-1 
also localized to the leading edge of migrating fibroblasts and hematopoietic stem and 
progenitor cells296, 371. Therein, rearrangement of the actin cytoskeleton is initiated by 
increasing levels of PIP3, which activates WASP/WAVE through the small Rho GTPase 
Cdc42 that trigger the activation of Arp2/3 complex. The latter localizes to existing 
actin filaments and nucleates actin monomers that rapidly polymerize into new filaments 
branching from the side of the original filament at a 70° angle235, 469-471. Interestingly, the 
angle (64.7 ± 12.5°) formed by two branches of a given microvillus on hprom-1-
transfected cells closely resembles the one of branched actin networks. The massive 
reduction of branched microvilli and microvillar clusters on cells treated with the 
Arp2/3 complex inhibitor CK-666472 strongly suggests that an Arp2/3 complex-
dependent mechanism, together with prominin-1, may be involved in their formation. 
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In addition, cells transfected with 2M mutants showed a two-fold increase in the 
number of branched microvilli. In addition, about 20% of the cells developed microvilli of 
irregular shape and/or with a knob-like structure at the tip. This phenotype has never 
been observed in untransfected cells or those carrying an empty vector. The irregular 
morphology is highly reminiscent of microvilli depleted of cholesterol by methyl-β-
cyclodextrin treatment, which also showed multiple membrane constrictions324. Similar 
microvilli were observed in the duodenal brush border of chicks receiving a low residue 
diet473. Dilated knob-like microvilli have been reported for endothelial cells of 
hypertensive rats474, insulin-induced rat hepatocytes167 and cells in the intestine of 
nematodes475-477 and rats478. Epithelial cells of chicken sperm storage tubules develop 
both microvillar phenotypes479. Interestingly, Lange and colleagues demonstrated that 
the inhibition of PI3K activity prevents insulin-induced dilation of microvilli in rat 
hepatocytes378. When prominin-1 is phosphorylated on tyrosine residue 828 it can 
directly interact with the 85-kDa regulatory subunit (p85) of the PI3K resulting in the 
activation of PI3K/Akt pathway313. The activated PI3K uses PIP2 as a substrate to 
generate PIP3, which in turn activates multiple downstream signaling pathways. 
Moreover, PIP2 mediates the coupling of the plasma membrane to actin core filaments of 
microvilli by specific scaffold and linker proteins such as myosin I and ERM-proteins374, 375, 
480, 481. Thus, I hypothesize that the overexpression of hprom-1, and particularly the 2M 
mutants, causes an activation of the PI3K. As a result, the conversion of PIP2 into PIP3 at 
the inner face of the microvillar membrane would favor its detachment from the 
underlying cytoskeleton resulting in microvilli with irregular or knob-like shapes (Fig. 34, 
model 2M). The treatment of hprom-1-transfected cells with the PI3K inhibitor 
LY294002 caused a dramatic decrease in microvilli with an irregular/knob-like 
phenotype showing that the PI3K is indeed involved in the formation of these structural 
alterations. To further investigate this issue, an additional mutation (Y828F) in hprom-1 
2M mutants was generated that affects their phosphorylation, and hence their 
interaction with the 85-kDa regulatory subunit of PI3K. Supporting my hypothesis, these 
mutants harbored less irregular/knob-like microvilli compared to the 2M mutants and 
resembled the distribution of microvillar phenotypes of their corresponding wild type. 
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Fig. 34 Schematic representation of the impact of prominin-1 on the organization of 
microvilli. 
Plus and minus ends of the actin filaments within a microvillus are indicated. Green arrow and STOP 
symbol indicate the elongation or termination of actin filaments, respectively. Decoupling of the plasma 
membrane from the underlying actin filaments is indicated by red double-headed arrow.  
 
 
 
 
Irregular/knob-like microvilli are often described in association with the release of 
extracellular membrane vesicles473, 475, 478, 479. In line with this, the overexpression of 2M 
mutants, which led to the creation of irregular/knob like microvilli in addition to 
enhanced branching, significantly reduced the release of hprom-1+ vesicles. The results 
imply that the physical alterations provoked by the two point mutations in the GM1-
binding site of prominin-1 seem to create vesicle releasing-competent microvilli that are 
impaired in proper budding and fission. Consistent with this is the observation of small 
protruding vesicle-like structures at the tips of irregular/knob-like microvilli. Moreover, 
the treatment of 2M mutants with PI3K inhibitor as well as the additional Y828F mutation, 
which both reduced the number of microvilli with structural alterations, restored the 
release of hprom-1+ vesicles. 
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Of note, I often observed cells harboring irregular/knob-like microvilli that show 
branching at the same time indicating that the formation of both phenotypes is 
connected. Actually, the combined inhibition of the PI3K and the Arp2/3 complex 
almost completely abolished microvilli with structural alterations. A convergence of the 
PI3K pathway on the Arp2/3 complex has already been reported for the formation of 
lamellipodia in migrating cells482, 483 and axonal actin patches in chicken dorsal root 
ganglia467. Moreover, the PI3K has been identified as an upstream activator of the small 
GTP-binding protein Rac1484, 485, which stimulates actin polymerization via the Arp2/3 
complex486. Furthermore, Sossey-Alaoui et al. demonstrated a direct interaction of the 
Arp2/3 complex activator WAVE3 with the p85 subunit of the PI3K487. The regulatory 
impact of the PI3K on the Arp2/3 complex explains the reduction of branched microvilli 
when cells were treated with the PI3K inhibitor LY294002. How the Arp2/3 complex 
signaling pathway influences the formation of knob-like/irregular microvilli, as seen by a 
reduction of this phenotype when cells were treated with the Arp2/3 complex inhibitor 
CK-666, is not known and will be interesting to investigate. 
Interestingly, the phosphorylation of prominin-1 that regulates its interaction with 
PI3K seems to be essential for the elongation of microvilli suggesting that a dynamic 
equilibrium of PIP2 and PIP3 is important for the biogenesis of microvilli (Fig. 34, model 
Y819/828F). It remains to be determined whether the lack of Y819/828 phosphorylation 
of prominin-1 directly interferes with actin-bundling or -capping proteins such as 
epidermal growth factor receptor substrate 8 (Eps8) protein members during the 
assembly of individual microvilli or clusters of them173.  
Surprisingly, when MDCK cells were treated with DMSO as vehicle control all cell 
lines showed a marked increase in short microvilli except for s2 2M mutant. However, it 
did not stimulate the release of hprom-1+ vesicles. At low concentrations, DMSO 
induces membrane thinning and increases fluidity of the membrane’s hydrophobic 
core488. Consequently, changing important membrane parameters, such as thickness and 
fluidity, seems to influence the formation of microvilli. Furthermore, the lack of the 
DMSO-effect on s2 2M-expressing cells might hint to alterations in their membrane 
characteristics. They possibly form a more stable membrane that resists the impact of 
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DMSO. How prominin-1, if at all, influences membrane characteristics would be an 
interesting question for future research.  
 In general, the structural impact of prominin-1 on microvillar organization seems to 
be less severe in s1 and its 2M mutant than in the s2 variants. This could be caused by 
the 9 amino acids encoded by exon 3 in the N-terminal extracellular domain of splice 
variant 2. They might act as a spacer element with impact on the ganglioside-binding site 
of prominin-1. The interaction of prominin-1 with GM1 within cholesterol-dependent 
microdomains of the outer leaflet of the microvillar membrane may determine the 
phospholipid composition in the inner leaflet (e.g., PIP2/PIP3 ratio) by regulating 
prominin-1–driven PI3K activation (Fig. 34). Thus, by promoting membrane lipid-
clustering prominin-1 may mediate a direct crosstalk between the outer and inner leaflet 
of the plasma membrane. 
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7.2. Hprom-1 Influences the Length of the Primary 
Cilium via its Interaction with HDAC6 
Prominin-1 specifically associates with curved plasma membrane subdomains that 
protrude into the surrounding extracellular milieu211, 302, 316, 351. Thus, it also localizes to 
different types of cilia (e.g., primary and motile ones) 213,316, 337, 351, but its function there is 
still unknown. Moreover, mutations in the PROM1 gene are associated with various 
forms of retinal degeneration388, which can be mimicked in genetically modified mice 
carrying either a null allele or a mutated form of prominin-1168, 332. Both mouse models 
show a severe disorganization of photoreceptor outer segments, which are specialized 
sensory cilia. These morphological evidences indicate a conserved involvement of 
prominin-1 in the maintenance of ciliary structure and function. To investigate the role 
of lipid/protein–prominin-1 complexes in the primary cilium, I used MDCK cells 
transfected with hprom-1.s1, s2 or their corresponding 2M mutants. The latter carried 
two mutated amino acids (Pro37→Ala and Tyr41→Ser) in the GM1-binding site of hprom-
1. Of note, two gangliosides, namely GM1 and GM3, were detected in the ciliary 
membrane suggesting a more complex membrane organization compared to microvillar 
membranes where GM3 is excluded
211. All hprom-1 proteins showed similar expression 
levels, were targeted to the primary cilium and colocalized with GM1 confirming 
previous reports211, 351. Interestingly, hprom-1 immunoreactivity was often 
asymmetrically distributed within the primary cilium revealing its enrichment in ciliary 
subcompartments (top, bottom and one side). This phenomenon might be related to the 
coexistence of distinct membrane micro- or nanodomains in the ciliary membrane211. 
The concentration of prominin-1 at the tip of primary cilia has been reported before and 
seems to correlate with membrane budding processes351, 489. This might also be true for 
its clustering on one side of the cilium. The localization of hprom-1 at the ciliary base 
might reflect its retention at the transition zone, where the entry of proteins is 
regulated.  
The data further showed preferential targeting of hprom-1.s1 to the primary cilium 
compared to splice variant 2. Astonishingly, the ciliary accumulation was significantly 
reduced in s1 2M mutants resembling the one of s2 wild type. The introduction of 2M 
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mutations in splice variant 2 did not change its ciliary accumulation. Thus, mutating the 
GM1-binding site of splice variant 1 seems to have a similar effect on the ciliary 
localization of hprom-1 as the additional 9 amino acids encoded by exon 3 in splice 
variant 2. This suggests that interfering with the ganglioside-binding motif or diverging it 
from the plasma membrane, and hence from its interaction partners, might cause a 
weakening of the binding of hprom-1 to GM1. The mutation of key residues in the GM1-
binding motif that is already displaced from the plasma membrane, as in s2 2M, did not 
show further impact on the ciliary targeting of hprom-1. In cells expressing s1 2M, s2 or 
its 2M mutant, the fragile interplay of hprom-1 and the lipid raft-associated ganglioside 
GM1 might lead to its partial exit from these specific membrane microdomains. The 
ciliary membrane is highly enriched in sterols, sphingolipids and glycolipids90 and its 
special lipid composition might serve to recruit or retain membrane proteins108. Hence, 
the dissociation of hprom-1 from its lipid rafts might impede its targeting to or entry 
into in the primary cilium. The fact that splice variant 1 showed the lowest overall 
accumulation at the ciliary base, where proteins enter the cilium, seems to corroborate 
this theory. 
At 6 dpc, the overexpression of hprom-1.s1 and s2 led to a significant increase in 
ciliary length, which was more pronounced in splice variant 2. The 2M mutations in s1 
led to an increase in intermediate and long cilia approximating their ciliary length to the 
one of splice variant 2. Thus, weakening of the binding of hprom-1 to GM1, by the 2M 
mutations in s1 or exon 3 in s2, might further interfere with the formation of primary 
cilia of appropriate length. In contrast, cells transfected with s2 2M showed significantly 
reduced ciliary length compared to its wild type. This could be explained by changes in 
membrane characteristics as seen for DMSO-treated microvilli of s2 2M-transfected 
cells. Since ciliary elongation is a result of axoneme expansion accompanied by an 
increase in the amount of membrane, a stabilized membrane in s2 2M-expressing cells 
might obstruct changes in ciliary length. At 14 dpc, the average ciliary length of both 
splice variants and their mutants was comparable and they all showed similar patterns of 
length distribution. All of them still developed a significant increase in ciliary length 
compared to untransfected cells. These data suggest that hprom-1 plays an important 
role in ciliary length control during polarization. 
DISCUSSION 
  
142 
 Interestingly, it has been reported that PIP2-triggered actin polymerization occurs 
in primary cilia, which results in the excision of ciliary tips and vesicle release facilitating 
ciliary resorption490. Since hprom-1-containing microdomains are involved in the release 
of membrane vesicles and the overexpression of hprom-1, and even more the mutation 
of its GM1-binding site, cause tremendous alterations of the actin cytoskeleton it seems 
likely that the mechanism of vesicle release is affected in all hprom-1-expressing cell 
lines thereby creating longer cilia.  
In vivo, the knockdown of prominin-3 in the zebrafish (Danio rerio) reduced the 
number of primary cilia in the Kupffer’s vesicle and the existing ones were significantly 
shortened, which led to left-right asymmetry defects in the development of the embryos 
(J.Jászai, unpublished data). The Kupffer’s vesicle is a transient embryonic structure 
composed of monociliated cells, which drive a directional fluid flow that is crucial for the 
breaking of early bilateral symmetry491. As a functional homologue of the ventral node it 
plays a pivotal role in the left-right axis determination492. Yuan et al. demonstrated the 
importance of appropriate cilia length for the proper function of the Kupffer’s vesicle; 
cilia that are too long or too short result in decreased motility and disruption of fluid 
flow493. Therefore, an intimate relationship between ciliary structure and function seems 
to exist in the Kupffer’s vesicle, whereby small changes in cilia size result in profound 
functional and developmental disturbances. Diverse studies provide evidence for the 
‘appropriate length-proper function’ concept of cilia as a universal principle applying for 
all primary and motile cilia of distinct cells and organs494-501.  
But how do cells regulate ciliary length? The competing processes of axonemal 
assembly and disassembly at the tip of the cilium and the size, rate and proper 
composition of IFT transport are important aspects502, 503. Besides, anterograde and 
retrograde motors such as members of the kinesin-2 and dynein-2 families are 
implicated in ciliary length control. Kinesin-8 and -13 family proteins possess 
microtubule-depolymerizing abilities and thereby contribute to ciliary disassembly497, 504, 
505. In addition, several direct modifiers of microtubule stability or microtubule binding 
proteins can control ciliary length. For example, an increase in cytosolic soluble tubulin 
leads to rapid elongation of primary cilia392. Tubulin acetylation is known to stabilize 
microtubule and is regulated by the tubulin deacetylase HDAC6506. Furthermore, 
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ubiquitination and methylation programs are activated in resorbing cilia507, 508 whereas 
binding of doublecortin domain proteins facilitate axoneme polymerization509, 510. Some 
basal body and transition zone proteins have also been shown to be essential regulators 
of ciliary length121, 511. Moreover, several protein kinases and a diverse set of 
developmentally regulated pathways as well as G-protein coupled receptor signaling and 
the regulation of second messengers are implicated in ciliary length control512. Thus, 
there are multiple controls for ciliary length regulation and the implemented studies 
draw a very complex image of the involved mechanisms. However, to effectively alter 
ciliary length, the ciliary membrane must also be extended or shortened in proportion 
to underlying changes of the axoneme. It was recently reported that Arl13b, a member 
of the Arf-like Ras superfamily of small GTPases, plays a key role in extending the ciliary 
membrane and thereby signaling the extension of the axoneme513. 
Hprom-1 can interact via its first intracellular loop with the second catalytic domain 
of the tubulin deacetylase HDAC6314. In the context of ciliary length control this 
interaction is very interesting because HDAC6 can deacetylate α-tubulin at lysine 40, 
which is necessary and sufficient for the destabilization and resorption of primary cilia390. 
To elucidate the molecular mechanism by which hprom-1 might directly influence the 
ciliary length I mutated lysine 138 (in reference to splice variant 2) in its HDAC6-binding 
site into glutamine (K138Q). This mutation neutralizes electric charge and mimics lysine 
acetylation. The single amino acid mutation K138Q led to the formation of fewer and 
shorter cilia, increased ciliary HDAC6 levels, and reduced α-tubulin acetylation. The 
remaining long cilia harbored membrane constrictions along their distal part resembling 
small membrane vesicle. In addition, K138Q mutant cells release more hprom-1+ 
membrane vesicles into the culture medium and showed an increase in dome formation. 
These findings suggest that by mimicking the acetylation of hprom-1 lysine 138 HDAC6 
might be more attracted to hprom-1 leading to its enhanced targeting to the primary 
cilium. At the same time, the proper binding between HDAC6 and hpom-1 is impaired 
by the mutation. As a result, the level of ‘free’ HDAC6 increases leading to enhanced 
tubulin deacetylation, subsequent axoneme destabilization as well as budding and fission 
of vesicles from ciliary tips eventually reducing their length. Therefore, it is likely that 
the interaction of hprom-1 with the HDAC6 is also altered in cells overexpressing 
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hprom-1 wild type and 2M mutants. Since these hprom-1 proteins are capable of binding 
HDAC6 they could capture HDAC6 in the primary cilium thereby inhibiting its activity 
towards acetylated tubulin leading to stabilization and elongation of the axoneme.  
Interestingly, preliminary data reveal the interaction of prominin-1 and Arl13b, its 
reduction in K138Q mutants as well as decreased levels of Arl13b in cilia of K138Q 
mutants compared to s2 wild type. The latter finding is in accordance with the 
shortening of cilia upon the loss of Arl13b513.  
In summary, hprom-1 and its interactions with HDAC6 as well as Arl13b might 
regulate ciliary length. However, the impact of hprom-1 on the formation and/or 
maintenance of primary cilia by its membrane microdomain- and actin-associated 
functions need further investigations. 
The reduction of ciliary length upon the expression of hprom-1 Y819/828F mutants 
suggests that prominin-1 phosphorylation is also a key element in the regulation of 
ciliary structure and dynamics.  
Fascinatingly, I observed branched primary cilia to varying degrees in hprom-1-
transfected MDCK cells (Fig. 35). In future studies, it would be very interesting to 
investigate if these branches are actin-based and caused by the same mechanisms as seen 
in branching microvilli or if these cilia represent extremely rarely branching of 
microtubules. So far branched microtubules have only been reported for cell-free 
extracts from Xenopus laevis oocytes514. 
 
 
 
Fig. 35 Branched 
primary cilia at the 
apical membrane of 
hprom-1-transfected 
MDCK cells. 
MDCK cells expressing 
hprom-1.s2 were grown 
on fibronectin-coated 
coverslips until 6 dpc and 
analyzed by SEM. Scale 
bar, 500 nm.  
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7.3. Canine Prominin-1 Shows No Cross-species 
Immunoreactivity 
MDCK cells are widely used as in vitro model for polarized epithelial cells. Dog tissues as 
well as cells derived therefrom are frequently studied since the dog appears to be a 
proper animal model for new cancer drugs and other applications. Using those sources 
for studies comes with the disadvantage of not having commercially available antibodies 
for them. In this study, the cross-reactivity of commercially available and homemade 
antibodies generated against hprom-1 or mprom-1 with the canine protein was tested. 
Various anti-hprom-1 antibodies including mouse mAbs AC133, AC141 and 293C3 have 
been evaluated. AC133 recognizes the CD133/1 epitope in hprom-1 while the other 
two antibodies mark the CD133/2 epitope. Kemper and colleagues have proposed that 
both epitopes are located in the second extracellular loop of prominin-1435. Zhao and 
coworkers report that mAb 293C3 can compete with a new antibody (CD133-scFv-1) 
indicating its binding to the first extracellular loop of prominin-1436. The two homemade 
antibodies (mouse mAb 80B258 and antiserum αhE2) were generated against a segment 
of the first extracellular loop of hprom-1316, 352. The commercial rat mAb 13A4 
recognizes an epitope in the second half of the second extracellular loop of mprom-1317. 
It is important to know that already the application of anti-hprom-1 antibodies on 
human samples need to be considered with caution because discrepancies in 
immunohistochemical expression patterns of hprom-1 have been observed407. 
Technically, the inconsistencies can be explained by a cross-reactivity of certain anti-
hprom-1 antibodies with other proteins408 or by differences in the methods, e.g., tissue-
fixation, antigen retrieval processes and antibody concentration316, 407, 515, 516. Biologically, 
the expression of different splice variants of prominin-1 carrying (or not) a given epitope 
or potential cleavage products may determine its immunodetection304, 517. 
Prominin-1 is often examined in canine models. In the absence of specific anti-
cprom-1 antibodies, investigators are using those against human and mouse proteins. 
Given the limited amino acid conservation between cprom-1 and various mammalian 
orthologs, the cross-species reactivity of antibodies directed against hprom-1 or 
mprom-1 with the canine protein is questionable. This is particularly true when they are 
DISCUSSION 
  
146 
directed against the large extracellular loops or the cytoplasmic C-terminal end. To 
evaluate this, I cloned cprom-1 cDNAs from two independent kidney mRNA sources, 
MDCK cells and adult beagle kidney, and determined its genomic organization. 
The genomic structure of the canine prom1 gene is similar to that of human and 
mouse317, 336. This allowed the prediction of facultative and/or alternative exons as those 
identified in other species304, 434. Besides three alternative 5’-UTRs, various cprom-1 
splice variants harboring facultative exons (i.e. exons 3, 11a, 19, 22) in the extracellular 
domains have been cloned and identified. Thus, like other members of the prominin-1 
family cprom-1 is subjected to alternative splicing. This is of importance because 
different splice variants can carry specific epitopes, whose absence can impede the 
immunodetection of prominin-1. In mouse and human, the expression of distinct 
isoforms is developmentally regulated and tissue-specific318, 434, 518. This might also be true 
for its expression in dogs. 
Analysis of the canine prom1 gene also revealed an alternative exon (exon 26a) in 
the cytoplasmic C-terminal domain. Murine glial cells expressing this exon showed that 
it hampers the detection of prominin-1 via antibodies directed against the cytoplasmic 
C-terminal end318. Furthermore, the C-terminal domain differs significantly between 
canine and human/mouse/rat prominin-1 in exon 27, which harbors a stop codon in 
cprom-1 that generates a truncated C-terminus. As a result, it lacks homology with the 
last 15 amino acids of prominin-1 in other species. Antibodies generated against this part 
of hprom-1 or mprom-1 whether commercial (e.g., rabbit antiserum ab66141 (Abcam) 
and #PAB12663 (Abnova)) or homemade (αI3;315) will fail to detect the canine ortholog. 
To evaluate the above-mentioned antibodies endogenous cprom-1 expressed by 
MDCK cells or recombinant cprom-1, overexpressed as GFP fusion protein in the same 
cell line, were used as antigens. I confirmed that the GFP-tag did not interfere with the 
intracellular transport of cprom-1 or its targeting to the apical plasma membrane as 
previously demonstrated for hprom-1-GFP and mprom-1-GFP211, 296, 302, 315, 351, 434. 
Moreover, the addition of a GFP tag did not interfere with the immunodetection of 
prominin-1 as shown for the human protein. In this study, splice variant 23 of cprom-1 
was used because it contains the same extracellular domains (i.e. corresponding exons) 
as hprom-1 and mprom-1. These domains are important for the recognition by anti-
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human and anti-mouse antibodies. Furthermore, hprom-1 and mprom-1 were 
overexpressed in MDCK cells and used as positive controls. The same cell line was used 
as host to rule out any negative effect of the glycosylation status on antibody 
recognition. This issue was largely debated particularly with mAb AC133302, 352, 435, 439. 
None of the antibodies mentioned above recognized native or recombinant cprom-1 
using antibody-based techniques such as immunocytochemistry, flow cytometry and 
immunoblotting under reducing and non-reducing conditions. Likewise, anti-hprom-1 
antibodies did not detect mprom-1 and vice versa. These results are in line with the low 
levels of amino acid conservation between the extracellular domains of prominin-1 
orthologs. Hence, caution in data interpretation is necessary when using anti-hprom-1 
or anti-mprom-1 antibodies on tissues or cells with canine origin. The lack of 
interspecies reactivity might occur in other antibodies as well. Thus, a well-conceived 
use of antibodies and a diverse set of experiments proving antibody reactivity are 
recommended. As a result of this study and the growing interest of prominin-1 as a 
biomarker of stem and cancer stem cells and dogs as experimental models, specific 
mAbs against cprom-1 need to be generated. 
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8. FUTURE PERSPECTIVES  
Prominin-1 is a lipid raft–associated, cholesterol-binding membrane glycoprotein 
selectively associated with plasma membrane protrusions and extracellular vesicles 
derived therefrom. Despite its worldwide use for stem cell isolation and its clinical 
importance in cancer-initiating cells and photoreceptor morphogenesis the function of 
prominin-1 was largely unknown. In this study, I deciphered its role in the architecture 
and dynamics of microvilli and primary cilia on polarized epithelial cells. Specific point 
mutations in prominin-1 were created to examine the role of molecular interaction 
partners that participate in these processes. In addition, I determined the sequence of 
cprom-1, which will serve as basis for future knockdown studies. For example, using 
stable shRNA cprom-1 knockdown in MDCK cells will further help to investigate the 
consequences of the lack of prominin-1 on epithelial protrusion. It would also be 
interesting to overexpress hprom-1 in such a prominin-1-deficient MDCK cell line for 
comparison with the existing data. Thereby effects provoked by potential interactions of 
interspecies prominin-1s could be determined. 
The binding of prominin-1 to membrane lipids is important for its localization as 
well as for the phospholipid composition in the inner leaflet (e.g., PIP2/PIP3 ratio) of 
membrane protrusions. Thus, the significance of the second ganglioside-binding site in 
prominin-1310 deserves further studies. 
Apart from its role in microvilli, it is key to investigate the role of prominin-1 in 
other actin-based protrusion such as filopodia or lamellipodia to ascertain if the 
observed molecular mechanisms are microvilli-specific or a common principle. 
Since prominin-1 plays an important role in ciliary length control its role in 
ciliopathies might be underestimated and needs further clarification. Examples of ciliary 
defects associated with prominin-1 are the degeneration of photoreceptor outer 
segments in Prom-1 null mice and human patients332 519 and the ependymal ciliary 
dysfunctions associated with delocalization of prominin-1 from the tip of cilia in the 
mouse model of type 2 diabetes520. It would be interesting to examine whether any of 
the observed interactions important for the formation/maintenance of epithelial 
protrusions are involved in photoreceptors morphogenesis or the function of 
ependymal cilia.  
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Prominin-1 is expressed in a wide range of somatic stem and progenitor cells321. It 
also marks cancer stem cells of solid tumors and hematopoietic malignancies, and is 
often associated with chemoresistant subpopulations321. Both stem and cancer stem cells 
are viewed as potential targets for either regenerative therapy or cancer treatment521, 522. 
Primary cilia appear to regulate stem cells in multiple aspects, such as lineage 
specification and stemness maintenance523, and ciliary dysfunction has long been 
proposed as a prerequisite step of cancer development159. It would be of great clinical 
importance to investigate the role of prominin-1 in the primary cilium of these cells and 
further examine its influence on stem and cancer stem cell characteristics. 
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